Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cytokine receptor activity (GO:0004896),0.6278981669954494,1.904082609132132,0.0,0.12129592878504555,0.111,24/83,10.93%,CD74;CCR2;CD44;IFNLR1;FLT3;IL27RA;IFNGR1;IL18RAP;XCR1;CCR1;IL10RA;ACKR2;CCR9;IL6R;IL2RG;IL17RA;CCRL2;CSF2RB;IFNAR1;IL6ST;IL1R2;IL1RAPL2;IL31RA;IL17RB
prerank,C-C chemokine binding (GO:0019957),0.7579129327200047,1.8600688712578646,0.0,0.13822094210388913,0.221,6/22,6.59%,CCR2;XCR1;CCR1;ACKR2;CCR9;CCRL2
prerank,C-C chemokine receptor activity (GO:0016493),0.76158976522783,1.8440891252109175,0.0015313935681470138,0.12474361668332849,0.286,6/21,6.59%,CCR2;XCR1;CCR1;ACKR2;CCR9;CCRL2
prerank,microtubule minus-end binding (GO:0051011),-0.7270081152253762,-1.800141957029549,0.0026455026455026454,0.7230320699708455,0.433,9/13,20.55%,CAMSAP1;NUMA1;TUBGCP5;CAMSAP2;MACF1;TUBGCP6;HAUS4;CEP290;TUBGCP2
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.6626636509980791,1.7948957087898085,0.0014265335235378032,0.22637205313953268,0.556,10/35,7.23%,FGR;HCK;LYN;FYN;SYK;SLA;ZAP70;STYK1;PTK2B;DYRK1A
prerank,chemokine receptor activity (GO:0004950),0.717472259479398,1.7873444883739231,0.01037037037037037,0.20234793701195192,0.589,7/24,6.59%,CCR2;XCR1;CCR1;ACKR2;CCR9;GPR35;CCRL2
prerank,transmitter-gated ion channel activity (GO:0022824),-0.5664288404064304,-1.7858698089024048,0.003246753246753247,0.4365263823380924,0.483,14/29,18.53%,GRIA4;GRIA2;GABRG3;GABRG2;GRIK4;GRID2;GABRB1;GRIK1;GLRA3;GLRA2;GABRA4;GABRB3;GABRA2;GABRA5
prerank,chemokine binding (GO:0019956),0.6976805673738038,1.7682846497038256,0.0014388489208633094,0.2148536412975419,0.681,7/30,6.59%,CCR2;ITGA4;XCR1;CCR1;ACKR2;CCR9;CCRL2
prerank,MAP kinase kinase kinase activity (GO:0004709),0.831171278541544,1.7670535207729765,0.0034129692832764505,0.18832435454776725,0.688,7/11,14.60%,MAP3K15;MAP3K5;MAP3K1;MAP3K4;MAP3K7;MAP3K20;MAP3K13
prerank,MHC protein binding (GO:0042287),0.7223959224410594,1.7540789316010652,0.006472491909385114,0.19604807094327129,0.737,4/20,6.24%,CD74;LILRB1;PILRA;TAP1
prerank,thioesterase binding (GO:0031996),0.8306966593135268,1.7538551230738946,0.003389830508474576,0.1743694273404315,0.738,6/11,8.24%,TRAF1;CDC42;TRAF4;ADRA2A;TRAF3;RAC1
prerank,MHC class II protein complex binding (GO:0023026),0.8073230277333691,1.7260802078064554,0.010309278350515464,0.22726531773136052,0.858,1/11,0.02%,CD74
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.7635456909311176,1.7232531294373539,0.009787928221859706,0.2124174651380114,0.87,6/15,6.59%,CCR2;XCR1;CCR1;ACKR2;CCR9;CCRL2
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.775954277221258,1.7169841729123858,0.0016556291390728477,0.21007389216583144,0.881,7/14,13.52%,KMO;CYBB;NOX1;CYB5R4;NCF2;AIFM1;NCF1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.7104180183689246,1.6942765879630588,0.013029315960912053,0.2538028706659063,0.929,7/18,13.36%,PDLIM5;STXBP6;ANXA2;PDLIM1;ANXA1;S100A11;TMOD3
prerank,nucleotidyltransferase activity (GO:0016779),0.6888185021304013,1.6892886254661177,0.014218009478672985,0.24977827195547306,0.94,9/19,14.89%,DNTT;PAPSS1;TUT1;PAPSS2;TENT2;MTPAP;TUT7;PNPT1;TENT4B
prerank,N-methyltransferase activity (GO:0008170),-0.6080932060869564,-1.6880527623389312,0.0028169014084507044,0.8222938830089648,0.838,7/20,9.06%,METTL15;TRMT1;ZCCHC4;SETD3;HNMT;TRMT1L;DIMT1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.6675838117934169,-1.681923719661584,0.012468827930174564,0.6578915051645798,0.862,7/13,18.53%,GABRG3;GABRG2;GLRA3;GLRA2;GABRA4;GABRA2;GABRA5
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.788139256917854,1.6815998408749833,0.013422818791946308,0.2539378850171677,0.962,2/11,3.32%,KCNE3;KCNQ1
prerank,endodeoxyribonuclease activity (GO:0004520),0.7013563736652604,1.6762468505755796,0.01393188854489164,0.25440410644886735,0.966,11/20,20.00%,DNA2;RBBP8;MRE11;FEN1;MBD4;RPS3;EXOG;ERCC4;ENDOV;SETMAR;APEX1
prerank,protein serine/threonine kinase activity (GO:0004674),0.49110056435388977,1.6625548855679093,0.0,0.2795392722661287,0.98,103/334,14.99%,GRK3;LRRK2;GRK5;STK10;MAP4K1;MAP3K15;SGK3;ALPK1;PRKCE;SIK1;STK24;CDK13;VRK1;DAPK1;SLK;CAMK1D;CASK;MAP3K5;LMTK2;AKT3;MAP3K8;MAPKAPK3;SYK;PIM1;PAK1;PKN1;STK17B;STKLD1;MAP3K14;ERN1;PRKCH;RPS6KA3;BMPR2;CSNK1G1;MAPKAPK2;STK38;EIF2AK2;SBK3;BCR;IKBKB;VRK2;TAOK3;SIK3;HIPK2;IRAK4;MAPK14;RPS6KA5;CDK14;HIPK1;MAP3K1;STK4;PRKAB2;PTK2B;PDPK1;MKNK2;PKN2;PAK2;DYRK1A;MAPK12;SIK2;RIOK1;ACVR2A;MINK1;STK38L;CSNK1G3;LATS1;PIKFYVE;BRAF;OXSR1;NEK8;CSNK2A2;CSNK2A1;MAP3K4;TLK2;GRK6;RIPK1;DMPK;NLK;LATS2;MAP4K3;PRKAA1;RPS6KA1;PIK3R4;MAP3K7;SMG1;CDK12;MAP3K20;MAPK8;EIF2AK3;AKT1;PDK3;LIMK2;MARK3;STK39;ROCK1;PRKAA2;TLK1;RPS6KA2;MOK;MAP3K13;AURKB;BRSK1;MAPK1
prerank,growth factor receptor binding (GO:0070851),0.5389896330566519,1.660689959611676,0.0011641443538998836,0.26970322149749787,0.982,21/95,9.51%,IL1B;FGF22;IL27RA;FYN;FGF5;PLSCR1;JAK2;KL;ERN1;CCDC88A;IL6R;VEGFC;SNX1;GLMN;ARF4;GRB2;ADAM17;IL6ST;IL6;HIP1;PGF
prerank,glutamate receptor activity (GO:0008066),-0.5849491099946157,-1.6531182406256961,0.024390243902439025,0.6774618739851636,0.922,7/19,10.38%,GRIA4;GRIA2;GRIA1;GRIK4;GRID2;GRIK1;GRM5
prerank,FAD binding (GO:0071949),0.668564507980712,1.6525837006506556,0.016272189349112426,0.2758975124343651,0.988,8/24,11.13%,KMO;AGPS;CRY1;CRY2;NQO2;MTRR;AIFM1;CYB5R1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.5817970155971521,-1.6503151366299027,0.014204545454545454,0.5773352800001214,0.926,8/19,18.53%,GABRG3;GABRG2;GRIK4;GRID2;GRIK1;GABRA4;GABRA2;GABRA5
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.6293051215765446,-1.6470533695313427,0.015873015873015872,0.5059774236033998,0.931,10/15,26.39%,HS3ST5;HS3ST4;HS6ST3;NDST1;HS3ST3B1;HS6ST1;HS6ST2;HS3ST2;HS3ST1;HS3ST3A1
prerank,flavin adenine dinucleotide binding (GO:0050660),0.576938025655836,1.643870211120842,0.009055627425614488,0.2862677947178846,0.995,14/53,11.79%,KMO;CYBB;GSR;AGPS;CRY1;ACOX3;CRY2;NQO2;LDHD;DLD;MTRR;AIFM1;CYB5R1;FOXRED2
prerank,sialyltransferase activity (GO:0008373),0.6864657792920382,1.6423169612212896,0.014586709886547812,0.2768448607153697,0.995,5/20,3.57%,ST3GAL1;ST8SIA4;ST3GAL4;ST8SIA1;ST8SIA6
prerank,lysophospholipase activity (GO:0004622),-0.5826167910873963,-1.6396729609453047,0.025714285714285714,0.47318557465330685,0.945,8/20,13.20%,ABHD12;PNPLA7;MGLL;GDE1;ENPP2;PLA2G4A;ABHD4;LYPLAL1
prerank,MAP kinase kinase activity (GO:0004708),0.7138188796498373,1.6219108491285965,0.016051364365971106,0.3246525282069084,0.999,8/15,18.90%,LRRK2;MAPKAPK3;MAPK14;MAP2K5;MAP2K3;MAP3K9;MAP2K4;MAP2K1
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.6155698508776828,-1.61720231430428,0.019444444444444445,0.4598754679050136,0.966,9/16,12.44%,ATP6V1C1;ATP6V0B;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;ATP6V1D;ATP6V0D1;ATP6V0A1
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.6155698508776828,-1.61720231430428,0.019444444444444445,0.4598754679050136,0.966,9/16,12.44%,ATP6V1C1;ATP6V0B;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;ATP6V1D;ATP6V0D1;ATP6V0A1
prerank,dipeptidyl-peptidase activity (GO:0008239),0.7757928488515068,1.6123423830002537,0.03074141048824593,0.3403399417376151,1.0,3/10,5.84%,DPP4;PRCP;FAP
prerank,fibroblast growth factor receptor binding (GO:0005104),0.666824727915412,1.6108052645180102,0.01740506329113924,0.3304687207047349,1.0,4/21,3.54%,FGF22;FGF5;KL;NPTN
prerank,mitogen-activated protein kinase binding (GO:0051019),0.6116337637522771,1.604607397312616,0.02702702702702703,0.33567943082373064,1.0,10/29,14.22%,ACE;DUSP16;MAPKAPK3;MAPKAPK2;MAPK14;DUSP6;DIRAS1;DUSP1;PPM1D;PTPRJ
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.43316900384334345,-1.6013912283227718,0.009950248756218905,0.47159615512635344,0.974,12/60,6.60%,MERTK;CSF1R;ERBB4;NRP1;FLT1;NTRK2;EPHA6;NTRK3;NRP2;EPHA5;FGFR2;RYK
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.6230469559608018,1.6006886204520439,0.02023121387283237,0.33437750672228117,1.0,15/28,19.01%,LRRK2;MAPKAPK3;MAPK14;RPS6KA1;MAP2K5;MAP2K3;AKT1;PRKAA2;RPS6KA2;AURKB;RPS6KB1;MAP3K9;MAP2K4;MAP2K1;PRKCG
prerank,calcium channel inhibitor activity (GO:0019855),0.7533019580667235,1.5968546007096607,0.02533783783783784,0.3331023711825899,1.0,4/11,11.63%,ITPR1;MCUB;SLC30A1;FKBP1B
prerank,hexosaminidase activity (GO:0015929),-0.6588464395308926,-1.5955586556453756,0.03526448362720403,0.45466798263767283,0.983,5/12,20.16%,HEXB;HEXD;HEXA;CEMIP;HYAL1
prerank,nuclease activity (GO:0004518),0.5593665419329157,1.5935168193708433,0.017766497461928935,0.33017208521998,1.0,15/52,13.69%,DNA2;SAMHD1;STK31;PLSCR1;SND1;MRE11;FEN1;XRN2;WRN;RNASE1;RNASE6;DFFB;EXOG;RNASEH2A;RNASEH1
prerank,protein phosphorylated amino acid binding (GO:0045309),0.5825403164728702,1.5907330385867036,0.01907356948228883,0.32711965397282133,1.0,11/42,7.11%,FGR;HCK;PLCG2;STAP1;SYK;CRK;PTPN6;FBXW7;ZAP70;GRB2;SAMSN1
prerank,histone acetyltransferase activity (GO:0004402),0.6054428084430382,1.5900101097532462,0.035161744022503515,0.3185663618013444,1.0,14/30,15.52%,BAZ1A;NCOA3;TAF9;KAT7;ATF2;TADA3;CLOCK;KAT6A;EPC2;TADA2A;SRCAP;KAT2B;CREBBP;TAF1
prerank,WW domain binding (GO:0050699),0.6282342644143046,1.5898388175423839,0.03288490284005979,0.308623674765651,1.0,8/26,15.41%,NFE2;RAPGEF2;TRAF4;TCEAL3;TCEAL6;PMEPA1;ENAH;WBP11
prerank,phosphotyrosine residue binding (GO:0001784),0.5905921575523705,1.5817670064022549,0.02857142857142857,0.3204292886145643,1.0,10/37,7.11%,FGR;HCK;PLCG2;STAP1;SYK;CRK;PTPN6;ZAP70;GRB2;SAMSN1
prerank,ligand-gated cation channel activity (GO:0099094),-0.4162038228534854,-1.5811246088890638,0.005747126436781609,0.4695847309111023,0.988,17/75,13.28%,GRIA4;KCNJ2;GRIA2;GRIA1;P2RX7;P2RX4;GRIK4;GRIK1;KCNN2;MCOLN1;CHRNA7;KCNK6;KCNJ6;SHROOM2;KCNN3;TRPM2;KCNJ9
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.5827074321875969,1.5761113411473762,0.034236804564907276,0.3263906188002576,1.0,8/34,8.46%,MYO1G;IQGAP2;IQGAP1;DAPP1;RACGAP1;ARAP1;GBF1;CYTH3
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.5389181893610158,1.5676196603808337,0.0199501246882793,0.34079565217011315,1.0,20/60,17.63%,LRRK2;CDC14A;LRRC2;PPP3CA;PTEN;MTMR3;SSU72;PPTC7;PHLPP1;CTDSPL2;PDP2;DUSP1;PGAM5;PPP1CB;PPM1D;TIMM50;ILKAP;PPM1G;LRRK1;TAB1
prerank,heme binding (GO:0020037),0.5365163337429248,1.563543957362022,0.015286624203821656,0.3430673334629084,1.0,12/65,8.78%,CYBB;JAK2;RSAD1;PTGIS;EIF2AK1;CYB5B;DGCR8;CYP27A1;CYB5R4;PTGES2;PXDN;BACH1
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.42495965511637346,-1.5550280972595631,0.015384615384615385,0.5255558493893275,0.996,12/60,6.60%,MERTK;CSF1R;TGFBR2;ERBB4;FLT1;NTRK2;EPHA6;NTRK3;EPHA5;FGFR2;ACVR1;RYK
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.6434936598942448,-1.5542764278855832,0.032036613272311214,0.49480509832638203,0.996,4/11,15.31%,SLC25A20;SLC22A5;SLC22A4;SLC25A47
prerank,cell-cell adhesion mediator activity (GO:0098632),0.5634768371647202,1.5499731925677314,0.026243093922651933,0.3737345919434144,1.0,11/42,13.36%,CD47;PDLIM5;EMB;STXBP6;ANXA2;PDLIM1;NPTN;IGSF9;ANXA1;S100A11;TMOD3
prerank,retinoic acid binding (GO:0001972),0.712851472536367,1.5484514504942015,0.034071550255536626,0.3689703729373719,1.0,1/12,0.51%,RARA
prerank,deoxyribonuclease activity (GO:0004536),0.7091790218046696,1.5466919290582803,0.04132231404958678,0.36475383235829384,1.0,7/14,20.00%,MRE11;MBD4;RPS3;DFFB;ERCC4;DNASE1L1;APEX1
prerank,anion transmembrane transporter activity (GO:0008509),-0.6169712976032533,-1.5306577195341455,0.04656862745098039,0.5510158598763776,0.999,5/12,22.36%,SLCO2B1;ABCG2;SLC26A11;ABCC5;SLC4A2
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.5766692067364628,-1.5294470931857898,0.04709141274238227,0.5228496569120182,0.999,5/15,11.21%,P2RY12;GPR34;P2RX7;P2RX4;P2RY13
prerank,protein phosphatase 1 binding (GO:0008157),0.6331036252325157,1.527726265434603,0.05238828967642527,0.41063650547940683,1.0,6/21,8.86%,LILRB1;KCNQ1;AKAP11;PPP1R9B;SHOC2;PPP1R15A
prerank,pyrophosphatase activity (GO:0016462),-0.42388858046921646,-1.5266584516176611,0.016,0.5031395813655675,1.0,28/50,35.33%,ENTPD1;ENPP1;DHX29;PLPP1;PRUNE2;ENTPD5;TRPM2;DHX9;NUDT6;ITPA;DDX3X;ATCAY;PPA2;NUDT3;PLPP4;NUDT16L1;NUDT16;FITM2;PLPP5;ENTPD7;NUDT1;DOLPP1;ENPP3;ENTPD3;ENTPD6;NUDT14;NUDT4;NUDT11
prerank,lipoprotein particle receptor binding (GO:0070325),-0.5056806513985673,-1.523958240909486,0.04024767801857585,0.4852667821612358,1.0,10/27,16.85%,APOE;SYT1;LRP1;AP2A1;HSP90B1;CLU;AP2M1;SNX17;APBB1;APBB3
prerank,carbohydrate:cation symporter activity (GO:0005402),0.7171073442197264,1.52221416273398,0.03559322033898305,0.4183299125307501,1.0,2/11,2.23%,SLC23A2;SLC23A1
prerank,CCR chemokine receptor binding (GO:0048020),0.596798047569508,1.515288979692694,0.049132947976878616,0.4298219507070001,1.0,3/28,10.19%,CCR2;CCRL2;CNIH4
prerank,nuclear export signal receptor activity (GO:0005049),0.7111362604118439,1.5094416993312152,0.06132879045996593,0.4383265023407911,1.0,5/11,12.68%,XPO1;XPO5;XPO6;XPO4;EIF4ENIF1
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.7185669647556232,1.5078534130669463,0.054770318021201414,0.4330091908782174,1.0,5/10,11.10%,PRKAG2;PKIB;CXCL10;PRKAR2A;PRKAG1
prerank,tumor necrosis factor receptor binding (GO:0005164),0.6975814848804334,1.5027775767600535,0.0670926517571885,0.43917417767115413,1.0,4/12,7.50%,TRAF1;TRAF4;STAT1;TRAF3
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.6464294216209218,-1.4968535499447162,0.06557377049180328,0.554343386563451,1.0,5/10,18.53%,GABRG3;GABRG2;GABRA4;GABRA2;GABRA5
prerank,chemorepellent activity (GO:0045499),0.5961782552511918,1.4952267356979876,0.055873925501432664,0.45242023256740843,1.0,2/25,2.18%,DPP4;SEMA4A
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.7174492019451303,1.4937041942037743,0.07093425605536333,0.4476134561063241,1.0,5/10,17.85%,CYBB;NOX1;NCF2;NCF1;CYBA
prerank,exopeptidase activity (GO:0008238),0.5292363461507695,1.4936583659958655,0.029649595687331536,0.43822980703223197,1.0,7/50,5.84%,DPP4;ACE2;ACE;LNPEP;DPEP1;PRCP;FAP
prerank,metal ion transmembrane transporter activity (GO:0046873),0.5987209608380296,1.4931539002110465,0.060240963855421686,0.4304124914833689,1.0,8/27,10.31%,ITPR1;SLC23A1;ATP2B1;ATP2A3;MMGT1;SLC4A8;ZDHHC13;MAGT1
prerank,SH3 domain binding (GO:0017124),0.5205701242633403,1.4921186098969332,0.03125,0.42446858799639414,1.0,22/62,15.18%,WIPF1;PTPN22;PLSCR1;WASF2;CRK;GPX1;REPS1;CBLB;ABI1;CBL;CD2AP;PTPN12;GRB2;AFAP1L2;SYNJ1;CABYR;VASP;AFAP1;NCF1;ENAH;ADAM9;ELMO1
prerank,filamin binding (GO:0031005),-0.6229212867585174,-1.4871038112560842,0.06378132118451026,0.5638264347733426,1.0,5/11,18.76%,NEBL;FBLIM1;DPYSL3;CRMP1;SYNPO2
prerank,MAP kinase phosphatase activity (GO:0033549),0.6728028076028998,1.4860225068907538,0.08207705192629816,0.43482239773144543,1.0,3/12,11.47%,DUSP16;DUSP6;DUSP1
prerank,BMP binding (GO:0036122),0.7029748612818756,1.4838746526202653,0.06890756302521009,0.4329706021565602,1.0,2/11,8.16%,BMPR2;ENG
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.6653468855266784,1.474117388233652,0.07868852459016394,0.4530695873044277,1.0,2/14,3.32%,KCNE3;KCNQ1
prerank,amyloid-beta binding (GO:0001540),0.49086616131742283,1.4712553011940896,0.018404907975460124,0.4526997535187958,1.0,15/79,6.87%,CD74;LILRB1;LILRB3;NGFR;LDLR;APBA1;CD36;CACNA1A;SORL1;APBA3;PICALM;ITGB2;HSPG2;PRNP;GSAP
prerank,CXCR chemokine receptor binding (GO:0045236),0.6966242408872387,1.4664616178860086,0.06756756756756757,0.45896039203506034,1.0,2/11,3.63%,ITCH;CXCL10
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.669167780562229,1.4638169708707816,0.08652246256239601,0.4583088455066245,1.0,7/12,15.47%,TENT5A;TUT1;TENT2;PAPOLG;MTPAP;TENT4B;PAPOLA
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.6988127574994472,1.4628539287729152,0.09380530973451327,0.4450981572797632,1.0,3/10,11.47%,DUSP16;DUSP6;DUSP1
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.6988127574994472,1.4628539287729152,0.09380530973451327,0.4450981572797632,1.0,3/10,11.47%,DUSP16;DUSP6;DUSP1
prerank,small GTPase binding (GO:0031267),0.4495804951287189,1.4611212629751678,0.012008733624454149,0.44191469162677843,1.0,53/169,16.01%,LRRK2;IQGAP2;IQGAP1;CYRIB;SRGAP2;RIN3;EPS8;NGFR;PAK1;PKN1;MYO1C;RCC2;SORL1;USP6NL;OCRL;UNC13D;PICALM;XPO5;FGD4;AFDN;ARHGDIB;MYO5B;RABGAP1L;RAB34;FLNA;CIB1;PAK2;MYCBP2;RABGAP1;GCC2;NOX1;RHOBTB3;FGD1;FGD3;BRAF;KIF3B;AP1G1;DVL3;SH3BP4;DNM1L;PEX5L;ANKFY1;STRN3;SGSM1;EVI5;MAPKAP1;TRIOBP;RAB29;EHD1;KCTD13;RNF41;EXOC2;HACE1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.6848544822272321,1.460154535084794,0.08419243986254296,0.4373410692049954,1.0,4/11,17.51%,PADI1;ARG2;DDAH1;PADI2
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.6440011443988011,1.4588249614582924,0.06666666666666667,0.43370346629536627,1.0,6/16,8.70%,MTMR14;INPP5F;PTEN;MTMR3;MTMR4;SYNJ1
prerank,transcription cis-regulatory region binding (GO:0000976),0.4266392177058682,1.454749523939921,0.002028397565922921,0.438031059637138,1.0,66/406,12.52%,CIITA;TRPS1;NFE2;ZBTB46;FOXP1;RARA;SP3;RUNX3;GLI1;KLF4;PPARG;ETV6;LONP1;NFKB1;FOSL2;STAT3;FOXJ1;FOS;ZBTB20;TAF9;SPI1;SCX;TBL1XR1;ATF6;ATF2;IRF2;RFX3;DEAF1;BBX;XRN2;RFX5;TIPARP;CDC5L;KLF10;SETX;AHR;CREBRF;ARID4A;CREM;NFE2L2;PURB;THRA;CRY2;ZFP3;ZBED4;E2F2;GABPB1;GABPB2;CTCF;NFYC;RBAK;E4F1;SNAPC3;SMAD4;RPS3;BNC2;NR3C1;PBX1;FOXO3;IKZF5;TAF7;REST;ATF6B;NFYA;TFAM;TEAD1
prerank,ligand-gated ion channel activity (GO:0015276),-0.460075339298384,-1.4434931165093927,0.05572755417956656,0.7099065409740692,1.0,7/30,6.82%,GRIA4;GRIA2;GRIA1;GRIK4;GRID2;GABRB1;GRIK1
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.4793633566165376,1.4408847137198022,0.03734939759036145,0.4708672164188665,1.0,6/73,2.73%,CRHR2;CYSLTR2;FPR1;LTB4R;FPR3;RXFP2
prerank,ligand-gated channel activity (GO:0022834),-0.4600796045722589,-1.4364139749666707,0.06153846153846154,0.7074856298853297,1.0,7/29,6.82%,GRIA4;GRIA2;GRIA1;GRIK4;GRID2;GABRB1;GRIK1
prerank,delayed rectifier potassium channel activity (GO:0005251),0.5449244595797491,1.4336327122105037,0.059154929577464786,0.4844523874041827,1.0,5/32,5.71%,KCNE3;KCNG4;KCNA6;KCNQ1;KCNH1
prerank,inward rectifier potassium channel activity (GO:0005242),-0.4880043986938183,-1.43153431284085,0.07317073170731707,0.6985456094628625,1.0,15/24,40.64%,KCNJ2;KCNN2;KCNK6;KCNJ6;KCNN3;KCNJ9;KCNK1;ABCC9;KCNJ3;KCNJ13;ABCC8;KCNH2;KCNJ12;KCNJ16;KCNN1
prerank,cytokine receptor binding (GO:0005126),0.47380553041744033,1.4267714416399107,0.0387409200968523,0.4983476143881716,1.0,19/83,16.25%,IL1B;IL27RA;SYK;JAK2;IL6R;VEGFC;CCRL2;ADAM17;PXDN;IL6ST;IL6;USP15;PGF;LIFR;TYK2;TIMM50;IL18;SPRED1;CD300LF
prerank,voltage-gated ion channel activity (GO:0005244),-0.5682614731798245,-1.4254309700165086,0.08483290488431877,0.694561977231276,1.0,6/14,16.13%,KCND2;PKD2;HCN1;VDAC1;GPR89B;GPR89A
prerank,GTPase binding (GO:0051020),0.43284455045482156,1.4245390849234356,0.016059957173447537,0.49724821181361417,1.0,55/194,16.01%,LRRK2;IQGAP2;IQGAP1;CYRIB;SRGAP2;LCP1;RIN3;EPS8;NGFR;PAK1;PKN1;MYO1C;RCC2;SORL1;USP6NL;OCRL;UNC13D;PICALM;XPO5;FGD4;AFDN;ARHGDIB;MYO5B;RABGAP1L;RAB34;FLNA;CIB1;PAK2;MYCBP2;RABGAP1;GCC2;NOX1;RHOBTB3;FGD1;GNB1;FGD3;BRAF;KIF3B;AP1G1;DVL3;SH3BP4;DNM1L;PEX5L;ANKFY1;STRN3;SGSM1;EVI5;MAPKAP1;TRIOBP;RAB29;EHD1;KCTD13;RNF41;EXOC2;HACE1
prerank,calcium channel regulator activity (GO:0005246),0.537053793876302,1.4233663150859455,0.07142857142857142,0.4931903291849549,1.0,5/37,8.43%,ITPR1;SGK3;MCUB;STIM2;SLC30A1
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.6232722004348474,1.4214832045044101,0.09105431309904154,0.4912604404860024,1.0,3/16,4.95%,HGD;ETHE1;HAAO
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.5771164844532776,-1.420516783595248,0.09647058823529411,0.6882817586755948,1.0,6/12,19.33%,IGF1;IRS1;PIK3R1;SOCS2;GNAS;YWHAH
prerank,tropomyosin binding (GO:0005523),-0.5256172176561793,-1.4196543342351815,0.08607594936708861,0.6659231059880555,1.0,5/16,18.69%,NEBL;CALD1;PYCARD;TMOD1;TMOD2
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.6122660781610464,-1.419395285702974,0.09176470588235294,0.643106973758334,1.0,5/10,16.22%,ECHS1;ECHDC1;HADHB;HADHA;ECI1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.5690541814545887,1.4191716930828788,0.08211143695014662,0.49125404262953865,1.0,7/25,9.47%,ZC3HAV1;PARP8;PARP4;TIPARP;PARP14;TNKS;PARP9
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.5024703696200842,-1.4188746835497181,0.0830945558739255,0.6227589688688584,1.0,9/22,16.85%,APOE;SYT1;AP2A1;HSP90B1;CLU;AP2M1;SNX17;APBB1;APBB3
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.5654129616953757,1.417203097884757,0.07963246554364471,0.4898442260540667,1.0,4/25,10.50%,KMO;CYP27A1;MSMO1;MTRR
prerank,phosphoric ester hydrolase activity (GO:0042578),0.5063806732149664,1.416541267848882,0.06754966887417219,0.4846732782305662,1.0,13/49,15.15%,PTPN22;SAMHD1;DUSP16;PTPRO;ARMT1;SMPDL3B;SMPDL3A;PXYLP1;DUSP12;PGAM5;PPP1CB;PTPRJ;DUSP28
prerank,CARD domain binding (GO:0050700),0.6377304367447895,1.416534379751274,0.10264900662251655,0.4778601373895401,1.0,3/14,13.54%,CARD11;CARD16;CARD19
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.6839945314551699,1.4146695025677605,0.08925619834710743,0.47660367366604617,1.0,2/11,3.73%,ITPR1;RASA3
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.5758472191584996,-1.4123915779328255,0.10208816705336426,0.6250862279389134,1.0,9/12,38.41%,ENTPD1;ENTPD5;SLC25A42;ENTPD7;ENTPD3;ENTPD6;CANT1;NUDT18;ENTPD2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.5261595075724004,-1.4100149932219144,0.07799442896935933,0.5934911740492943,1.0,3/16,5.84%,TTYH3;ANO10;TTYH2
prerank,intracellular chloride channel activity (GO:0061778),-0.5261595075724004,-1.4100149932219144,0.07799442896935933,0.5934911740492943,1.0,3/16,5.84%,TTYH3;ANO10;TTYH2
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.5226997566015882,-1.405871217764833,0.1012987012987013,0.5904778995294453,1.0,5/17,6.82%,GRIA4;GRIA2;GRIA1;GRIK4;GRIK1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.552522638895877,1.4014682405075614,0.09343065693430656,0.5079951295904652,1.0,14/28,23.64%,TRAF1;TRAF4;STAT1;TRAF3;SIVA1;PIDD1;RIPK1;MYD88;TRAF2;FEM1B;BID;TNF;MADD;CASP8AP2
prerank,semaphorin receptor activity (GO:0017154),-0.5886775720362117,-1.4007781390543104,0.08958837772397095,0.5904618143223413,1.0,5/11,6.69%,PLXNA4;NRP1;NRP2;PLXNB2;PLXNA2
prerank,ligand-gated calcium channel activity (GO:0099604),0.6033771700288599,1.4005232319317293,0.09341500765696784,0.5041290566254643,1.0,2/19,3.73%,ITPR1;RASA3
prerank,lipase activity (GO:0016298),0.5172464703099109,1.3981427689629278,0.0871313672922252,0.5042776375732182,1.0,2/43,0.54%,PLBD1;PLA1A
prerank,GTPase activator activity (GO:0005096),0.4158409569289131,1.3975038274246785,0.008238928939237899,0.4995477067068323,1.0,61/313,9.74%,ARHGAP15;LRRK2;VAV3;RIN2;RAP1GAP2;DOCK5;IQGAP2;IQGAP1;TIAM1;ARHGEF18;SRGAP2;RASGRP4;TBC1D1;RIN3;RAP1A;DOCK2;DENND3;TBC1D8;RACGAP1;SIPA1L3;DOCK10;TBC1D9;CCDC88C;ARHGAP18;RASGRP2;ARHGEF10L;ARHGAP30;DENND1A;RAPGEF2;RGS2;ARHGAP26;RGS3;USP6NL;TBC1D10C;CCDC88A;DOCK11;TBC1D2B;OCRL;BCR;RP2;TAGAP;DLC1;ARAP1;FGD4;TBC1D8B;DENND1B;RABGAP1L;CCZ1;NUCB2;MYCBP2;RABGAP1;PLCB1;FGD1;CYTH3;FGD3;SOS1;CYTH2;DEPDC5;TBC1D5;ARHGEF6;ARFGEF1
prerank,sodium channel activity (GO:0005272),-0.41915660670828137,-1.3955781685818036,0.04797047970479705,0.5909622940519452,1.0,9/37,12.06%,SCN1A;PKD2;SCN3A;GRIK4;GRIK1;HCN1;HCN2;SHROOM2;SCN1B
prerank,carbohydrate kinase activity (GO:0019200),-0.5813563269214839,-1.3927630775593118,0.10858585858585859,0.5837584718160349,1.0,4/11,3.48%,FGGY;HK3;NAGK;HK1
prerank,calcium activated cation channel activity (GO:0005227),-0.5219477557472699,-1.3893283083044687,0.09840425531914894,0.5795353396359477,1.0,5/17,8.25%,KCNMA1;ANO10;KCNN2;TMEM63B;KCNMB2
prerank,actinin binding (GO:0042805),0.5627495638661132,1.3860625523465586,0.09216589861751152,0.5265315471009356,1.0,4/21,2.13%,RARA;PDLIM5;PPARG;NFKB1
prerank,DNA replication origin binding (GO:0003688),0.5478201520720962,1.3835672601887112,0.10149253731343283,0.5262063791886328,1.0,9/23,17.58%,CDC45;KAT7;ORC5;MCM6;ORC4;MCM2;MCM9;HSPD1;ORC2
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.5403869789722786,1.3829483196720942,0.09682299546142209,0.5214856072797552,1.0,8/25,14.24%,MYO1G;DAPP1;SESTD1;PLEKHA2;HIP1;AKT1;NCF1;MAPKAP1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.4321339320851333,1.3810102170777365,0.0407040704070407,0.5205146804432681,1.0,30/147,9.74%,VAV3;RIN2;DOCK5;TIAM1;ARHGEF18;RASGRP4;RIN3;RAP1A;DOCK2;DENND3;DOCK10;CCDC88C;RASGRP2;DENND1A;RAPGEF2;CCDC88A;DOCK11;BCR;FGD4;DENND1B;CCZ1;NUCB2;MYCBP2;FGD1;CYTH3;FGD3;SOS1;CYTH2;ARHGEF6;ARFGEF1
prerank,serine-type endopeptidase activity (GO:0004252),0.4570296214234588,1.379441509838093,0.06150061500615006,0.5187899658658695,1.0,12/80,13.38%,DPP4;PRSS53;HP;HPR;PARL;FAP;C1RL;HGF;RHBDL2;MBTPS1;CORIN;PCSK5
prerank,retinoid binding (GO:0005501),0.5597849705930659,1.3788950017391624,0.09891808346213292,0.5141144797766607,1.0,1/22,0.51%,RARA
prerank,monocarboxylic acid binding (GO:0033293),0.5793873338011029,1.3771532868065228,0.11367127496159754,0.5129389243979912,1.0,2/18,7.58%,RARA;PSAP
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.633410858547325,1.3758167405301316,0.13367174280879865,0.5101794524027335,1.0,6/13,13.14%,PIP4K2A;PIK3C2A;PIKFYVE;PIP4K2B;PIK3CA;PIP5K1A
prerank,adenylyltransferase activity (GO:0070566),0.5702870500428278,1.3753903407342696,0.13015873015873017,0.5054162964213357,1.0,9/21,15.47%,OAS2;OASL;TUT1;TENT2;PAPOLG;MTPAP;NMNAT3;TENT4B;PAPOLA
prerank,ligand-gated anion channel activity (GO:0099095),-0.5122081093978065,-1.3745456192261447,0.1239193083573487,0.6132919614774464,1.0,9/17,18.53%,GABRG3;GABRG2;GABRB1;GLRA3;GLRA2;GABRA4;GABRB3;GABRA2;GABRA5
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.6189618142874036,1.3742337274119898,0.10963455149501661,0.5024257991219756,1.0,5/14,8.70%,MTMR14;PTEN;MTMR3;MTMR4;SYNJ1
prerank,cGMP binding (GO:0030553),0.6579492707733539,1.372976052031447,0.14385964912280702,0.5000336310406235,1.0,2/11,7.50%,RAPGEF2;PDE2A
prerank,alpha-actinin binding (GO:0051393),0.5405886103918325,1.3728501019417505,0.10030864197530864,0.49481088496359,1.0,4/24,2.28%,RARA;PDLIM5;PPARG;PDLIM1
prerank,ribosomal large subunit binding (GO:0043023),-0.5900159508689697,-1.3728074551131286,0.13032581453634084,0.6033510145070526,1.0,6/11,12.82%,CPEB2;MRRF;LTN1;CPSF6;RBM3;NPM1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.47247491388288093,-1.3726879267490428,0.11275964391691394,0.5885210335527125,1.0,10/22,12.44%,ATP6V1C1;ATP6V0B;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;ATP2A2;ATP6V1D;ATP6V0D1;ATP6V0A1
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.5161067083167831,1.3649806161056144,0.11764705882352941,0.5105818000456128,1.0,15/31,21.00%,BIRC6;UBE2E1;UBE2D3;UBE2QL1;UBE2N;UBE2W;UBE2Z;UBE2S;UBE2G1;UBE2J2;TAF1;UBE2Q2;AKTIP;UBE2E3;CDC34
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.41381735890813176,1.3647523136028348,0.0319031903190319,0.5055355212791373,1.0,53/181,18.22%,KLF4;CREB1;PPARG;DTX3L;STAT3;FOS;MAD2L2;RBBP8;NCOA3;SPI1;NFKBIA;CRY1;MTA3;ATF2;RBPJ;HIPK2;STAT1;MAPK14;FAF1;ANXA4;BUD31;TADA3;NFE2L2;CPNE1;WWP2;BCAS3;ID2;NCOA2;PARP9;SMARCE1;NCOA1;SPEN;BAZ2A;TACC1;NRIP1;CHD4;HCLS1;HDAC3;RELA;DUSP26;CREBBP;MIER1;TAF1;BHLHE40;MED1;RBL2;RB1;PROX1;SIRT1;BBS10;SMARCD3;HDAC1;NCOA7
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.6232591151476146,1.363105906912509,0.10305958132045089,0.5047435748548164,1.0,2/13,4.13%,DNA2;FEN1
prerank,magnesium ion binding (GO:0000287),0.42776555548759315,1.3601723277629922,0.049886621315192746,0.507290480725121,1.0,41/135,17.17%,LRRK2;SIK1;MAP3K5;PLSCR1;ERN1;STK38;FEN1;RP2;SIK3;STK4;GSS;IMPA1;WRN;PDE2A;MAPK12;SIK2;STK38L;MSH6;IDH1;PGM1;LATS1;OXSR1;NLRC4;TDG;MTPAP;RHEB;NLK;GNAI1;EXD2;MAP3K20;XXYLT1;NT5C3A;BRSK1;PAPOLA;SRR;DYRK2;ENDOV;IRAK3;MVK;PI4K2A;ABL2
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.5436381860927111,1.354399310038539,0.1276595744680851,0.5180125790865889,1.0,6/24,7.09%,DAPK1;CAMK1D;MAPKAPK3;MAPKAPK2;PTK2B;MKNK2
prerank,protein kinase C activity (GO:0004697),0.6087241879288798,1.3533610764483583,0.12956810631229235,0.5155627136326927,1.0,3/14,2.87%,PRKCE;PKN1;PRKCH
prerank,phosphatidylinositol binding (GO:0035091),0.4418043917094237,1.353219015212731,0.07773851590106007,0.510501951438195,1.0,26/91,13.64%,ITPR1;FRMPD2;PLEKHF1;MYO1E;DENND1A;CCDC88A;PICALM;DPEP1;MITD1;ESYT3;SCARB1;SNX1;DENND1B;ESYT1;SESTD1;PITPNB;ZFYVE9;PHF12;PITPNM1;BCAS3;HIP1;SNX9;ING2;ESYT2;NCF1;ANKFY1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.5257787671882974,1.3514359051036715,0.10549777117384844,0.5101892469706264,1.0,12/30,15.38%,RPS6KA3;BIRC6;DPEP1;BIRC3;CAST;SERPINB9;TNFAIP8;CARD16;UBE2Z;RPS6KA1;XIAP;PRDX5
prerank,cholesterol transfer activity (GO:0120020),-0.5063127797580763,-1.349316614745203,0.13068181818181818,0.6488608260820514,1.0,4/16,17.01%,ABCA1;GRAMD1A;MTTP;STARD5
prerank,ephrin receptor binding (GO:0046875),0.5537351267015842,1.344690170372165,0.1267387944358578,0.5229596469291474,1.0,7/21,10.41%,LYN;FYN;CRK;CBL;GRB2;EFNA2;PTPN1
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.4056872609215108,1.3431090820426341,0.035483870967741936,0.5221520123723273,1.0,33/188,12.36%,CIITA;GLI1;KLF4;PPARG;NFKB1;STAT3;FOXJ1;FOS;ZBTB20;TAF9;SPI1;TBL1XR1;ATF6;RFX3;AHR;ARID4A;NFE2L2;THRA;CRY2;ZBED4;GABPB1;GABPB2;CTCF;NFYC;SMAD4;BNC2;PBX1;FOXO3;TAF7;REST;ATF6B;NFYA;TFAM
prerank,protein kinase binding (GO:0019901),0.3906391235926891,1.3422659069241916,0.006066734074823054,0.5190052484894537,1.0,116/479,15.99%,FGR;PTPRC;RND3;NEDD9;GRK5;RARA;IQGAP1;CD226;PDLIM5;SIK1;PLCG2;ACE;VRK1;MARVELD3;STAP1;DUSP16;MAPKAPK3;UTRN;PKN1;PPP1R12A;MSN;RACGAP1;PRKAG2;JAK2;STAT3;CRK;BMPR2;MAD2L2;KCNQ1;KIF20A;RCC2;MAPKAPK2;STK38;PTPN6;CCDC88A;RAC2;BCL2L14;IKBKB;VRK2;SLC12A7;CDC42;AXIN1;IBTK;ATF2;CCND3;ADRA2A;BCAR1;ITGB2;CAV2;IRAK4;PRKRIP1;FAF1;TIRAP;TEX14;CDKN2C;AP2A2;MAP3K1;CCND1;GRB2;PRKAB2;NBEAL2;PAK2;RHOBTB3;EZR;RAC1;CACUL1;HDAC9;DUSP6;PPP1R15A;RHOA;LATS1;RNF13;DIRAS1;OXSR1;SPRED3;GSKIP;RPS3;NR3C1;CEP250;DAXX;PTPN1;IL31RA;CYLD;PRKAR2A;TRIM14;YWHAZ;PRKAG1;FOXO3;DUSP1;PPP1CB;MAP2K3;CASS4;PPM1D;CCND2;MVP;CSK;RNF138;HCLS1;DNAJC3;KAT2B;PTPRJ;MAPKAP1;USP37;MAP3K13;ADAM9;RB1CC1;GSTP1;RELA;FBXO7;RHOG;SPRED1;MAML1;APC;IRAK3;DUSP22;EXOC2
prerank,voltage-gated calcium channel activity (GO:0005245),-0.40814386801622554,-1.3408952798740916,0.06551724137931035,0.6631151043626085,1.0,8/37,7.16%,CACNA1D;CACNB2;CACNA2D3;CACNA2D1;PKD2;CACNA1C;CACHD1;TPCN2
prerank,chloride channel inhibitor activity (GO:0019869),-0.5890197592752271,-1.3405541123115674,0.12183908045977011,0.6489004939545334,1.0,7/10,21.55%,WNK1;WNK2;VTI1B;STX1A;VAMP8;STX8;WNK3
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.4204137188197309,-1.340434612500361,0.08360128617363344,0.634716743029647,1.0,9/28,18.53%,GABRG3;GABRG2;GRIK4;GRID2;GRIK1;GABRA4;CHRNA7;GABRA2;GABRA5
prerank,ADP binding (GO:0043531),0.5255890848217625,1.3332671258685505,0.1122754491017964,0.5389206324275104,1.0,11/25,14.67%,LONP1;PRKAG2;ERN1;MYH9;TAP1;COQ8A;MSH6;GLUD1;PRKAG1;ABCD1;ABCG1
prerank,G protein-coupled receptor activity (GO:0004930),0.3965616659238429,1.3318450163279087,0.030334728033472803,0.5377089764960212,1.0,22/239,11.27%,GPR141;FFAR4;CRHR2;CYSLTR2;FPR1;ADGRG5;LTB4R;FPR3;ADGRG6;ADGRE5;RXFP2;LPAR3;GPR35;ADRA2A;P2RY14;CYSLTR1;OPRM1;HRH1;S1PR5;TAPT1;GPR88;GLP2R
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.5481203693014023,1.3248267700355116,0.15045592705167174,0.5523951923230189,1.0,2/20,1.59%,CARD11;CASK
prerank,transcription coregulator binding (GO:0001221),-0.3802508288470445,-1.3171202968504228,0.07983193277310924,0.7008485587236901,1.0,32/50,31.39%,VGLL4;NEK6;LMO2;EED;CTNNB1;THRB;CTBP1;PGR;MTF2;SMAD3;MED25;PER1;PHF1;PER3;ESR1;ZBTB49;PER2;AR;EHMT2;HDAC6;CDK9;HDGF;THAP7;CHD6;ZBTB17;CIT;PPARD;RORA;USP11;UBE2I;SUZ12;ZBTB7A
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.42164091972281537,1.3168065006761387,0.0855421686746988,0.56992745766382,1.0,22/100,14.24%,MYO1G;IQGAP2;IQGAP1;DAPP1;RACGAP1;PLEKHF1;DENND1A;GOLPH3L;ARAP1;KCNH1;DENND1B;SESTD1;GBF1;CYTH3;SNX20;HIP1;WIPI2;SNX3;BTK;AKT1;ANKFY1;MAPKAP1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.4523596609881544,-1.3163985796481914,0.11898016997167139,0.687746064792522,1.0,10/22,21.91%,IKBKE;ZRANB1;MINDY2;RNF169;OPTN;OTUD7A;OTUD7B;SQSTM1;SPRTN;WDR81
prerank,SUMO transferase activity (GO:0019789),-0.49672594583495105,-1.3142683149040097,0.15469613259668508,0.6804330085243606,1.0,8/16,30.40%,RANBP2;PIAS2;PIAS4;MDM2;HDAC4;EGR2;CBX4;UBE2I
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.6187859228063582,1.311688952120908,0.16693679092382496,0.5799077346602269,1.0,1/11,0.07%,ITPR1
prerank,mannosyltransferase activity (GO:0000030),-0.4602920741085726,-1.3107550125081997,0.13496932515337423,0.6773490764703475,1.0,13/21,30.50%,DPY19L4;ALG8;PIGB;ALG2;ALG9;POMT1;PIGV;ALG1;DPY19L3;TMTC1;ALG3;DPM1;POMT2
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.6093998379795775,1.310581205937811,0.16838487972508592,0.577805626651716,1.0,6/12,20.93%,PNLDC1;CNOT6;CNOT2;CNOT8;CNOT6L;PARN
prerank,actin monomer binding (GO:0003785),0.5371410948977349,1.3102831268391073,0.17050691244239632,0.5731529798587208,1.0,4/22,4.99%,PRKCE;CORO1A;MYL4;TMSB10
prerank,nucleotide diphosphatase activity (GO:0004551),-0.5139798946762278,-1.307260043336424,0.14180929095354522,0.6751736958274667,1.0,4/14,20.64%,FHIT;ENPP1;NUDT6;NUDT3
prerank,sterol transfer activity (GO:0120015),-0.4790219627436537,-1.3063574377199911,0.14565826330532214,0.6646029572961345,1.0,2/17,2.57%,ABCA1;GRAMD1A
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.6021878358234696,1.306276018899716,0.17452006980802792,0.5792994434085179,1.0,3/10,13.93%,HEXIM1;CDKN2C;KAT2B
prerank,GTPase regulator activity (GO:0030695),0.39384478227175873,1.3049403724185917,0.051961823966065745,0.5779578622212505,1.0,40/212,9.74%,ARHGAP15;LRRK2;VAV3;RIN2;RAP1GAP2;IQGAP2;IQGAP1;SRGAP2;TBC1D1;TBC1D8;RACGAP1;SIPA1L3;TBC1D9;ARHGAP18;ARHGEF10L;ARHGAP30;RAPGEF2;RGS2;ARHGAP26;RGS3;USP6NL;TBC1D10C;CCDC88A;TBC1D2B;OCRL;BCR;RP2;TAGAP;DLC1;ARAP1;TBC1D8B;RABGAP1L;RABGAP1;PLCB1;SOS1;RGS12;DEPDC5;TBC1D5;ARHGEF6;ARFGEF1
prerank,histone demethylase activity (GO:0032452),0.5040270498732868,1.3031970715860046,0.17372262773722627,0.5775639229034318,1.0,4/27,7.20%,JARID2;KDM6A;KDM7A;KDM3B
prerank,actin binding (GO:0003779),0.39925718137674665,1.3016501905908209,0.06623235613463627,0.5765616910888881,1.0,22/170,7.93%,LRRK2;FXYD5;IQGAP2;PHACTR2;PRKCE;LCP1;PDLIM5;EPS8;UTRN;PDLIM1;MSRB1;HPCA;CORO1A;MYL4;CCDC88A;FHL3;MYH9;TMSB10;FLNB;CAPZB;PAWR;EZR
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.48710238211106927,1.299257357704641,0.15595075239398085,0.5785762435887559,1.0,13/35,18.12%,FOXP1;FOS;H3-3A;STAT1;KLF10;GTF2A1;SNAPC3;NR3C1;BAZ2A;RELA;TAF1;TAF1C;HDAC1
prerank,microtubule plus-end binding (GO:0051010),-0.4641969627173898,-1.2989306637651916,0.13978494623655913,0.6767850888962672,1.0,5/20,6.93%,DST;NUMA1;CLIP1;CLASP2;CLIP2
prerank,chemokine receptor binding (GO:0042379),0.49079168633548304,1.2927755239099168,0.15353260869565216,0.5920228617153822,1.0,5/35,6.59%,ITCH;CXCL10;CKLF;CXCL16;CCRL2
prerank,cAMP response element binding (GO:0035497),0.6196384922835585,1.291000666146005,0.1867145421903052,0.5920176610598639,1.0,3/10,9.35%,CREB1;ATF2;E4F1
prerank,titin binding (GO:0031432),-0.5260581852323085,-1.2902339695283285,0.18159806295399517,0.6920995207155225,1.0,4/13,18.81%,CAPN3;CALM1;ACTN2;MYBPC1
prerank,phospholipase inhibitor activity (GO:0004859),0.6234324638483398,1.2901847337081098,0.20104895104895104,0.5895051422633466,1.0,4/10,15.12%,ANXA2;ANXA4;ANXA1;ANGPTL3
prerank,androgen receptor binding (GO:0050681),0.5097765447780735,1.2875618508434759,0.16031746031746033,0.5919421204078827,1.0,5/25,13.35%,FOXP1;PKN1;PRPF6;DAXX;NSD1
prerank,hyaluronic acid binding (GO:0005540),0.6173850034403796,1.2824360850262333,0.18904593639575973,0.6015674992551036,1.0,1/10,0.26%,CD44
prerank,cadherin binding (GO:0045296),0.3790091395220754,1.2819177815993483,0.038894575230296824,0.5978885521693664,1.0,74/315,14.67%,FXYD5;IQGAP1;AHNAK;ZC3HAV1;PDLIM5;STK24;SLK;STXBP6;CNN2;ANXA2;PTPRO;PDLIM1;SHTN1;WASF2;HSPA1A;ARHGAP18;EPS15;BMPR2;PRDX6;STK38;SND1;CTNNA1;KIF5B;ABI1;MRE11;CBL;MYH9;PICALM;LRRFIP1;CHMP4B;CD2AP;RPL6;SNX1;STAT1;FLNB;AFDN;CAST;CAPZB;FLNA;PKN2;PAK2;GIGYF2;PHLDB2;TRIM25;F11R;EZR;STX5;CAPZA1;IDH1;EPS15L1;EEF1G;RTN4;PTPN1;ANXA1;SNX9;VASP;YWHAZ;BZW2;TBC1D2;CDH9;S100A11;RPL34;TLN1;ESYT2;PACSIN2;LRRC59;SWAP70;TMOD3;KTN1;RPS2;PTPRJ;EIF3E;TAGLN2;EHD1
prerank,protein tyrosine phosphatase activity (GO:0004725),0.4350427468002429,1.2793834037944174,0.12960609911054638,0.6002801804779301,1.0,25/71,18.30%,PTPRC;CDC14A;PTPN22;PTPRE;PTPRU;PTPRO;PTPN6;PTPN7;PTPN12;TNS2;PTEN;MTMR3;PTPN1;PTP4A2;PTPDC1;DUSP1;TIMM50;PTPRJ;PTPRG;DUSP26;DUSP22;EYA3;PTPN4;PTPRA;PTP4A3
prerank,DNA-binding transcription factor binding (GO:0140297),0.38581623569785745,1.2791622369066102,0.07080610021786492,0.5958837322256155,1.0,47/189,18.12%,CIITA;SIK1;KLF4;CREB1;PPARG;STAT3;FOS;MAD2L2;RBBP8;TAF9;SPI1;SCX;MTA3;ATF2;RBPJ;HIPK2;STAT1;CGGBP1;CREM;NFE2L2;PURB;HDAC9;WWP2;ID2;PSMD9;SPEN;YWHAZ;TXLNG;NLRP3;TLE1;CHD4;HCLS1;CRTC3;RELA;DUSP26;CREBBP;MIER1;TAF1;BHLHE40;RBL2;RB1;DAPK3;CHCHD2;SIRT1;BBS10;HDAC7;HDAC1
prerank,1-phosphatidylinositol binding (GO:0005545),0.5599689998545484,1.278067788512471,0.17420435510887772,0.5943265440837803,1.0,6/15,10.55%,FRMPD2;PICALM;SCARB1;SESTD1;ZFYVE9;SNX9
prerank,GTPase inhibitor activity (GO:0005095),0.5774572424760046,1.2774167774237442,0.19381107491856678,0.5912486861176367,1.0,2/13,0.55%,IQGAP2;IQGAP1
prerank,cation:chloride symporter activity (GO:0015377),0.6067210683288996,1.2750051825026816,0.2060931899641577,0.593099943050222,1.0,3/10,11.25%,SLC12A7;SLC12A6;SLC12A9
prerank,MAP-kinase scaffold activity (GO:0005078),0.5948570603658119,1.2749542489170533,0.17529215358931552,0.5884308831096047,1.0,1/11,0.55%,IQGAP1
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.4256774842691331,1.2746426885444306,0.1355081555834379,0.5845423394756692,1.0,11/72,9.43%,MYO1G;SVIL;STXBP6;ANXA2;KCNQ1;PICALM;SESTD1;TIRAP;PLCB1;SNX20;HIP1
prerank,retinoid X receptor binding (GO:0046965),0.588824666888533,1.2744401621041612,0.18388791593695272,0.580430167870492,1.0,5/11,13.35%,PPARG;RARG;TACC1;NRIP1;NSD1
prerank,protein tyrosine kinase activity (GO:0004713),0.40705390823627136,1.2742964460464592,0.10714285714285714,0.5762265557441907,1.0,17/108,8.29%,FGR;HCK;LYN;FLT3;FYN;RET;LMTK2;SYK;JAK2;SLA;ZAP70;HIPK2;STYK1;HIPK1;PTK2B;DYRK1A;EPHB2
prerank,alanine transmembrane transporter activity (GO:0022858),-0.5117522539231063,-1.2729697227662489,0.2040302267002519,0.7348864503015128,1.0,4/12,12.61%,SLC36A4;SLC36A1;SLC7A8;SLC3A2
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.5164963901920521,1.268196152665642,0.19940476190476192,0.5888068500529269,1.0,5/22,11.47%,DUSP16;MTMR3;DUSP6;DUSP12;DUSP1
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.5467615815932757,1.2667027482615356,0.19803600654664485,0.5881442128298139,1.0,6/16,11.50%,SLC25A13;SLC25A30;SLC1A5;SLC25A12;SLC1A4;SLC25A18
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.5911979358443951,1.2657490493130021,0.20689655172413793,0.5860923647465863,1.0,7/12,18.12%,FOS;H3-3A;STAT1;GTF2A1;RELA;TAF1;HDAC1
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.5284358655119868,-1.2638652986374936,0.21103117505995203,0.7512941139608654,1.0,5/11,19.43%,CTC1;NABP2;TERF2IP;TERF1;HNRNPA2B1
prerank,protein phosphatase regulator activity (GO:0019888),0.4386572055790816,1.263838561117208,0.15994962216624686,0.587030344431907,1.0,19/53,16.28%,LMTK2;PPP2R5A;EIF2AK2;PPP1R9B;SHOC2;PPP2R2A;PPP4R2;PPP1R15A;PPP1R2;ANKLE2;PPP4R1;DMPK;PPP2R3A;PPP1R15B;LGALS3;PPP6R2;PPP2R5C;PPP2R5E;PPP1R7
prerank,aspartic-type endopeptidase activity (GO:0004190),0.5897909091611603,1.2627187174929264,0.2233502538071066,0.5855710078786664,1.0,4/12,16.93%,NAPSA;SPPL2A;BACE2;PSEN1
prerank,vitamin D receptor binding (GO:0042809),0.5538858118155252,1.2599368177766914,0.20141342756183744,0.5883579124929306,1.0,6/14,15.77%,MED30;MED13;MED12;TAF7;MED14;MED1
prerank,serine-type peptidase activity (GO:0008236),0.4095361040349182,1.2598699615290652,0.11947431302270012,0.584096773345671,1.0,10/96,10.52%,DPP4;PRSS53;HP;HPR;PARL;FAP;C1RL;HGF;RHBDL2;MBTPS1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.5283550272437033,-1.2598423305274566,0.2,0.7513339918701439,1.0,5/11,31.06%,AKR1A1;AKR1B1;RDH13;DHRS13;RDH11
prerank,nuclear receptor binding (GO:0016922),0.3923118222866316,1.257818630217203,0.12412177985948478,0.5850076121028143,1.0,33/111,18.22%,FOXP1;PKN1;NCOA3;STAT5B;CRY1;MED30;PRPF6;STAT1;MED13;BUD31;TADA3;OASL;LATS1;BCAS3;NCOA2;SMARCE1;NCOA1;DAXX;MED12;TAF7;BAZ2A;MED14;TACC1;NRIP1;NSD1;TAF1;MED1;PROX1;SIRT1;NR4A1;PADI2;SMARCD3;NCOA7
prerank,death receptor binding (GO:0005123),0.5493817072800515,1.2559902728310741,0.19370860927152317,0.5858144116137014,1.0,9/15,24.90%,NGF;PIDD1;RIPK1;MYD88;FEM1B;BID;MADD;CASP8AP2;BDNF
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.5096290095240208,-1.2537229460629298,0.1951219512195122,0.7581402964573394,1.0,11/14,34.09%,POP1;RPP30;TSEN2;RPP14;TSEN34;ELAC2;RPP40;POP4;POP5;RPP21;POP7
prerank,ubiquitin-protein transferase activity (GO:0004842),0.3655241845638393,1.2525815078920686,0.05555555555555555,0.5908751688187612,1.0,95/346,18.68%,TRAF1;NEURL3;NEURL1B;DTL;ITCH;RNF149;DTX3L;NEDD4L;TRIM26;CUL3;CUL5;RSPRY1;BIRC6;CBLB;UBE2E1;MALT1;RNF38;TRIM7;CBL;ANKIB1;CDC42;RNF146;CBLL1;TRIM62;PEX12;BIRC3;ARIH1;TRAF3IP2;RNF20;RNF213;PELI1;RC3H1;UBE2D3;UBE2QL1;FBXW11;UBE2N;UBR5;RNF217;HLTF;FBXW2;HECTD1;MYCBP2;TRIM25;TRAF3;FBXO4;UBR2;COP1;ARIH2;RNF130;RNF141;WWP2;RNF13;TRIM71;UBE2W;KCMF1;UBE2Z;FANCL;TRIM14;RNF31;UBE2S;MEX3C;RCHY1;UBE2G1;TRIM17;SH3RF1;AREL1;RNF138;UBE2J2;RNF150;UHRF2;FBXO7;RNF166;RMND5B;KCTD13;XIAP;RNF122;TAF1;TRIM35;RNF41;HACE1;UBR3;TRIM36;MSL2;MAEA;UBE2Q2;TRAF2;RNF144A;TSPAN17;RNF19B;FBXO3;NEURL4;SMURF2;ANAPC11;FBXL14;ANAPC4
prerank,ATP hydrolysis activity (GO:0140603),0.4604684512859145,1.2504579995862775,0.18601398601398603,0.592334286078457,1.0,8/41,7.92%,DNA2;HSPA1A;MYO1E;ATP2B1;ABCA3;RNF213;SMCHD1;RHOBTB3
prerank,calcium-activated potassium channel activity (GO:0015269),-0.5411116967740839,-1.2475549644643706,0.21052631578947367,0.7657961804125073,1.0,4/11,12.75%,KCNMA1;KCNN2;KCNMB2;KCNN3
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.4750850895320495,1.2468146245183835,0.21796759941089838,0.5980648325529364,1.0,8/29,15.21%,PRKAG2;PKIB;HEXIM1;CDKN2C;CIB1;PRKAR2A;KAT2B;SPRED1
prerank,sterol binding (GO:0032934),-0.34960836975520826,-1.2465609570972027,0.14864864864864866,0.7563073368415786,1.0,26/56,32.78%,ABCA1;OSBPL11;OSBPL8;GRAMD1A;APOD;OSBPL1A;ERLIN2;STARD3;VDAC1;SIDT1;NPC1;GPR183;STARD5;OSBPL6;PTCH1;OSBPL7;SOAT2;OSBPL5;OSBP;NR1H3;CAV1;RORA;PROM1;OSBPL2;STARD4;STAR
prerank,acetylcholine receptor activity (GO:0015464),-0.4241922909391037,-1.2460092139114993,0.18895348837209303,0.7453047995913017,1.0,4/22,9.42%,CHRM3;CHRM2;CHRFAM7A;CHRNA7
prerank,transcription corepressor binding (GO:0001222),-0.42456269126454976,-1.244714107680653,0.16300940438871472,0.7365301725771655,1.0,13/27,21.45%,NEK6;EED;CTBP1;MTF2;PER1;PHF1;PER3;ESR1;PER2;EHMT2;HDAC6;HDGF;THAP7
prerank,double-stranded RNA binding (GO:0003725),0.42460579309437213,1.2437168300783175,0.16276202219482122,0.6021908915494696,1.0,13/70,8.49%,MBNL1;OAS2;MSN;VIM;DHX58;EIF2AK2;LRRFIP1;DGCR8;RC3H1;IFIH1;PRKRIP1;OASL;TLR3
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.4664564592877847,1.2435791679351174,0.19428571428571428,0.5983059370962465,1.0,15/34,21.00%,BIRC6;UBE2E1;UBE2D3;UBE2QL1;UBE2N;UBE2W;UBE2Z;UBE2S;UBE2G1;UBE2J2;TAF1;UBE2Q2;AKTIP;UBE2E3;CDC34
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.5257992310554173,1.2404732611528007,0.19778481012658228,0.6024584528175592,1.0,5/18,17.80%,HSD17B14;HSD17B7;DHRS9;RDH5;HSD17B2
prerank,protein kinase C binding (GO:0005080),0.44896322519133364,1.24028648784266,0.172,0.59871903531424,1.0,6/43,8.44%,GRK5;PDLIM5;PKN1;CCDC88A;TIRAP;HDAC9
prerank,aspartic-type peptidase activity (GO:0070001),0.5887966108985493,1.240210677668154,0.24028268551236748,0.5946899978954349,1.0,1/10,0.17%,NAPSA
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.35781864904383154,1.2382358605113521,0.03006012024048096,0.5958819214651647,1.0,73/597,12.52%,CIITA;NFE2;BACH2;FOXP1;RUNX2;RARA;SP3;RUNX3;GLI1;KLF4;CREB1;PPARG;BCL6;NFKB1;PITX3;STAT3;FOXJ1;ELF4;RFX7;FOS;ZBTB20;CDC45;TAF9;SPI1;TBL1XR1;ATF6;KAT7;ATF2;IRF2;RFX3;ORC5;HIVEP1;KLF5;MCM6;IRF4;BBX;RFX5;KLF13;KLF10;AHR;ARID4A;MBD4;CREM;NFE2L2;ORC4;THRA;CRY2;CLOCK;ZBED4;RARG;E2F2;GABPB1;GABPB2;CTCF;NFYC;ELF1;PKNOX1;IRF7;MEF2B;SMAD4;BNC2;NR3C1;GMEB2;PBX1;FOXO3;TAF7;ETS2;REST;MBD2;ATF6B;NFYA;TFAM;TEAD1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.5879710374198069,1.236771621091718,0.2393617021276596,0.5957669535027259,1.0,7/10,20.57%,NSD3;SETD5;ASH1L;SETD2;NSD1;SETMAR;PRDM9
prerank,potassium channel regulator activity (GO:0015459),0.44066198649371474,1.2354146172548066,0.18673883626522328,0.595395949891084,1.0,6/49,6.81%,KCNE3;SGK3;NEDD4L;SUMO1;KCNIP3;FLNA
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.3685809720662801,-1.235263517201558,0.15053763440860216,0.7565939534775865,1.0,16/40,22.16%,DNMT3A;COMT;SETD3;HNMT;DPH5;METTL2A;METTL2B;AS3MT;METTL8;PCMT1;SUV39H1;THUMPD2;LCMT1;METTL9;PCMTD2;N6AMT1
prerank,MHC class I protein binding (GO:0042288),0.5559881982735587,1.235248097748197,0.23550087873462214,0.5917486138143824,1.0,3/13,6.24%,LILRB1;PILRA;TAP1
prerank,muscle alpha-actinin binding (GO:0051371),0.542027858619037,1.2332281591726926,0.2282793867120954,0.5927947795525591,1.0,2/15,2.28%,PDLIM5;PDLIM1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.5248252932449985,1.231659654745763,0.2304,0.5931706010134301,1.0,8/18,15.38%,RPS6KA3;DPEP1;BIRC3;SERPINB9;TNFAIP8;RPS6KA1;XIAP;PRDX5
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.49683761794813375,-1.2302556633671746,0.2216867469879518,0.7606736922538126,1.0,7/13,24.56%,TRMT1;TRMT1L;METTL1;THUMPD2;TRMT10A;WDR4;TRMT5
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.5361826383987642,1.222310032055298,0.23027375201288244,0.6096056029708714,1.0,5/16,3.77%,PTPRC;PTPRE;PTPRU;PTPRO;PTPN6
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.5361826383987642,1.222310032055298,0.23027375201288244,0.6096056029708714,1.0,5/16,3.77%,PTPRC;PTPRE;PTPRU;PTPRO;PTPN6
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.3935056835511571,1.2200763043662832,0.162874251497006,0.6113975480145847,1.0,13/91,9.43%,MYO1G;SVIL;STXBP6;ANXA2;KCNQ1;PICALM;KCNH1;SESTD1;TIRAP;PLCB1;GBF1;SNX20;HIP1
prerank,kinesin binding (GO:0019894),-0.40209515673808216,-1.2198135090255353,0.22012578616352202,0.7835309275205938,1.0,11/27,26.50%,PLEKHM2;NEK6;KIF1B;AP1AR;TOR1B;CROCC;NEFH;ATCAY;KLC2;PRC1;SPTBN5
prerank,vinculin binding (GO:0017166),0.5700574985791884,1.219764763134952,0.24040066777963273,0.608237288736117,1.0,4/11,12.50%,UTRN;CTNNA1;PXN;TLN1
prerank,kinase activity (GO:0016301),0.3886232478323393,1.2189428584099113,0.17233560090702948,0.6065101724485301,1.0,22/109,15.56%,LRRK2;LYN;DGKG;CERKL;NADK;ITPKC;PIK3C2A;IP6K3;PANK1;PANK4;PKN2;PAPSS1;COQ8A;PAPSS2;CSNK2A1;PIK3CA;PGM2L1;AKT1;STK39;IPMK;TAF1;SEPHS1
prerank,voltage-gated anion channel activity (GO:0008308),-0.4650041824920259,-1.2183186654984293,0.2077922077922078,0.7756415358655163,1.0,7/15,21.05%,CLCN6;CLCN4;VDAC1;CLCN3;GPR89B;GPR89A;CLCN2
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.5341617261006967,-1.2178990843779431,0.21140142517814728,0.7650795128015033,1.0,3/10,3.50%,CACNA1D;CACNB2;CACNA1C
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.4455589462780626,1.2142230331796884,0.20905459387483355,0.6147965590722293,1.0,12/42,14.79%,CCNJL;CCND3;HEXIM1;CDKN2C;CCND1;CCNH;CCNT2;CCNT1;CCNL1;CCND2;KAT2B;CDK5R2
prerank,glucose transmembrane transporter activity (GO:0005355),-0.43881276494434096,-1.2132966209386327,0.2265625,0.7688346971991787,1.0,5/17,25.81%,SLC2A3;MFSD4A;SLC2A5;SLC2A8;SLC5A11
prerank,kinase binding (GO:0019900),0.353861620665414,1.211339191214807,0.05876393110435663,0.6185827161275916,1.0,96/434,15.21%,FGR;PTPRC;RND3;SP100;IQGAP1;TIAM1;CD226;PTPN22;SIK1;PLCG2;VRK1;STAP1;PPP2R5A;UTRN;PPP1R12A;MSN;RACGAP1;PRKAG2;JAK2;STAT3;CRK;KIF20A;RCC2;PTPN6;RAC2;BCL2L14;IKBKB;VRK2;SLC12A7;CDC42;AXIN1;IBTK;ATF2;CCND3;BTG1;ADRA2A;BCAR1;ITGB2;CAV2;IRAK4;TNS2;PRKRIP1;FAF1;TEX14;CDKN2C;AP2A2;MAP3K1;CCND1;GRB2;PRKAB2;FLNA;NBEAL2;PAK2;MOB1B;RHOBTB3;CARD16;RAC1;CACUL1;PPP1R15A;RHOA;LATS1;OXSR1;SPRED3;GSKIP;RPS3;NR3C1;CEP250;DAXX;PTPN1;IL31RA;CYLD;TRIM14;YWHAZ;PRKAG1;FOXO3;HTT;PPP1CB;MAP2K3;EIF4ENIF1;CCND2;PIP5K1A;MVP;RNF138;HCLS1;DNAJC3;KAT2B;PTPRJ;MAPKAP1;USP37;MAP3K13;RB1CC1;AURKB;RELA;FBXO7;RHOG;SPRED1
prerank,5'-3' exonuclease activity (GO:0008409),0.5501449910181759,1.2095323703337362,0.24878836833602586,0.6195117844000343,1.0,6/14,15.24%,MRE11;FEN1;XRN2;DCP2;EXOG;CPSF3
prerank,syntaxin-1 binding (GO:0017075),0.4948607124848601,1.2088530415782357,0.23708206686930092,0.6175665988524448,1.0,2/22,1.35%,LRRK2;DAPK1
prerank,acylglycerol lipase activity (GO:0047372),-0.5107260108465296,-1.2048858139761773,0.25392670157068065,0.7846498168703564,1.0,3/11,10.31%,ABHD12;MGLL;ABHD3
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.4083457239090551,1.2016299863405282,0.21482412060301506,0.6325472395609588,1.0,11/69,9.27%,CERS6;HHAT;NAA16;CERS1;ZDHHC7;ZDHHC13;ZDHHC6;ZDHHC17;KAT6A;NAA15;MOGAT3
prerank,acyl-CoA hydrolase activity (GO:0047617),0.5116213481349057,1.2005212953304116,0.24237560192616373,0.6316908616814217,1.0,6/17,16.46%,ACOT11;ACOT2;ACAA2;ABCD1;PLA2G6;PPT1
prerank,phospholipase activator activity (GO:0016004),0.5740663870169171,1.2001490396936196,0.2557726465364121,0.6286959139959251,1.0,4/10,16.89%,FYN;PDPK1;BTK;ARHGAP6
prerank,tau-protein kinase activity (GO:0050321),0.48854245475697683,1.2000519625054875,0.24848484848484848,0.6251110886280699,1.0,7/20,14.90%,FYN;SIK3;DYRK1A;PRKAA1;MARK3;ROCK1;BRSK1
prerank,metal ion binding (GO:0046872),0.35082457872918477,1.1999313722757454,0.0707070707070707,0.6215933231670034,1.0,81/477,13.00%,ITPR1;LRRK2;IQGAP1;LCP1;PADI1;SIK1;RET;ACER3;MAP3K5;TNNC1;ANXA2;EFCAB9;TPM4;PLSCR1;TRIM26;HPCA;C2CD5;ERN1;RASGRP2;RAPGEF2;SELL;MCTP2;DYSF;STK38;CLGN;FEN1;RP2;ESYT3;PPP3CA;SIK3;SLC25A13;S100A4;STIM2;ESYT1;STK4;GSS;PRNP;IMPA1;ANXA4;WRN;ATP2A1;NUCB2;CIB1;S100A10;PDE2A;MAPK12;SIK2;STK38L;CABYR;RPE;MSH6;IDH1;PGM1;CPNE1;PITPNM1;LATS1;BRAF;OXSR1;FBN1;CAMKK2;NLRC4;PAPOLG;ANXA1;SLC25A12;TDG;LETM1;TPD52;MTPAP;CALB2;RHEB;NLK;EFCAB11;CDH9;S100A11;GNAI1;EXD2;ESYT2;MAP3K20;XXYLT1;MICU3;NT5C3A
prerank,ribonuclease P RNA binding (GO:0033204),-0.533525778575389,-1.1994619938416866,0.2237442922374429,0.7914072693931596,1.0,8/10,34.09%,POP1;RPP30;RPP14;RPP40;POP4;POP5;RPP21;POP7
prerank,single-stranded DNA helicase activity (GO:0017116),0.49773937897828024,1.1978165148880866,0.2614173228346457,0.6234161240552629,1.0,4/19,13.02%,DNA2;MCM6;CHTF18;MCM2
prerank,tau protein binding (GO:0048156),-0.34967939610432247,-1.1953457118086257,0.14893617021276595,0.793489648066085,1.0,9/40,12.09%,LGMN;BIN1;APOE;MAP2;MARK1;STUB1;MAP1A;CDK5;CLU
prerank,Toll-like receptor binding (GO:0035325),0.5655435015045794,1.1934714514382434,0.25989672977624784,0.6311776263238364,1.0,6/11,22.24%,CD36;TIRAP;TLR2;MYD88;TLR1;UNC93B1
prerank,ATP binding (GO:0005524),0.35949604982595956,1.1931120389410785,0.13641133263378805,0.6283099656557576,1.0,75/266,18.87%,MAP4K1;RUNX3;SIK1;DAPK1;MAP3K5;LMTK2;AKT3;OAS2;LONP1;PIM1;STK17B;PRKAG2;HSPA1A;ERN1;STK38;MYH9;ZAP70;SIK3;MCM6;RPS6KA5;SMARCA5;DARS2;STK4;TAP1;GSS;MKNK2;ATP7A;RHOBTB3;SIK2;MINK1;STK38L;MSH6;SMC4;LATS1;OXSR1;TLK2;NLRC4;PIP4K2B;TDG;MTPAP;DMPK;PRKAG1;NLK;LATS2;MAP4K3;CAD;MAP3K20;HSPA9;BTK;ABCD1;AKT1;PDK3;TLK1;HASPIN;MYO1F;ABCG1;BRSK1;PAPOLA;SRR;DYRK2;IRAK3;INSR;DAPK3;GCK;MVK;PI4K2A;PRPS2;HSPA5;ABCB8;PTPA;PYGL;STK3;MTHFD1L;ABCE1;PINK1
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.43918533779217,-1.1920290462795715,0.23450134770889489,0.7922091744144567,1.0,5/18,14.08%,TGFBR2;TGFBR1;SMAD7;SMAD3;TGFB2
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.3551886298100577,1.1916123850774796,0.13146997929606624,0.628860524810924,1.0,77/269,17.95%,TRAF1;PTPN22;RPL5;NGFR;CD40;ITCH;DTX3L;HSPA1A;CUL3;CUL5;LAPTM5;PRDX6;NFKBIA;FBXW7;SUMO1;AXIN1;TRAF4;ARIH1;STAT1;RNF20;SPOP;FAF1;GLMN;UBE2N;TSG101;HLTF;WFS1;NEDD8;ELOB;UBXN7;TRAF3;ATXN3;RALB;WRAP53;PARP9;UBE2W;TANK;CAMLG;RTN4;FANCL;SUMO2;DAXX;SNX9;PRKAR2A;RIPK1;RNF31;YWHAZ;STAM;GPI;NLK;NDUFS2;SLC25A5;UBE2G1;DNM1L;HSPA9;RPL11;STAT2;TNFRSF1B;UBE2J2;VCP;TRIOBP;USP7;RELA;FBXO7;TCP1;APC;TUBA1B;RB1;CCDC50;AMBRA1;SMAD5;TRAF2;HSPD1;BECN1;SMC6;VCL;HSPA5
prerank,aminopeptidase activity (GO:0004177),-0.3867072629273136,-1.1892198893528965,0.2182890855457227,0.7904246133299526,1.0,7/26,9.21%,METAP1D;MMP16;LTA4H;METAP2;MMP14;BLMH;TRHDE
prerank,endonuclease activity (GO:0004519),0.425028824688594,1.1883202779092095,0.23398692810457516,0.6339156278170832,1.0,16/49,20.00%,ZC3H12D;ERN1;SND1;MRE11;FEN1;MBD4;KHNYN;RPS3;INTS11;EXOG;ERCC4;CPSF3;SMG6;NYNRIN;SETMAR;APEX1
prerank,transferrin receptor binding (GO:1990459),0.5712239904340728,1.1861850015379796,0.29711375212224106,0.6354502370715849,1.0,2/10,5.29%,IKBKB;SNX1
prerank,ion channel inhibitor activity (GO:0008200),0.4373726109148582,1.1859595936302776,0.24594594594594596,0.6322930547615162,1.0,6/35,11.63%,ITPR1;NEDD4L;MCUB;SLC30A1;STX7;FKBP1B
prerank,carboxypeptidase activity (GO:0004180),-0.35824440606216873,-1.1830802321282994,0.18241042345276873,0.8001417044048136,1.0,17/35,30.40%,CTSA;FOLH1;NAALAD2;MINDY2;CTSZ;BLMH;MINDY1;AEBP1;AGBL1;AGBL4;CPA6;CPE;SCPEP1;PEPD;AGBL3;CPD;VASH2
prerank,translation elongation factor activity (GO:0003746),-0.4593175921179584,-1.1825647594183395,0.2376470588235294,0.7906333202886804,1.0,6/14,25.63%,GFM2;EEF1A1;EIF5A;EIF5AL1;GTPBP2;EEF1B2
prerank,sodium channel regulator activity (GO:0017080),0.4365051939503549,1.1822828753028596,0.23822714681440443,0.6386085759661644,1.0,3/37,2.59%,FXYD5;SGK3;NEDD4L
prerank,calcium-release channel activity (GO:0015278),0.5165557033544973,1.181815875395481,0.2507788161993769,0.636049216613091,1.0,2/17,3.73%,ITPR1;RASA3
prerank,exoribonuclease activity (GO:0004532),-0.4739584513552997,-1.1814955755377776,0.2625,0.7836835985455807,1.0,6/12,22.50%,EXOSC1;EXOSC9;EXOSC5;EXOSC10;EXOSC3;CNOT7
prerank,adenyl ribonucleotide binding (GO:0032559),0.3537511695534783,1.1814893941359377,0.14464099895941726,0.6333292154714985,1.0,80/291,18.87%,MAP4K1;RUNX3;SIK1;DAPK1;MAP3K5;LMTK2;AKT3;OAS2;LONP1;PIM1;STK17B;PRKAG2;HSPA1A;ERN1;RAPGEF2;STK38;MYH9;ZAP70;SIK3;MCM6;RPS6KA5;SMARCA5;DARS2;STK4;TAP1;GSS;MKNK2;PDE2A;ATP7A;RHOBTB3;SIK2;COQ8A;MINK1;STK38L;MSH6;SMC4;LATS1;OXSR1;TLK2;NLRC4;PIP4K2B;TDG;MTPAP;DMPK;GLUD1;PRKAG1;NLK;LATS2;MAP4K3;CAD;MAP3K20;HSPA9;BTK;ABCD1;AKT1;PDK3;TLK1;HASPIN;MYO1F;ABCG1;BRSK1;PAPOLA;SRR;DYRK2;IRAK3;INSR;DAPK3;GCK;MVK;PI4K2A;PRPS2;HSPA5;ABCB8;PTPA;PYGL;PDE4B;STK3;MTHFD1L;ABCE1;PINK1
prerank,neuropeptide binding (GO:0042923),0.5027986929628986,1.1798330509855868,0.27980922098569155,0.6338720106280431,1.0,2/18,9.12%,SORL1;OPRM1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.3474623329282033,1.179271457974425,0.10772357723577236,0.6316898542401528,1.0,102/431,17.24%,LRRK2;RND3;MAP4K1;RUNX3;SIK1;RAP1A;DAPK1;MAP3K5;LMTK2;AKT3;OAS2;LONP1;PIM1;STK17B;PRKAG2;HSPA1A;RABL3;ERN1;NOA1;STK38;RAC2;MYH9;ZAP70;CDC42;SIK3;RAB7A;MCM6;RPS6KA5;SMARCA5;DARS2;RAB6A;ARF4;STK4;TAP1;GSS;RAB39A;GNL1;MKNK2;ARF1;ATP7A;RHOBTB3;SIK2;RAC1;MINK1;STK38L;RALB;MSH6;RHOA;SMC4;LATS1;DIRAS1;OXSR1;ATL3;TLK2;NLRC4;PIP4K2B;TDG;MTPAP;DMPK;GLUD1;PRKAG1;RHEB;NLK;LATS2;MAP4K3;CAD;GNAI1;MAP3K20;HSPA9;BTK;ABCD1;AKT1;PDK3;TUBD1;ARL8B;GBP5;MMAA;TLK1;HASPIN;RRAD;RAB29;MYO1F;ABCG1;GBP2;BRSK1;ATL1;GBP3;RHOG;DRG2;PAPOLA;SRR;SEPHS1;DYRK2;IRAK3;TUBA1B;INSR;DAPK3;RAB35;GCK;MVK;PI4K2A;PRPS2
prerank,low-density lipoprotein particle binding (GO:0030169),0.5153252237706037,1.1792246309562526,0.2698412698412698,0.6282289271389311,1.0,4/16,5.03%,LDLR;CD36;SORL1;SCARB1
prerank,phosphatidylinositol kinase activity (GO:0052742),0.5246259608905547,1.1776803391969113,0.28917609046849757,0.6286850914056941,1.0,4/15,10.70%,PIK3C2A;PI4K2B;PIKFYVE;PIK3CA
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.5677619897772302,1.1747613352745105,0.28073394495412846,0.6325221893877429,1.0,1/10,1.14%,GDA
prerank,ion channel activity (GO:0005216),-0.3051821263610015,-1.1724980027831233,0.19411764705882353,0.801704576637876,1.0,15/80,9.42%,GRIA4;TRPV2;TRPM3;PKD2;GRIA2;GRIA1;UNC80;GRIK4;GRID2;GABRB1;GRIK1;TMEM63B;TRPC1;MCOLN1;CHRNA7
prerank,receptor ligand activity (GO:0048018),0.3533790875374005,1.172118168464151,0.1619644723092999,0.6353551244384752,1.0,18/245,9.51%,DPP4;IL1B;FGF22;NGF;TNFSF13B;METRNL;SEMA4A;FGF5;CXCL10;GDF1;GDNF;VEGFC;IL33;OSGIN2;BMP3;IL6;HGF;PGF
prerank,cell adhesion mediator activity (GO:0098631),0.4742884822272628,1.1714310525895504,0.28869047619047616,0.6334604136140632,1.0,4/24,6.72%,CD47;EMB;NPTN;IGSF9
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.4897979743679788,-1.170837885792566,0.2916666666666667,0.7964543470491313,1.0,7/12,18.53%,GABRG3;GABRG2;GABRB1;GABRA4;GABRB3;GABRA2;GABRA5
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.33938207352808314,-1.1693681649636027,0.20883534136546184,0.7907105788604721,1.0,9/46,13.68%,HEXB;LARGE1;B3GALNT1;MGAT5;PIGP;MGAT4C;HEXA;PIGA;MGAT4A
prerank,ubiquitin protein ligase activity (GO:0061630),0.34505118820592123,1.1667985307472037,0.1724867724867725,0.6414725505291964,1.0,54/228,16.67%,NEURL3;NEURL1B;ITCH;RNF149;DTX3L;NEDD4L;TRIM26;CUL3;CBLB;RNF38;TRIM7;CBL;ANKIB1;CDC42;CBLL1;TRIM62;BIRC3;ARIH1;TRAF3IP2;PELI1;RC3H1;UBE2D3;UBR5;RNF217;HLTF;HECTD1;MYCBP2;TRIM25;UBR2;COP1;ARIH2;RNF130;WWP2;RNF13;TRIM71;KCMF1;FANCL;TRIM14;MEX3C;RCHY1;TRIM17;SH3RF1;AREL1;RNF138;RNF150;UHRF2;RNF166;XIAP;RNF122;TRIM35;RNF41;HACE1;UBR3;MSL2
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.4812236595486372,1.1664733845460122,0.27382753403933435,0.6387384299944765,1.0,4/23,7.82%,PLCG2;CCR1;PLCB1;PLCD4
prerank,protein kinase regulator activity (GO:0019887),0.37645633885377555,1.1663944631786682,0.2354988399071926,0.6354587195531202,1.0,24/95,13.89%,PRKAG2;GPRC5C;CXCL10;CCNJL;GMFG;CCND3;TAOK3;HEXIM1;PRKRIP1;FAF1;CCND1;CCNH;MBIP;GSKIP;DAXX;PRKAR2A;PRKAG1;CCNT2;CCNT1;SH3BP5;CCNL1;CCND2;KIDINS220;DNAJC3
prerank,solute:proton symporter activity (GO:0015295),-0.43972355339666025,-1.165025246870765,0.2552083333333333,0.7938197411278376,1.0,5/16,12.84%,SLC11A2;SLC36A1;SLC25A3;SLC2A9;SLC15A2
prerank,growth factor activity (GO:0008083),0.38743856575073926,1.164593481656149,0.22777101096224117,0.6368904996801908,1.0,9/74,9.51%,FGF22;NGF;FGF5;GDNF;VEGFC;OSGIN2;IL6;HGF;PGF
prerank,CoA hydrolase activity (GO:0016289),0.49966709014027955,1.1617465807086216,0.2861685214626391,0.6406854516236713,1.0,5/16,14.48%,ACOT11;ACOT2;ACAA2;ABCD1;HIBCH
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.29362882875778973,-1.1607853977418892,0.1402439024390244,0.7970072502571653,1.0,15/85,13.20%,ABHD12;PON3;PNPLA7;MGLL;PLA2G15;GDE1;ENPP2;LIPA;PLA2G4A;DDHD2;ABHD3;CA2;ABHD4;PTRH2;LYPLAL1
prerank,hexose transmembrane transporter activity (GO:0015149),-0.46837676264390626,-1.1603863195465347,0.2616136919315403,0.7884687282535033,1.0,4/12,21.74%,SLC2A3;MFSD4A;SLC2A5;SLC2A8
prerank,calcium channel activity (GO:0005262),-0.30573158681935075,-1.1603364537059755,0.17261904761904762,0.7788738026143441,1.0,21/84,14.97%,CACNA1D;SLC24A3;CACNB2;CACNA2D3;CACNA2D1;TRPV2;PKD2;CACNA1C;TRPC4;P2RX4;CACHD1;TPCN2;TRPC1;MCOLN1;CHRNA7;CACNG2;TRPC7;TRPM2;TRPV4;TRPC3;NCS1
prerank,lipase activator activity (GO:0060229),0.5583063041884807,1.1528366151944045,0.31876138433515483,0.6605304929112119,1.0,4/10,16.89%,FYN;PDPK1;BTK;ARHGAP6
prerank,cholesterol binding (GO:0015485),-0.33658256643320766,-1.1518306134557406,0.2288135593220339,0.7964467451627028,1.0,10/47,12.88%,ABCA1;OSBPL8;GRAMD1A;APOD;OSBPL1A;ERLIN2;STARD3;VDAC1;SIDT1;NPC1
prerank,lipoprotein particle binding (GO:0071813),0.4904633363576524,1.1510574020263,0.3051643192488263,0.6616191852367068,1.0,4/20,5.03%,LDLR;CD36;SORL1;SCARB1
prerank,PDZ domain binding (GO:0030165),-0.3202230908863697,-1.1496133552284604,0.2361111111111111,0.7939586036846933,1.0,17/61,14.73%,PRKN;CADM1;DOCK4;NLGN1;DLG4;GRIA1;ATP2B2;GRID2;TBC1D10A;SLC22A5;GNG12;ATP2B3;CLCN3;ADRB1;CXADR;SLC22A4;ERC1
prerank,ion gated channel activity (GO:0022839),-0.38826110230818084,-1.149365643856176,0.278125,0.7853258403555634,1.0,6/24,17.98%,TTYH3;ANO10;TTYH2;TMEM63B;KCNT2;ANO8
prerank,phosphatase activator activity (GO:0019211),0.5057181527765817,1.1490755763373808,0.3139717425431711,0.6633614927654191,1.0,5/14,15.71%,PPP2R5A;PPP1R15A;PPP2R5C;FRS2;PPP2R5E
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3392467939835749,1.1462238865591234,0.21180189673340358,0.6670156703989751,1.0,54/232,16.67%,NEURL3;NEURL1B;ITCH;RNF149;DTX3L;NEDD4L;TRIM26;CUL3;CBLB;RNF38;TRIM7;CBL;ANKIB1;CDC42;CBLL1;TRIM62;BIRC3;ARIH1;TRAF3IP2;PELI1;RC3H1;UBE2D3;UBR5;RNF217;HLTF;HECTD1;MYCBP2;TRIM25;UBR2;COP1;ARIH2;RNF130;WWP2;RNF13;TRIM71;KCMF1;FANCL;TRIM14;MEX3C;RCHY1;TRIM17;SH3RF1;AREL1;RNF138;RNF150;UHRF2;RNF166;XIAP;RNF122;TRIM35;RNF41;HACE1;UBR3;MSL2
prerank,thyroid hormone receptor binding (GO:0046966),0.4479384546742833,1.1461835417538555,0.2978395061728395,0.6636139359620842,1.0,9/28,15.77%,NCOA3;MED30;MED13;OASL;MED12;TAF7;TACC1;NSD1;MED1
prerank,double-stranded DNA binding (GO:0003690),0.3333642653639567,1.1461696968325685,0.1280241935483871,0.6601789008426057,1.0,60/531,12.52%,NFE2;BACH2;FOXP1;RUNX2;RARA;SP3;RUNX3;KLF4;CREB1;PPARG;BCL6;POLR3F;PITX3;ELF4;RFX7;FOS;RBBP8;ZBTB20;MRE11;FEN1;CRY1;MBD1;CAMTA2;ATF6;ATF2;IRF2;RFX3;HIVEP1;STAT1;KLF5;RBMS1;IRF4;BBX;RFX5;KLF13;KLF10;AHR;CGGBP1;CREM;MECP2;MSH3;CLOCK;RARG;E2F2;ELF1;MSH6;PKNOX1;IRF7;MEF2B;RPS3;NR3C1;MAU2;GMEB2;TDG;PBX1;FOXO3;ETS2;ATF6B;PQBP1;TEAD1
prerank,protein homodimerization activity (GO:0042803),0.3349227509654367,1.145811120371469,0.12663316582914572,0.6576807475850973,1.0,88/589,11.03%,DPP4;JAML;LRRK2;STK10;SRGAP2;EXT1;KYNU;PECAM1;LILRB1;SLK;PIP4K2A;MAP3K5;MCL1;NECTIN1;TNNC1;PTPRO;TPM4;STAT3;RABL3;ERN1;UPB1;RBPMS;ABCB7;CORO1A;GLIPR2;SLC8B1;EIF2AK1;CCDC88A;INPP5F;IL6R;MYH9;IKBKB;PANK1;LRRFIP1;CHMP4A;CHMP4B;AXIN1;GDNF;DGCR8;ADRA2A;SNX1;STAT1;CAV2;EXD1;SMCHD1;FAP;PRMT8;DARS2;STK4;TSG101;TAP1;GSS;AHR;IMPA1;FLNA;WRN;ATP2A1;IKZF3;S100A10;CPQ;PDE2A;PSAP;MSH3;F11R;FBXO4;PAPSS1;TOX3;PDCD6IP;RPE;MSH6;SPPL2A;SNF8;IDH1;NQO2;HIP1;SMAD4;NLRC4;KYAT1;PIP4K2B;SNX9;NUDT21;RIPK1;TDG;TRIM14;B2M;SCARB2;TPD52;MTPAP
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.5187590921619546,1.1439573828199194,0.3112244897959184,0.6588770297180205,1.0,1/11,3.56%,CHRNA4
prerank,voltage-gated cation channel activity (GO:0022843),-0.2874928544161187,-1.1435397195645502,0.13513513513513514,0.7941343151925359,1.0,16/97,10.45%,CACNA1D;KCNMA1;KCNQ5;CACNB2;CACNA2D3;KCND2;CACNA2D1;KCNQ3;PKD2;CACNA1C;CACHD1;TPCN2;KCNA2;HCN1;CACNG2;HCN2
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.439909424769885,-1.1416635400433506,0.26700251889168763,0.790854854751516,1.0,5/15,28.54%,ALDH9A1;ALDH7A1;ALDH3B1;ALDH1L1;ALDH1A2
prerank,single-stranded RNA binding (GO:0003727),-0.3376434061115276,-1.141408586226516,0.22134387351778656,0.782555448191588,1.0,20/43,21.94%,AGO3;AGO1;ADARB2;JMJD6;CNBP;FXR1;STRBP;PTBP1;DHX9;LACTB2;EIF4H;HNRNPF;ZFR2;SNRPC;TLR7;DDX3X;EXOSC10;DDX11;SRA1;HNRNPU
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.5034939378610404,-1.1413793223630218,0.3051643192488263,0.7737909516380655,1.0,4/10,14.63%,DLG4;GNAS;IGSF11;SQSTM1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.4096665155545818,1.141280180080814,0.2765957446808511,0.6623777477643522,1.0,21/44,21.43%,NSD3;KMT2C;SETD7;SETDB2;DOT1L;SETD5;ASH1L;SETD2;KMT5B;NSD1;EZH2;KMT2E;KMT2A;ASH2L;SETMAR;EHMT1;WDR5;TTLL12;PRDM9;SMYD5;RBBP5
prerank,RNA cap binding (GO:0000339),-0.42856096877210165,-1.1402289009732227,0.27887323943661974,0.7686833787761703,1.0,2/16,1.51%,LARP1;EIF4A1
prerank,guanyl ribonucleotide binding (GO:0032561),0.3463577675415834,1.1386633485712674,0.226215644820296,0.665543600660987,1.0,41/196,16.83%,LRRK2;RND3;RAP1A;RABL3;NOA1;RAPGEF2;RAC2;CDC42;RAB7A;RAB6A;ARF4;RAB39A;GNL1;ARF1;PDE2A;RHOBTB3;RAC1;RALB;RHOA;DIRAS1;ATL3;PIP4K2B;GLUD1;RHEB;GNAI1;TUBD1;ARL8B;GBP5;MMAA;RRAD;RAB29;GBP2;ATL1;GBP3;RHOG;DRG2;SEPHS1;TUBA1B;INSR;RAB35;RAB9B
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.5299544250565924,1.1384866320797729,0.32274247491638797,0.6626037172860981,1.0,4/12,15.37%,PIK3C2A;PIK3R6;PIK3CA;IPMK
prerank,cardiolipin binding (GO:1901612),-0.47876808519150715,-1.1341289420083265,0.3415841584158416,0.7788668398047875,1.0,7/10,46.57%,PLEKHN1;STOML2;UQCC3;GSDME;OPA1;NME4;MME
prerank,GTP binding (GO:0005525),0.34772289983197363,1.133792979551505,0.25,0.6715879650426404,1.0,38/172,16.66%,LRRK2;RND3;RAP1A;RABL3;NOA1;RAC2;CDC42;RAB7A;RAB6A;ARF4;RAB39A;GNL1;ARF1;RHOBTB3;RAC1;RALB;RHOA;DIRAS1;ATL3;PIP4K2B;GLUD1;RHEB;GNAI1;TUBD1;ARL8B;GBP5;MMAA;RRAD;RAB29;GBP2;ATL1;GBP3;RHOG;DRG2;SEPHS1;TUBA1B;INSR;RAB35
prerank,ubiquitin protein ligase binding (GO:0031625),0.33785830611934836,1.1325862278363408,0.228125,0.6714490903941106,1.0,71/254,17.95%,TRAF1;PTPN22;RPL5;NGFR;CD40;HSPA1A;CUL3;CUL5;LAPTM5;PRDX6;NFKBIA;FBXW7;SUMO1;AXIN1;TRAF4;ARIH1;RNF20;SPOP;FAF1;GLMN;UBE2N;TSG101;HLTF;WFS1;NEDD8;ELOB;UBXN7;TRAF3;ATXN3;RALB;WRAP53;UBE2W;TANK;CAMLG;RTN4;FANCL;SUMO2;DAXX;SNX9;PRKAR2A;RIPK1;RNF31;YWHAZ;GPI;NLK;NDUFS2;SLC25A5;UBE2G1;DNM1L;HSPA9;RPL11;TNFRSF1B;UBE2J2;VCP;TRIOBP;USP7;RELA;FBXO7;TCP1;APC;TUBA1B;RB1;CCDC50;AMBRA1;SMAD5;TRAF2;HSPD1;BECN1;SMC6;VCL;HSPA5
prerank,DNA binding (GO:0003677),0.3288337925780523,1.1315911256734725,0.11923847695390781,0.6705367085716717,1.0,127/694,15.79%,CIITA;NFE2;HIVEP2;DNA2;GLI1;SAMHD1;PPARG;MLH1;BCL6;LONP1;POLR3F;STAT3;EHF;FOXJ1;TRIM26;RBBP8;POLL;CRLF3;CDC45;TAF9;MRE11;MYRF;SLPI;FEN1;CRY1;FAM111A;SCX;ZEB2;MBD1;CAMTA2;ATF6;LRRFIP1;RYBP;PARP4;IRF2;RFX3;RBPJ;RPL6;STAT1;NUFIP1;MCM6;RBMS1;IRF4;RFX5;SMARCA5;TSHZ1;TSG101;TRIM16;CDC5L;SMC1B;SETX;AHR;PHF19;CGGBP1;WRN;ARID4A;MBD4;CBFB;CREM;IKZF3;NFE2L2;OASL;MECP2;PURB;MSH3;NABP1;CRY2;CLOCK;RARG;GTF2A1;E2F2;CTCF;NFYC;BRIP1;MSH6;KAT6A;EZH1;SNAPC3;ZNF496;IRF7;CHTF18;SMAD4;RPS3;CSRNP1;MAU2;TDG;PBX1;AIFM1;ING2;SRRT;FOXO3;DEDD2;ETS2;RPA3;NLRP3;XRCC4;BCLAF3;GTF3C6;NFYA;APP;CCNT1;LIN9;TFAM;PQBP1;MSL3;TEAD1;MCM2;ERCC3;ERCC4;CHD4;RNF138;JUNB;CHRAC1;RPL7;SLTM;MAFK;SP4;CENPC;RELA;CREBBP;WBP11;STN1;TAF1;INO80;ENDOV;ZNF148;MCM9
prerank,poly-purine tract binding (GO:0070717),-0.3683641428232328,-1.1295388851376003,0.27245508982035926,0.7844633318860452,1.0,13/27,23.99%,ATXN1;RBMS3;ZC3H14;HNRNPDL;TIA1;PATL1;ELAVL4;KHDRBS2;PPIE;DDX3X;DAZAP1;HNRNPU;MCRS1
prerank,phosphatidylglycerol binding (GO:1901611),-0.44291271368705365,-1.128932252190031,0.3393782383419689,0.7776530404605714,1.0,3/13,14.72%,PITPNC1;PLEKHN1;STOML2
prerank,calcium ion binding (GO:0005509),0.33374010045239677,1.1269697450487517,0.20949432404540763,0.6790503399223581,1.0,45/323,11.61%,ITPR1;IQGAP1;LCP1;PADI1;RET;ACER3;TNNC1;ANXA2;EFCAB9;TPM4;PLSCR1;HPCA;C2CD5;RASGRP2;RAPGEF2;SELL;MCTP2;DYSF;CLGN;ESYT3;PPP3CA;SLC25A13;S100A4;STIM2;ESYT1;PRNP;ANXA4;ATP2A1;NUCB2;CIB1;S100A10;CABYR;CPNE1;PITPNM1;BRAF;FBN1;CAMKK2;ANXA1;SLC25A12;LETM1;TPD52;CALB2;EFCAB11;CDH9;S100A11
prerank,protease binding (GO:0002020),0.360549689631663,1.1268573303646015,0.27744982290436837,0.6759526601767881,1.0,15/99,10.27%,DPP4;LDLR;ANXA2;SELL;CD177;SUMO1;FAP;PTEN;PRNP;SERPINB9;PSAP;CARD16;SPATA2;NLRC4;FN1
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.31336625105673765,-1.1255250333549496,0.2880658436213992,0.7789456767775085,1.0,12/53,12.61%,SLC38A6;SLC1A3;SLC7A6;SLC7A1;SLC36A4;SLC7A7;SLC36A1;SLC17A6;SFXN1;SLC7A2;SLC7A8;SLC3A2
prerank,FMN binding (GO:0010181),-0.4677273393587238,-1.1236473190278802,0.3148614609571788,0.7759509040494366,1.0,2/11,7.04%,PPCDC;DUS2
prerank,pentosyltransferase activity (GO:0016763),0.42705206731428896,1.122629524362739,0.31645569620253167,0.6835731726894431,1.0,7/36,9.47%,ZC3HAV1;PARP8;PARP4;TIPARP;PARP14;TNKS;PARP9
prerank,mechanosensitive ion channel activity (GO:0008381),0.5128953386450901,1.1225330601584944,0.33774834437086093,0.6804374128529713,1.0,6/12,22.11%,TMC8;PIEZO1;TMC6;TMC4;PIEZO2;TMEM63A
prerank,histone methyltransferase binding (GO:1990226),-0.47664640031822403,-1.1204212721280125,0.3173076923076923,0.776961155475527,1.0,5/11,26.09%,CTNNB1;CBX1;PHF1;HSP90AB1;NOP56
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.3247509657010675,1.1194269104166623,0.122,0.6850251646132487,1.0,85/831,9.99%,BCL11A;TRPS1;NFE2;ZBTB46;BACH2;FOXP1;RUNX2;HIVEP2;RARA;SP3;RUNX3;STAT4;GLI1;KDM6A;HNF4G;KLF4;CREB1;PPARG;ETV6;STAT5A;BCL6;NFKB1;PITX3;FOSL2;STAT3;EHF;FOXJ1;ELF4;RFX7;FOS;CIART;REL;ZBTB20;SPI1;STAT5B;SCX;ZEB2;PGBD1;ATF6;LRRFIP1;KLF8;ATF2;IRF2;RFX3;H3-3A;RBPJ;ZNF319;KCNIP3;HIVEP1;DEAF1;STAT1;KLF5;IRF4;BBX;RFX5;KLF13;CDC5L;KLF10;CREBRF;CREM;IKZF3;NFE2L2;PURB;THRA;CLOCK;ZFP3;RARG;GTF2A1;E2F2;CTCF;NFYC;ELF1;ZBTB11;ZNF182;BACH1;NFE2L1;RBAK;E4F1;SNAPC3;PKNOX1;ZNF496;IRF7;MEF2B;SMAD4;RPS3
prerank,phosphatase activity (GO:0016791),0.3773947877108173,1.117588733288927,0.28376703841387857,0.6864033179308778,1.0,16/73,17.34%,PTPN22;DUSP16;PTPRO;ARMT1;OCRL;PXYLP1;DUSP12;PGAM5;HDDC2;ACP5;PPP1CB;PTPRJ;DUSP26;DUSP28;LHPP;PLPPR2
prerank,cysteine-type peptidase activity (GO:0008234),-0.2955562855042051,-1.1163986922211573,0.23423423423423423,0.7807937973495617,1.0,20/73,11.70%,LGMN;USP35;CTSB;CAPN3;USP46;USP2;USP29;USP12;USP28;CTSZ;USP20;CASP4;BLMH;CTSF;OTUD7B;OTULIN;ATG4A;USP16;CASP3;USP21
prerank,tRNA methyltransferase activity (GO:0008175),-0.4242316936134854,-1.1161997748326726,0.2975,0.7732792928079721,1.0,10/16,25.06%,ALKBH8;METTL2A;METTL2B;THUMPD2;TRMT44;TRMT12;LCMT2;TRMT9B;TRMT5;BCDIN3D
prerank,P-type ion transporter activity (GO:0015662),0.5128404809238133,1.1152444707021527,0.3476027397260274,0.6891967667310753,1.0,4/12,7.66%,ATP2B1;ATP2A3;ATP2A1;ATP7A
prerank,peptidase activator activity (GO:0016504),0.4596920181681281,1.1146963014230606,0.33484848484848484,0.6871664425249643,1.0,8/22,18.87%,PSME3;PSME2;PSME4;TANK;NLRC4;VCP;MAL;PINK1
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.3167931563953451,-1.1139245199579244,0.23552123552123552,0.7718572799555047,1.0,10/47,14.55%,SLC38A6;SLC7A6;SLC7A1;SLC36A4;SLC7A7;SLC36A1;SLC7A2;SLC7A8;SLC3A2;SLC22A4
prerank,glycerophospholipid flippase activity (GO:0140333),-0.4655217769478541,-1.1139174344433682,0.33647058823529413,0.7640949228392317,1.0,4/11,7.01%,ATP8A2;ABCB4;ATP8A1;ATP8B1
prerank,nucleosomal DNA binding (GO:0031492),0.45492658774223266,1.11212610961777,0.3468118195956454,0.6903000490956329,1.0,10/21,20.17%,GATAD2B;H3-3A;RBBP4;SMARCE1;MBD2;CHD4;SMARCC2;HDAC1;ACTB;HNRNPC
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.4838784772672653,1.1114286301850915,0.3565640194489465,0.6885718071439779,1.0,5/15,11.50%,SLC25A13;SLC1A5;SLC25A12;SLC1A4;SLC25A18
prerank,endopeptidase activity (GO:0004175),0.3295060656601247,1.1113055931848286,0.27035490605427975,0.6855302021644295,1.0,48/257,16.11%,DPP4;NAPSA;ACE2;ACE;PRSS53;MALT1;MMP1;PSMB7;HP;HPR;PARL;FAP;USP49;ADAM17;C1RL;ADAMTS6;HGF;USP48;CPNE1;RHBDL2;USP15;PIDD1;PSMB8;ADAM19;PSMA5;MBTPS1;CASP2;USP42;PSMB3;USP40;TPP2;THSD4;ADAMTS12;PSMB1;CAPN7;BACE2;CORIN;PCSK5;CASP7;USP37;ADAM9;USP7;CASP6;MIPEP;USP9X;PROC;ADAMTS19;USP47
prerank,beta-tubulin binding (GO:0048487),0.42634678575540746,1.1104297362652864,0.32798833819241985,0.6846163431175929,1.0,9/31,13.72%,UXT;RACGAP1;PEX14;BCAS3;SPAST;HTT;ARL8B;EML4;TBCD
prerank,chloride channel activity (GO:0005254),-0.30727685605569355,-1.1093546562760503,0.23267326732673269,0.7698768778739488,1.0,11/59,9.18%,TTYH3;CLCN6;GABRG3;GABRG2;CLCN4;TTYH2;CLCN7;GABRB1;GLRA3;GLRA2;GABRA4
prerank,palmitoyltransferase activity (GO:0016409),0.4244032049199923,1.1069830824589955,0.3289665211062591,0.689889444888061,1.0,6/28,9.01%,HHAT;ZDHHC7;ZDHHC13;ZDHHC6;ZDHHC23;ZDHHC17
prerank,nucleoside-triphosphatase activity (GO:0017111),0.3293181143910348,1.1060843820038297,0.26919032597266035,0.6891667655932661,1.0,46/248,15.11%,LRRK2;RND3;GNA14;DNA2;RAP1A;RAB19;HSPA1A;RABL3;MYO1E;RAC2;MYH9;ATP2B1;ABCA3;CDC42;RAB7A;RNF213;SMCHD1;ARHGDIB;RAB6A;GNL1;RHOBTB3;RAC1;GNG10;GNB1;RALB;RHOA;DIRAS1;ATL3;GPR88;RHEB;GNAI1;DNM1L;ABCD1;ARL8B;GBP5;MMAA;GNAI2;VCP;RAB29;KIF5A;GBP2;GNA11;ATL1;GBP3;RHOG;DRG2
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.33774153106416055,-1.106041230962213,0.3010033444816054,0.7718030350403174,1.0,7/32,12.61%,SLC38A6;MFSD12;SLC36A4;SLC36A1;SFXN1;SLC7A8;SLC3A2
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.4375432344024919,-1.10474609371899,0.3360655737704918,0.7684164818144774,1.0,7/14,30.05%,BLVRB;QDPR;DHFR;MTHFD1;ALDH1L1;PYCR3;NOXRED1
prerank,clathrin adaptor activity (GO:0035615),0.48402589792932976,1.1043589061235675,0.3457792207792208,0.6901820073011286,1.0,7/15,16.77%,AP2A2;HIP1;AP1G1;AP2B1;STON1;AP2S1;AP1M1
prerank,motor activity (GO:0003774),0.3754634544171219,1.104151747914509,0.3227931488801054,0.6874966650444982,1.0,12/60,10.97%,DNAH2;DNAH8;MYO1E;KIF20A;KIF5B;KIF6;MYH9;KIF23;KIF24;KIFC3;KIF3B;GPR88
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.46219656764046435,-1.1025694595512194,0.3316708229426434,0.7672859299098392,1.0,5/11,26.03%,SLC25A25;LRRC8A;SLC17A9;SLC35B2;SLC25A42
prerank,epidermal growth factor receptor binding (GO:0005154),0.4441728244818584,1.1017178531836007,0.33925925925925926,0.6903646765008746,1.0,6/25,9.43%,PLSCR1;CCDC88A;SNX1;ARF4;GRB2;HIP1
prerank,microtubule binding (GO:0008017),-0.24585209409624129,-1.0986657590516744,0.16666666666666666,0.7713831585333383,1.0,71/222,20.67%,DST;NAV3;KIF13B;CAMSAP1;STARD9;FMN1;GAS2L3;NUMA1;TUBGCP5;IRAG2;MTUS2;MAP2;MAP1B;FGF13;CLIP1;RMDN1;MAST2;CEP57;KIF1B;CLASP2;KIF1A;CKAP5;CCDC66;GOLGA2;CLIP2;DCX;KIF5C;CEP57L1;MAP1A;MTCL1;MTUS1;DNM1;CDK5;EML2;SNPH;MAP1LC3B;MAPRE1;CAMSAP2;CHP1;EML3;TRPV4;HOOK1;CCDC88B;REEP1;MACF1;TPPP;TUBGCP6;CETN3;CCDC181;HAUS4;WHAMM;MAP6D1;CENPE;NEFH;KIF15;RAB11A;TERF1;HDAC6;VAPB;FAM161A;ARL3;KIF3A;MAST1;KIF21B;KIF18A;MAP9;CEP290;NDEL1;TUBGCP2;NEFM;SUN2
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.33697090703488,1.0985826716890565,0.3116178067318133,0.694857158428846,1.0,30/173,15.76%,BCL11A;TRPS1;FOXP1;PPARG;ETV6;BCL6;NFKB1;ZBTB20;ZEB2;LRRFIP1;KLF8;KCNIP3;DEAF1;CREM;CTCF;BACH1;E4F1;NR3C1;FOXO3;IKZF5;ETS2;REST;SREBF2;NFIL3;ZNF436;MAFK;RELA;ZBTB25;BHLHE40;ZNF148
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.37364865020309307,-1.0974708262990782,0.3133514986376022,0.7675280039106603,1.0,4/21,10.38%,GRIA1;CHRFAM7A;CHRNA7;GRM5
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.33225476066822773,-1.0957644959210584,0.30944625407166126,0.764767150452782,1.0,21/35,32.25%,DUS2;QTRT1;DTWD2;PTRH2;GATB;GATC;DUS3L;TARS2;DUS1L;TRMT12;LCMT2;ELAC2;TRMT9B;TRMT5;BCDIN3D;DTWD1;QRSL1;QTRT2;FTSJ1;ALKBH1;AARS2
prerank,chemokine activity (GO:0008009),0.42432544880547163,1.0945542489528608,0.3328690807799443,0.7012062347785514,1.0,3/31,6.27%,CXCL10;CKLF;CXCL16
prerank,cation channel activity (GO:0005261),-0.2721537269036675,-1.0918162747787716,0.2582781456953642,0.7684989560831444,1.0,19/94,15.09%,CACNA1D;SLC24A3;CACNB2;TRPV2;TRPM3;PKD2;UNC80;ANO10;TMEM63B;TRPC1;KCNA2;MCOLN1;CHRNA7;HCN1;TMEM38A;TRPM2;TRPV4;TRPC3;KCNA1
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.33901952548297254,-1.0917606784715215,0.3167259786476868,0.7615085555803185,1.0,11/32,11.89%,PHYHD1;KDM2A;ALKBH5;EGLN3;KDM2B;TYW5;KDM4A;EGLN2;TET1;PHF8;TET3
prerank,nuclear receptor coactivator activity (GO:0030374),0.3767401471747094,1.0899233167972722,0.3413400758533502,0.7095710936458652,1.0,16/52,18.22%,PKN1;NCOA3;MED30;MED13;HELZ2;BUD31;CNOT6;NCOA2;NCOA1;MED12;MED14;TACC1;MED1;ZMIZ2;SS18;NCOA7
prerank,retinoic acid receptor binding (GO:0042974),0.46391927630596336,1.0896095820003544,0.3401709401709402,0.7071578292127728,1.0,6/17,15.77%,PPARG;RARG;TACC1;NRIP1;NSD1;MED1
prerank,voltage-gated chloride channel activity (GO:0005247),-0.46574491556898956,-1.0895916431635226,0.36596736596736595,0.7606588372984728,1.0,5/10,27.95%,CLCN6;CLCN4;CLCN3;CLCN2;CLCN1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.3159609594500634,1.0878382724035902,0.19739478957915832,0.7087019591586453,1.0,85/732,12.19%,BCL11A;NFE2;BACH2;FOXP1;RUNX2;HIVEP2;RARA;SP3;RUNX3;STAT4;GLI1;KDM6A;HNF4G;KLF4;CREB1;PPARG;STAT5A;BCL6;NFKB1;PITX3;FOSL2;STAT3;EHF;FOXJ1;ELF4;RFX7;FOS;CIART;REL;ZBTB20;SPI1;STAT5B;ZEB2;PGBD1;ATF6;LRRFIP1;KLF8;ATF2;IRF2;RFX3;H3-3A;RBPJ;ZNF319;KCNIP3;HIVEP1;STAT1;KLF5;IRF4;RFX5;KLF13;TIPARP;KLF10;AHR;CREM;IKZF3;NFE2L2;THRA;CLOCK;RARG;E2F2;CTCF;NFYC;ELF1;ZBTB11;ZNF182;BACH1;NFE2L1;E4F1;SNAPC3;PKNOX1;ZNF496;IRF7;MEF2B;SMAD4;NR3C1;GMEB2;PBX1;FOXO3;IKZF5;ZNF260;ETS2;REST;ZNF418;ATF6B;NFYA
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.3154206608021255,1.0863221031535373,0.1933867735470942,0.7093173124391221,1.0,85/731,12.19%,BCL11A;NFE2;BACH2;FOXP1;RUNX2;HIVEP2;RARA;SP3;RUNX3;STAT4;GLI1;KDM6A;HNF4G;KLF4;CREB1;PPARG;STAT5A;BCL6;NFKB1;PITX3;FOSL2;STAT3;EHF;FOXJ1;ELF4;RFX7;FOS;CIART;REL;ZBTB20;SPI1;STAT5B;SCX;ZEB2;PGBD1;ATF6;LRRFIP1;KLF8;ATF2;IRF2;RFX3;H3-3A;RBPJ;ZNF319;KCNIP3;HIVEP1;STAT1;KLF5;IRF4;RFX5;KLF13;KLF10;AHR;CREM;IKZF3;NFE2L2;THRA;CLOCK;RARG;E2F2;CTCF;NFYC;ELF1;ZBTB11;ZNF182;BACH1;NFE2L1;E4F1;SNAPC3;PKNOX1;ZNF496;IRF7;MEF2B;SMAD4;NR3C1;GMEB2;PBX1;FOXO3;IKZF5;ZNF260;ETS2;REST;ZNF418;ATF6B;NFYA
prerank,poly-pyrimidine tract binding (GO:0008187),-0.3733553412978396,-1.0848595775919776,0.3128654970760234,0.7668180143585283,1.0,7/23,14.23%,ATXN1;RBMS3;HNRNPH1;PATL1;SSB;PTBP1;DIS3L2
prerank,transaminase activity (GO:0008483),-0.45455579895576526,-1.084258183130722,0.3722627737226277,0.7615763018354632,1.0,2/11,7.26%,GOT1;PSAT1
prerank,protein phosphatase binding (GO:0019903),0.34652421442411696,1.0831878329602371,0.3359908883826879,0.7139665496362293,1.0,27/117,15.45%,IQGAP1;LILRB1;MAP3K5;STAT3;KCNQ1;AKAP11;PPP1R9B;MAPK14;STX17;MTMR3;SHOC2;STRN4;TRAF3;MTMR4;KCNN4;PXN;PPP1R15A;ANKLE2;SNX3;LGALS3;EIF2AK3;MVP;GRIN3A;STRN3;VCP;ANAPC7;TBK1
prerank,phospholipase activity (GO:0004620),0.36624759204773927,1.0829745707766076,0.3496932515337423,0.7113165009783323,1.0,4/67,4.70%,PLBD1;PLD4;PRDX6;SMPDL3A
prerank,DNA secondary structure binding (GO:0000217),-0.3463604817045053,-1.0803710612007797,0.3238993710691824,0.764908147346302,1.0,17/31,27.98%,MEF2C;RAD51B;HMGB1;BLM;MSH2;HMGB2;FANCM;RAD51C;HMGA2;CLSPN;XPC;NEIL3;GEN1;MEN1;RAD51AP1;RAD51D;ABL1
prerank,hydro-lyase activity (GO:0016836),-0.32196236686732393,-1.0800848965206407,0.2901960784313726,0.7591172926310226,1.0,13/41,21.75%,ECHS1;HACD2;ECHDC1;ENO2;TGDS;HADHB;CA2;HADHA;TBXAS1;ECI1;PCBD2;ENO3;NAXD
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.4372676929756088,-1.0799099305497801,0.36455696202531646,0.7528937278405667,1.0,4/13,10.70%,SLC7A6;SLC7A1;SLC7A7;SLC7A2
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.3909605653198939,-1.079687694313814,0.3506849315068493,0.7469157176731993,1.0,6/18,17.12%,TGFBR2;TGFBR1;ACVR1;ACVR2B;BMPR1B;ACVR1B
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.38169249448902853,-1.079182095342782,0.3460410557184751,0.7416631077628749,1.0,6/21,8.73%,PDE3B;PDE1B;PDE8B;PDE1A;PDE1C;PDE4A
prerank,proton transmembrane transporter activity (GO:0015078),-0.3215548764990686,-1.0784471332286825,0.3356401384083045,0.7372811919279492,1.0,9/39,19.87%,ATP6V1B2;SLC11A2;CLCN4;CLCN3;COX10;NNT;UQCR10;UQCRC1;COX5B
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.28015758728384516,-1.0780238084863853,0.29577464788732394,0.7320654302675541,1.0,18/78,11.69%,LGMN;USP35;CTSB;CAPN3;CFLAR;USP46;USP2;USP29;USP12;USP28;CTSZ;USP20;CAPNS1;CASP4;PYCARD;CTSF;USP16;CASP3
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.37035508178812,-1.0763875268493663,0.35798816568047337,0.7305108295666319,1.0,6/23,8.73%,PDE3B;PDE1B;PDE8B;PDE1A;PDE1C;PDE4A
prerank,sulfuric ester hydrolase activity (GO:0008484),0.508309820377306,1.0760538869596956,0.4073455759599332,0.7253726387205609,1.0,3/12,5.51%,SULF2;ARSI;ARSJ
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.4480354611553279,-1.0748028722496403,0.38341968911917096,0.7288035428122663,1.0,3/12,6.22%,TGFBR2;TGFBR1;ACVR1
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.40070457352031685,1.0734414145604496,0.3888888888888889,0.7291818299624289,1.0,11/34,20.93%,XRN2;PNLDC1;CNOT6;ERI1;CNOT2;EXD2;PNPT1;CNOT8;DIS3L;CNOT6L;PARN
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.373099891736264,1.0729061857520423,0.35324675324675325,0.7273282155300395,1.0,6/55,6.98%,ITPR1;ANXA2;CUL5;ATP2B1;ATP2A3;ATP2A1
prerank,voltage-gated sodium channel activity (GO:0005248),-0.37479009671628666,-1.0726610672034367,0.36809815950920244,0.7280287202139364,1.0,6/22,12.06%,SCN1A;PKD2;SCN3A;HCN1;HCN2;SCN1B
prerank,disordered domain specific binding (GO:0097718),0.4323100277761787,1.071060455618134,0.39039039039039036,0.7285096497986636,1.0,5/23,11.66%,FYN;HSPA1A;NCOA3;FN1;DFFB
prerank,phosphatidate phosphatase activity (GO:0008195),-0.4310150686853138,-1.0680074803426487,0.38421052631578945,0.7337940623680484,1.0,7/13,31.24%,PLPP3;PLPP1;PLPPR1;PLPPR4;PLPP4;PLPP5;PLPP2
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.4273686030178147,-1.066793926021618,0.34183673469387754,0.7312947171943622,1.0,5/13,28.54%,ALDH9A1;ALDH7A1;ADH5;ALDH1L1;ALDH1A2
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.41147024649157987,1.0646592260103882,0.36546762589928056,0.7415882230752877,1.0,7/29,13.62%,SLC25A13;SLC25A30;SLC1A5;SLC25A12;SLC1A4;SLC25A18;SLC26A7
prerank,phospholipase C activity (GO:0004629),0.42967956113293865,1.062064130925592,0.38023952095808383,0.7447659967086099,1.0,4/25,7.82%,PLCG2;CCR1;PLCB1;PLCD4
prerank,histone methyltransferase activity (GO:0042054),0.40089307365324056,1.062039137747675,0.3803863298662704,0.7416233108802361,1.0,13/32,20.57%,NSD3;PRMT8;KMT2C;SETD7;DOT1L;SETD2;KMT5B;EZH2;KMT2E;NTMT1;EHMT1;TTLL12;PRDM9
prerank,four-way junction DNA binding (GO:0000400),-0.3992768952198041,-1.0618382283881842,0.38133333333333336,0.7384234727989702,1.0,11/17,27.98%,RAD51B;HMGB1;BLM;MSH2;HMGB2;FANCM;RAD51C;GEN1;MEN1;RAD51D;ABL1
prerank,tubulin binding (GO:0015631),-0.23063299315521,-1.0608275479593277,0.19444444444444445,0.7350427493484579,1.0,87/295,20.67%,DST;NAV3;PRKN;DIP2B;KIF13B;CAMSAP1;STARD9;FMN1;GAS2L3;NUMA1;TUBGCP5;IRAG2;MTUS2;MAP2;MAP1B;FGF13;CLIP1;RMDN1;RAB11FIP5;MAST2;CEP57;IFT74;KIF1B;DIXDC1;CLASP2;KIF1A;CKAP5;CCDC66;GOLGA2;TTLL11;CLIP2;TRAPPC14;DCX;CDK5R1;KIF5C;CEP57L1;MAP1A;MTCL1;MTUS1;DNM1;WASHC1;CDK5;EML2;SNPH;MAP1LC3B;TTLL5;CHP1;GJA1;EML3;TRPV4;HOOK1;NCALD;CCDC88B;REEP1;TPPP;TUBGCP6;CETN3;CCDC181;TPR;WHAMM;MAP6D1;CENPE;NEFH;KIF15;RAB11A;TBCA;TERF1;PDCD5;HDAC6;BRCA1;VAPB;DDX3X;AGBL1;ARL4C;FAM161A;ARL3;KIF3A;MAST1;AGBL4;KIF21B;ATF5;KIF18A;MAP9;NDEL1;TUBGCP2;NEFM;SUN2
prerank,3'-5' exonuclease activity (GO:0008408),0.3786365722678037,1.0603561985548609,0.38865836791147995,0.742426895303094,1.0,15/45,20.93%,MRE11;EXD1;XRN2;PNLDC1;WRN;CNOT6;ERI1;EXD2;PNPT1;POLD1;CNOT8;DIS3L;APEX1;CNOT6L;PARN
prerank,potassium channel activity (GO:0005267),-0.2660965168333191,-1.0578585164483247,0.2981366459627329,0.7367647197905131,1.0,15/89,10.54%,KCNMA1;KCNK13;KCNQ5;KCND2;KCNQ3;PKD2;GRIK4;GRIK1;KCNN2;KCNMB2;KCNA2;KCNK6;HCN1;HCN2;TMEM38A
prerank,protein phosphatase activator activity (GO:0072542),0.47780272143589886,1.0551339310048715,0.4074074074074074,0.7524528393876049,1.0,5/13,18.00%,PPP2R5A;PPP1R15A;PPP2R5C;PPP2R5E;PTPA
prerank,tRNA binding (GO:0000049),-0.30859056533007345,-1.0547562066031972,0.3484848484848485,0.7389569474562918,1.0,19/43,24.60%,ALKBH8;NSUN2;TRNT1;EIF2AK4;PSTK;EEF1A1;DALRD3;ELP5;TYW5;ELP1;PTCD1;SSB;IGHMBP2;KARS1;TRMT10A;NSUN6;TRMT9B;CARS1;NAT10
prerank,water transmembrane transporter activity (GO:0005372),-0.4444793170547988,-1.0546706755236996,0.38717339667458434,0.7334482154796397,1.0,6/11,55.56%,AQP4;PDPN;AQP11;AQP1;SLC5A1;SLC4A11
prerank,rRNA binding (GO:0019843),0.38622000461778655,1.0534484381566718,0.376,0.7535367931250657,1.0,11/42,16.48%,RPL5;MRPL18;RPS14;RPF2;ERI1;RPS3;RPLP0;PTCD3;RPL11;MRPS6;MRPS27
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.3142560086715266,1.0512576007670247,0.3637316561844864,0.7556398263160479,1.0,31/254,10.32%,HNF4G;KLF4;CREB1;NFKB1;FOSL2;PLSCR1;STAT3;EHF;FOXJ1;ELF4;REL;SCX;ATF6;ATF2;IRF2;RBPJ;ZNF319;KLF5;IRF4;RFX5;CDC5L;KLF10;CREBRF;CLOCK;E2F2;NFYC;ELF1;E4F1;MEF2B;SMAD4;NR3C1
prerank,ribonuclease P activity (GO:0004526),-0.45471229528844986,-1.0505882579191386,0.41723356009070295,0.7382990824412962,1.0,8/11,34.09%,POP1;RPP30;RPP14;RPP40;POP4;POP5;RPP21;POP7
prerank,TBP-class protein binding (GO:0017025),0.43169266020822034,1.0504438758337986,0.40120663650075417,0.754406172762804,1.0,4/21,7.99%,TAF13;AHR;THRA;GTF2A1
prerank,ubiquitin binding (GO:0043130),-0.27464731154466737,-1.0503355917960102,0.3241758241758242,0.7334267947977395,1.0,26/73,22.51%,PRKN;BIRC2;MVB12B;BUB3;VPS36;PLAA;NBR1;GGA3;AUP1;UCHL3;NPLOC4;DNAJB2;SMAD3;ASCC2;TOM1L1;USP16;UCHL1;OTUB1;SQSTM1;TRIM32;SPRTN;SHARPIN;USP5;RAD23A;UBE2L6;CKS2
prerank,zinc ion binding (GO:0008270),0.3113474120477361,1.05025864351022,0.39546858908341914,0.7517070495830497,1.0,41/293,11.67%,ACE2;SAMHD1;GDA;ACE;KLF4;ACER3;LNPEP;PPARG;TET2;PLSCR1;KDM7A;MSRB1;UPB1;DHX58;CBLB;SMPDL3B;DPEP1;MBD1;SMPDL3A;PEX12;ARIH1;RC3H1;IFIH1;CRIP1;MYCBP2;PDE2A;ARIH2;CTCF;RBAK;KAT6A;TNKS;NQO2;RASSF1;SLU7;PTPN1;CYLD;RNPEP;TAB3;DUSP12;IKZF5;CAD
prerank,ribonuclease activity (GO:0004540),0.36804516953427174,1.0490211282538482,0.4092071611253197,0.7516894629107774,1.0,14/56,16.15%,ZC3H12D;SAMHD1;ERN1;SND1;CNOT6;RNASE1;KHNYN;RNASE6;INTS11;EXOG;RNASEH2A;RNASEH1;CPSF3;SMG6
prerank,GTPase activity (GO:0003924),0.3181541395459039,1.046915556308734,0.39761646803900325,0.7538948575600647,1.0,34/192,15.11%,LRRK2;RND3;GNA14;RAP1A;RAB19;RABL3;RAC2;CDC42;RAB7A;ARHGDIB;RAB6A;GNL1;RHOBTB3;RAC1;GNG10;GNB1;RALB;RHOA;DIRAS1;ATL3;RHEB;GNAI1;DNM1L;ARL8B;GBP5;MMAA;GNAI2;RAB29;GBP2;GNA11;ATL1;GBP3;RHOG;DRG2
prerank,poly(U) RNA binding (GO:0008266),-0.3718010493453568,-1.0446075684055545,0.4040114613180516,0.7428706557827666,1.0,6/20,14.23%,ATXN1;RBMS3;HNRNPH1;PATL1;SSB;DIS3L2
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.3860418347877609,-1.0444729730270743,0.38873994638069703,0.7375761131690961,1.0,6/17,13.51%,ABCA1;PITPNC1;ABCB4;ATP8B1;MTTP;ABCA7
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.4586876721066429,1.0428016165627136,0.4237012987012987,0.7609987470028179,1.0,3/15,12.61%,PLEKHF1;SESTD1;SNX3
prerank,nucleobase-containing compound kinase activity (GO:0019205),-0.3826765976735985,-1.0427146964809835,0.3901098901098901,0.736627138861832,1.0,9/17,42.16%,AK3;DTYMK;AK1;CMPK2;AK4;NME2;NOL9;AK9;NME4
prerank,MAP kinase activity (GO:0004707),0.4631701003872021,1.04254873130588,0.41545893719806765,0.7584614255808828,1.0,5/14,14.99%,MAPK14;MAPK12;NLK;MAPK8;MAPK1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.44934720657605254,-1.0408984966921213,0.4298440979955457,0.7356502397252672,1.0,1/10,0.11%,SLCO2B1
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.4357295729552985,-1.040892984486939,0.43155452436194897,0.7302176894332009,1.0,5/11,20.27%,PPP1R14C;PPP1R8;PPP1R11;PPP1R14A;PPP1R14B
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.47681685626701714,1.0408540485555937,0.4067796610169492,0.7595585407883588,1.0,4/11,9.52%,SAMD8;SGMS1;SGMS2;PIGF
prerank,insulin-like growth factor binding (GO:0005520),-0.39412933950869733,-1.0400630537649271,0.3903061224489796,0.7268970436402776,1.0,8/15,31.43%,ITGA6;ITGB3;IGFBP5;IGFBP2;IGFBP4;IGF2R;ITGB4;IGFBP3
prerank,calcium-dependent phospholipid binding (GO:0005544),0.36761499424865884,1.0378482686341532,0.43108108108108106,0.7638273214737997,1.0,11/49,12.63%,ANXA2;C2CD5;MCTP2;DYSF;ESYT3;ESYT1;ANXA4;CPNE1;ANXA1;CPNE2;ESYT2
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.35314787888968774,-1.0333212307566944,0.4084084084084084,0.7323828204744365,1.0,11/21,20.98%,CDK8;CDK11B;CDKL3;CDK5;CCNK;CDK10;CDK4;CDKL1;CDK20;CDK9;CDK7
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.35314787888968774,-1.0333212307566944,0.4084084084084084,0.7323828204744365,1.0,11/21,20.98%,CDK8;CDK11B;CDKL3;CDK5;CCNK;CDK10;CDK4;CDKL1;CDK20;CDK9;CDK7
prerank,I-SMAD binding (GO:0070411),-0.413303036700007,-1.0315300983508962,0.4502487562189055,0.7317961934241785,1.0,4/13,10.21%,TGFBR1;CTNNB1;SMAD7;SMAD3
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.4660416538133917,1.0298683249131813,0.44366197183098594,0.7800496632544701,1.0,4/13,13.41%,KCNQ1;EZR;PRKAR2A;CSK
prerank,single-stranded DNA binding (GO:0003697),0.33169445467732495,1.02907545318971,0.43364928909952605,0.7787616955993518,1.0,19/93,15.79%,SAMHD1;MLH1;LONP1;RBBP8;CDC45;FAM111A;MCM6;RBMS1;PURB;MSH3;NABP1;CRY2;RPA3;MCM2;ERCC4;RNF138;WBP11;STN1;MCM9
prerank,calcium:sodium antiporter activity (GO:0005432),-0.4442915095455877,-1.0286228052470565,0.4230769230769231,0.7339492580119698,1.0,2/10,1.02%,SLC8A1;SLC24A3
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.4124778611974681,1.0273940375970139,0.4239290989660266,0.7799572081729771,1.0,2/24,2.91%,ITPKC;IP6K3
prerank,G protein-coupled receptor binding (GO:0001664),0.32174431697074724,1.0263864352873964,0.4047350620067644,0.7793157785860769,1.0,6/132,2.62%,GRK3;GNA14;FPR1;ACE;HSPA1A;CCDC88C
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.47921059793837484,1.0252477032465959,0.4464579901153213,0.7789828374693012,1.0,2/11,3.51%,MARVELD3;STK38
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.3816442736117416,-1.0251610892635334,0.44502617801047123,0.736639770162483,1.0,7/17,28.89%,BLVRB;DPYD;PECR;TECR;PTGR2;DECR2;PTGR1
prerank,endoribonuclease activity (GO:0004521),0.3933480219673976,1.0244547469999332,0.4275766016713092,0.777772711563796,1.0,10/32,17.83%,ZC3H12D;ERN1;SND1;KHNYN;INTS11;EXOG;CPSF3;ENDOV;SMG6;NYNRIN
prerank,metalloexopeptidase activity (GO:0008235),0.3621485223945516,1.0227999078861274,0.4403183023872679,0.7788326962221179,1.0,6/51,7.46%,ACE2;ACE;LNPEP;DPEP1;RNPEPL1;CPQ
prerank,sequence-specific DNA binding (GO:0043565),0.29596845326093857,1.022403452811656,0.43029087261785354,0.7767075169269032,1.0,89/590,17.66%,NFE2;BACH2;FOXP1;RUNX2;RARA;SP3;RUNX3;KLF4;CREB1;PPARG;BCL6;LONP1;PITX3;ELF4;RFX7;FOS;ZBTB20;MYRF;SCX;ZEB2;MBD1;ATF6;ATF2;IRF2;RFX3;RBPJ;HIVEP1;KLF5;IRF4;BBX;RFX5;KLF13;KLF10;AHR;CBFB;CREM;IKZF3;NFE2L2;MECP2;CLOCK;RARG;E2F2;CTCF;ELF1;PKNOX1;IRF7;MEF2B;SMAD4;NR3C1;CSRNP1;UPF2;GMEB2;PBX1;FOXO3;ETS2;NLRP3;MBD2;ATF6B;SMG1;TFAM;TEAD1;JUNB;SREBF2;SLTM;MAFK;SP4;KMT2A;STN1;TAF1;HSF5;BHLHE40;ZNF148;ELF2;FOXN2;SMG6;IRF5;HOXC9;PROX1;BPTF;FOXK1;CREB3L4;CREB3;SMAD5;ELK4;CHCHD2;LRWD1;NR4A1;ERH;NFATC3
prerank,microtubule motor activity (GO:0003777),0.35655803762102306,1.0220934673580786,0.4578804347826087,0.77437905956044,1.0,9/51,10.62%,DNAH2;DNAH8;KIF20A;KIF5B;KIF6;KIF23;KIF24;KIFC3;KIF3B
prerank,insulin-like growth factor I binding (GO:0031994),-0.40003693558991793,-1.0219481968693718,0.4363207547169811,0.7394750879757195,1.0,5/13,20.83%,ITGA6;ITGB3;IGFBP5;IGFBP2;IGFBP4
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.3695055910757488,-1.0203824897144527,0.4361111111111111,0.7328861861957471,1.0,4/17,11.68%,EPHA6;EPHA5;EFNB3;EPHA7
prerank,ephrin receptor activity (GO:0005003),-0.3695055910757488,-1.0203824897144527,0.4361111111111111,0.7328861861957471,1.0,4/17,11.68%,EPHA6;EPHA5;EFNB3;EPHA7
prerank,UDP-galactosyltransferase activity (GO:0035250),0.48922020591530185,1.0202336159212866,0.45195729537366547,0.7757632257565859,1.0,4/10,22.59%,B4GALT5;B3GALT2;B4GALT7;B3GALT5
prerank,exonuclease activity (GO:0004527),0.36352757865602475,1.0155111423417937,0.44754316069057104,0.7839960839249008,1.0,10/46,12.32%,MRE11;FEN1;APEX2;EXD1;XRN2;WRN;CNOT6;ERI1;EXOG;EXD2
prerank,transcription coactivator binding (GO:0001223),-0.3620952655042592,-1.0153319258376208,0.4024024024024024,0.7400606051385917,1.0,13/20,29.17%,VGLL4;THRB;PGR;SMAD3;MED25;ESR1;ZBTB49;AR;CDK9;ZBTB17;CIT;PPARD;RORA
prerank,protein kinase inhibitor activity (GO:0004860),0.3720861546186244,1.014418618048371,0.435933147632312,0.7836723650632906,1.0,11/42,15.21%,IBTK;GMFG;TAOK3;HEXIM1;PRKRIP1;CIB1;MBIP;GSKIP;SH3BP5;DNAJC3;SPRED1
prerank,E-box binding (GO:0070888),0.38039480665042175,1.0102655350270597,0.4415954415954416,0.7907411767304415,1.0,5/34,7.68%,PPARG;CIART;SCX;AHR;CLOCK
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.3773685011506392,1.0097438448015759,0.4492753623188406,0.7889083110467533,1.0,11/33,20.93%,XRN2;PNLDC1;DCP2;CNOT6;ERI1;EXD2;PNPT1;CNOT8;DIS3L;CNOT6L;PARN
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.34637887227408426,-1.0071094204961646,0.4257703081232493,0.7551716358362389,1.0,8/22,17.50%,RBMS3;CPEB2;CPEB1;ELAVL1;EXOSC9;ELAVL4;CPEB3;ELAVL3
prerank,endopeptidase activator activity (GO:0061133),0.49684745480372866,1.0029795779901642,0.5,0.8016493926872239,1.0,3/10,10.15%,PSME3;PSME2;NLRC4
prerank,3'-5' DNA helicase activity (GO:0043138),-0.3733149851720531,-0.9987778384749869,0.46419098143236076,0.7708827708138967,1.0,1/16,0.02%,NAV2
prerank,NF-kappaB binding (GO:0051059),0.40352216813413644,0.9986782706477261,0.4594594594594595,0.808744807384269,1.0,12/24,26.14%,NFKBIA;FAF1;ANXA4;CPNE1;HDAC3;RELA;HDAC1;GSK3B;HIF1AN;PSMA6;SETD6;HDAC2
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.35877176833476876,-0.998159571114497,0.4481792717086835,0.767266987267624,1.0,6/19,10.73%,GAS6;ERCC6;NRG3;DGKQ;GRM5;EFNA5
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.3702199662108988,0.9968103061095557,0.46264367816091956,0.8101186556711171,1.0,13/34,21.37%,NSD3;SETD7;CAMKMT;DOT1L;SETD2;KMT5B;EZH2;EEF1AKMT1;KMT2E;EHMT1;TTLL12;PRDM9;ATPSCKMT
prerank,GABA receptor activity (GO:0016917),-0.3476009518447135,-0.9966449822670918,0.4485981308411215,0.7657740007528178,1.0,8/21,18.53%,GABRG3;GABRG2;GABRB1;GABRA4;GABBR1;GABRB3;GABRA2;GABRA5
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.4201845830685995,-0.9965465576559541,0.49502487562189057,0.7609019556117521,1.0,9/12,36.17%,SDHB;FXN;ISCA2;FDX1;ISCU;CIAPIN1;AOX1;ISCA1;CISD3
prerank,telomerase RNA binding (GO:0070034),0.4022790696326554,0.9964769622466418,0.46543778801843316,0.8078001195070957,1.0,9/22,20.93%,TEP1;SNRPB;DCP2;NHP2;WRAP53;TENT4B;SMG6;HNRNPC;PARN
prerank,solute:sodium symporter activity (GO:0015370),0.39393124605928,0.9924875453145356,0.47858197932053176,0.8142704297920055,1.0,3/27,12.25%,SLC4A7;SLC4A8;SLC28A2
prerank,sulfotransferase activity (GO:0008146),-0.29706280782083644,-0.9916011103431759,0.4470198675496689,0.7676954038175428,1.0,13/33,26.39%,TPST2;CHST11;CHST9;CHST1;HS6ST1;CHST8;CHST3;GAL3ST4;CHST2;HS3ST2;HS3ST1;SULT1A1;HS3ST3A1
prerank,NAD+ binding (GO:0070403),0.4535410021069429,0.9838608361568205,0.4964788732394366,0.83145647390302,1.0,6/12,21.25%,ZC3HAV1;PARP9;GLUD1;SIRT1;HPGD;SIRT3
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.38615464680591693,0.9802777423910218,0.48104956268221577,0.8368087024934715,1.0,4/27,7.53%,SLC9A7;SLC23A1;SLC8B1;SLC4A8
prerank,histone deacetylase binding (GO:0042826),0.3199369460876367,0.9801435479400793,0.5017835909631391,0.8339525325746495,1.0,20/88,16.35%,PKN1;HSPA1A;NIPBL;SPI1;MTA3;CAMTA2;RBBP4;CCND1;IKZF3;PKN2;HDAC9;MEF2B;NUDT21;MAPK8;CHD4;KAT2B;HDAC3;RELA;MIER1;KPNA2
prerank,kinase activator activity (GO:0019209),-0.2999720843365402,-0.9785026378904463,0.49691358024691357,0.7945991247659727,1.0,9/30,13.66%,TREM2;WNK1;RPTOR;FGF13;STRADA;CDK5R1;NCKAP1L;GPRC5B;RPLP1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.32609674033508207,-0.977393328209949,0.4891640866873065,0.7922956419771682,1.0,4/26,10.58%,SLC16A6;ABCG2;SLC27A1;MPC2
prerank,amino acid:sodium symporter activity (GO:0005283),-0.41970503120460345,-0.975964590450582,0.4858490566037736,0.7904175983025085,1.0,2/11,5.53%,SLC1A3;SLC6A15
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.3959923968226794,0.9749937826266646,0.5039619651347068,0.8430834119877748,1.0,6/23,14.24%,SESTD1;GBF1;HIP1;WIPI2;SNX3;MAPKAP1
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.26886417026284015,-0.9742082263891694,0.5164835164835165,0.7895389401581895,1.0,13/51,18.40%,SLCO2B1;ANKH;CLCN4;SLC25A3;SLC35C2;SLC25A11;SLC7A8;SLC25A14;CLCN3;SLC22A4;SLC35E1;SLC35D2;SLC35E3
prerank,O-methyltransferase activity (GO:0008171),-0.41629527525784205,-0.9738562782377339,0.49160671462829736,0.7852876214173931,1.0,5/10,25.55%,COMT;COQ3;FTSJ3;BCDIN3D;ASMT
prerank,cyclic nucleotide binding (GO:0030551),0.4064258288514443,0.9733665001018823,0.5179968701095462,0.8436199990780133,1.0,3/21,7.50%,RAPGEF2;KCNH1;PDE2A
prerank,signaling receptor complex adaptor activity (GO:0030159),0.36412247311045615,0.9730576580716775,0.5111111111111111,0.8411142191140715,1.0,6/38,12.58%,LRRK2;STAP1;AXIN1;SPATA2;DEDD2;RGS14
prerank,GABA-A receptor activity (GO:0004890),-0.3514099464340351,-0.9702386109440347,0.486646884272997,0.7892090068479529,1.0,7/18,18.53%,GABRG3;GABRG2;GABRB1;GABRA4;GABRB3;GABRA2;GABRA5
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.4709951799098444,0.9697913472397672,0.5,0.8453103874244647,1.0,2/10,10.70%,PIK3C2A;PIK3CA
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.39072635545959766,-0.9665483951220106,0.5112781954887218,0.7932163970693604,1.0,4/12,8.73%,PDE3B;PDE1B;PDE8B;PDE4A
prerank,transition metal ion binding (GO:0046914),0.28278209635418183,0.9658822358106183,0.6076845298281092,0.8510391213564601,1.0,55/397,12.32%,ACE2;SAMHD1;GDA;ACE;KLF4;ACER3;LNPEP;PPARG;PIM1;TET2;PLSCR1;KDM7A;MSRB1;UPB1;DHX58;CBLB;ETHE1;FEN1;SMPDL3B;DPEP1;MBD1;SMPDL3A;HEPH;PEX12;ARIH1;RC3H1;IFIH1;PRNP;IMPA1;CRIP1;WRN;MYCBP2;PDE2A;ATP7A;GALNT2;ARIH2;CTCF;RBAK;KAT6A;TNKS;NQO2;RASSF1;SLU7;ARG2;ATOX1;PTPN1;CYLD;MTPAP;RNPEP;TAB3;DUSP12;IKZF5;CAD;RCHY1;EXD2
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.43692622476909626,0.9642881772001995,0.5318791946308725,0.8517708988635148,1.0,2/14,6.11%,CAPN13;CAPN2
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.2743516879468091,-0.9637069375678289,0.51440329218107,0.7947897342704865,1.0,19/49,22.51%,IKBKE;AGAP3;ZRANB1;MINDY2;RNF169;UBQLN4;OPTN;OTUD7A;MINDY1;OTUD7B;SQSTM1;UBL7;UBQLN2;HDAC6;SPRTN;SHARPIN;WDR81;RAD23A;ZFAND2B
prerank,adrenergic receptor binding (GO:0031690),-0.35582730414531033,-0.9628718615460191,0.4540682414698163,0.7916834574257606,1.0,9/16,23.60%,MAGI2;DLG4;SAV1;ADRB1;UCHL1;GNAS;APLP1;AKAP5;C1QBP
prerank,transforming growth factor beta binding (GO:0050431),-0.3296358829825303,-0.9593801887351286,0.4941860465116279,0.7948861887257122,1.0,3/23,6.22%,TGFBR2;TGFBR1;ACVR1
prerank,carboxy-lyase activity (GO:0016831),-0.331158311086155,-0.9587693226385516,0.4915254237288136,0.791511301959475,1.0,9/23,22.57%,PPCDC;ECHDC1;PCK2;UMPS;GGCX;MLYCD;ODC1;GAD1;DDC
prerank,solute:anion antiporter activity (GO:0140323),-0.37231097161690135,-0.9556369995095071,0.5155440414507773,0.7941637052342886,1.0,6/14,30.65%,SLC26A11;SLC26A2;SLC4A2;SLC26A8;SLC26A6;SLC4A3
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.45032628102988814,0.9548583416494238,0.5227655986509275,0.8702104836122977,1.0,1/11,3.91%,HCN4
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.3754476274273946,0.953810275278316,0.5244648318042814,0.8693098772099147,1.0,3/24,5.88%,PLEKHF1;GOLPH3L;SESTD1
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.3256627999375052,-0.952456902510294,0.532258064516129,0.7968319074084161,1.0,3/21,9.42%,P2RX7;P2RX4;CHRNA7
prerank,RNA stem-loop binding (GO:0035613),-0.39311904432070244,-0.9517779976586865,0.5280373831775701,0.7936569866717277,1.0,5/12,21.25%,RC3H2;DHX9;CPEB3;DDX3X;MYH10
prerank,chloride channel regulator activity (GO:0017081),-0.3693633630809137,-0.9502459355033962,0.5103092783505154,0.7925724173580383,1.0,9/14,21.55%,WNK1;SGK1;WNK2;VTI1B;CHRNA7;STX1A;VAMP8;STX8;WNK3
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.3163263618080634,-0.9498306090938821,0.541033434650456,0.7888463804120154,1.0,10/27,27.54%,ANKH;SLC26A11;SLC25A11;SLC25A14;GET3;LRRC8A;SLC26A2;SLC26A8;SLC26A6;SLC25A10
prerank,SUMO binding (GO:0032183),-0.36870600855957225,-0.942657449523967,0.5264483627204031,0.8010637793275163,1.0,7/13,30.19%,HERC2;SIMC1;HABP4;RNF4;UBA2;CBX4;USP25
prerank,protein tyrosine kinase binding (GO:1990782),0.3122360841620856,0.9424243323719927,0.5329192546583851,0.8927635675081971,1.0,12/71,13.28%,NEDD9;ITGAX;CRK;BMPR2;CBLB;CBL;ELMO2;PITPNM1;PTPN1;MAP3K7;CASS4;LRP4
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.4251470112299821,0.9423221213237365,0.5271565495207667,0.8897564981581308,1.0,5/13,16.33%,CCDC88A;ARHGDIB;SH3BP4;RGS14;GPSM2
prerank,hexosyltransferase activity (GO:0016758),-0.23464224707827722,-0.9402697824395709,0.5611510791366906,0.8018568421588625,1.0,20/101,20.16%,HEXB;LARGE1;DPY19L4;B3GALNT1;CHPF2;GYG1;B4GALT4;MGAT4C;PIGB;ALG9;HEXA;MGAT4A;POMT1;PIGV;GCNT1;ALG1;POGLUT2;GBA2;DPY19L3;HYAL1
prerank,adenylate cyclase binding (GO:0008179),-0.4143448556349356,-0.93985939754518,0.5603644646924829,0.7980689579152366,1.0,6/10,34.28%,AKAP12;AKAP6;CALM1;AKAP5;ADCY2;CALM2
prerank,gated channel activity (GO:0022836),0.41667824072860243,0.9370967349134847,0.5332278481012658,0.8980341205408945,1.0,7/14,24.34%,TMC8;PIEZO1;TMC6;TMC4;PIEZO2;TMEM63A;PACC1
prerank,5'-3' RNA polymerase activity (GO:0034062),0.3690801930930081,0.9353251391156971,0.5537790697674418,0.8987602991209168,1.0,4/27,9.02%,POLR3F;POLR3A;POLR2C;TENT2
prerank,ATPase regulator activity (GO:0060590),-0.28775640168199357,-0.9338022768769,0.5543859649122806,0.8068848189966675,1.0,9/38,9.82%,FNIP2;FNIP1;ATP1B3;ATP1B1;PFN1;BAG4;BAG1;DNAJA2;DNAJB2
prerank,alpha-tubulin binding (GO:0043014),0.3523013372782925,0.9310950961711906,0.5520231213872833,0.9050113087056213,1.0,9/31,16.50%,FYN;RACGAP1;SPAST;SETD2;ARL8B;EML4;EFHC2;INO80;TRIM36
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.4286677516111831,0.9296647447372406,0.5447019867549668,0.9049894268211358,1.0,4/12,15.68%,CCDC88A;VEGFC;PGF;ITGA5
prerank,glutamate receptor binding (GO:0035254),-0.3473050255603559,-0.9287821917216154,0.5342465753424658,0.8139389973185204,1.0,7/17,23.38%,DLG4;GNAS;IGSF11;SQSTM1;CAMK2A;AKAP5;HOMER3
prerank,voltage-gated potassium channel activity (GO:0005249),0.3055460175039147,0.9287499131968827,0.580335731414868,0.9038796646653279,1.0,6/80,5.71%,KCNE3;KCNG4;KCNA6;KCNQ1;HCN4;KCNH1
prerank,N-acyltransferase activity (GO:0016410),0.35246132629110527,0.9282768870331638,0.5485232067510548,0.9018040607858795,1.0,4/32,12.28%,CERS6;CERS1;SMARCE1;NMT2
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.36644894974307685,0.9272047630861315,0.5659824046920822,0.9011102491050885,1.0,3/27,4.14%,POLR3F;POLR3A;POLR2C
prerank,protein heterodimerization activity (GO:0046982),-0.21291636402137126,-0.9269813445502184,0.7261904761904762,0.813133159984887,1.0,51/178,21.15%,MEF2C;RALGAPA2;NPAS3;BCL2L1;TENM4;UBA3;IRAK2;TENM2;USF2;ATF3;ATP1B1;RALGAPB;HIF1A;RALGAPA1;ATF4;SAE1;ATP1A2;FXR1;NAE1;QTRT1;PDGFA;ALG2;IRAK1;FXR2;HEXA;MIGA2;MTTP;TLR4;P4HB;ADD2;PRMT5;ADRA1B;BHLHE41;BAX;ADRB1;TENM1;RRAGC;BMP6;PAFAH1B2;SMC1A;ZHX2;RAN;ADCY8;TCF4;VAPB;YWHAH;GCA;TCF3;TCOF1;BCL2L2;PPP2R1A
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.42236841829208166,0.9266754416030081,0.5671140939597316,0.8990590997250009,1.0,5/14,15.47%,MINDY3;ATXN3;USP15;USP7;USP9X
prerank,damaged DNA binding (GO:0003684),0.340527905749242,0.926542570141308,0.5644504748982361,0.8961880634163795,1.0,16/44,22.12%,RBBP8;FEN1;CRY2;RPS3;TDG;RPA3;ERCC3;ERCC4;CREBBP;POLD1;SMC6;FANCG;APEX1;XPA;POLQ;SDE2
prerank,phosphatase binding (GO:0019902),0.3023525263309939,0.9263899898202301,0.6043577981651376,0.8934427498627899,1.0,28/105,18.94%,IQGAP1;MAP3K5;STAT3;CRY1;MAPK14;STX17;MTMR3;SHOC2;TRAF3;CRY2;MTMR4;KCNN4;PXN;SNX3;LGALS3;EIF2AK3;MVP;VCP;MAPK1;ANAPC7;SPRED1;TBK1;ELL;PIK3R2;TRAF2;CTSC;ANAPC4;BAD
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.37907386664913667,-0.9228019261750281,0.5336426914153132,0.8133409831187083,1.0,6/11,22.22%,PFN1;BAG4;BAG1;GRPEL1;HSPH1;BAG5
prerank,adenyl nucleotide binding (GO:0030554),-0.37907386664913667,-0.9228019261750281,0.5336426914153132,0.8133409831187083,1.0,6/11,22.22%,PFN1;BAG4;BAG1;GRPEL1;HSPH1;BAG5
prerank,ankyrin binding (GO:0030506),0.38628857192113625,0.9213928305728334,0.5572998430141287,0.9012043562344216,1.0,1/19,0.30%,PTPRC
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.38414381403216247,-0.9200263198065866,0.5574837310195228,0.8147505492056417,1.0,4/11,11.69%,CFLAR;CASP4;PYCARD;CASP3
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.37524746029754297,0.9166305973376544,0.5703363914373089,0.9082107611582001,1.0,5/21,9.95%,WASF2;KCNQ1;EZR;ARFGEF1;GSKIP
prerank,anion channel activity (GO:0005253),0.3181934788419173,0.9148808800444007,0.5979772439949431,0.9088771330490565,1.0,6/61,5.12%,LRRC8C;GABRB2;LRRC8D;CLIC4;GABRR2;LRRC8B
prerank,general transcription initiation factor binding (GO:0140296),0.3651600963030662,0.9142677276481278,0.586764705882353,0.9070596814994997,1.0,6/25,15.52%,TAF13;AHR;THRA;GTF2A1;RELA;TAF1
prerank,RNA binding (GO:0003723),0.26401697213023295,0.9138274366625145,0.849,0.9048267752560148,1.0,273/1321,16.61%,TENT5A;MBNL1;AHNAK;DNA2;ZC3H12D;ZC3HAV1;SAMHD1;CDK13;RPL5;PTBP3;OAS2;ANXA2;LONP1;MSN;DHX40;FASTKD1;MEX3D;STAT3;VIM;SEPSECS;VIRMA;HSPA1A;TCF20;NOA1;DHX58;IFIT2;RBPMS;EIF4G3;ANKRD17;RCC2;SND1;CTNNA1;CORO1A;NOL6;GTF2E2;RPS10;CRNKL1;EIF2AK2;RBM27;SLPI;FARS2;MYH9;STAU1;XPO5;MBNL3;SUMO1;ZMAT3;LRRFIP1;SNRPD2;RPL37A;PRPF6;DIAPH1;DGCR8;RPL6;S100A4;NUFIP1;RC3H1;FLNB;EXD1;RBMS1;DDX42;IFIH1;RPS18;HEXIM1;XRN2;HELZ2;PRKRIP1;TEP1;UBE2N;SNRPB;DARS2;DBR1;CDC5L;KMT2C;CAST;POLR1G;DEK;HLTF;GRB2;SETX;CLUH;DHX37;LGALS1;PNLDC1;RPS14;FNDC3A;FLNA;RBM34;RPL35A;SRSF10;SAMSN1;BUD13;OASL;PKN2;NUP98;GIGYF2;MECP2;DDX41;PURB;PUM2;FNDC3B;HTATSF1;ARF1;DCP2;TRIM25;RBMS2;FIP1L1;SAP18;IMMT;RPL22L1;YTHDF3;TUT1;DNAJC21;ZBED4;NHP2;EZR;UTP6;RBM10;KHNYN;LSM5;MAGOHB;DDX46;TLR3;MRPL13;RPL13;RPF2;PRPF3;ZFP36L2;ERI1;ASCC3;ACAA2;SEC63;SF3B6;ETF1;SCAF8;DDX49;NSA2;RBM22;RP9;WRAP53;SRSF4;NAA15;DHX34;DHX8;MDH2;RPS3;RTN4;IGF2BP3;RPS21;NOC4L;CELF2;PIN4;SUMO2;PTPN1;ALG13;YTHDC1;FDPS;NUDT21;RBM15;SPEN;DCP1A;YWHAZ;MTPAP;CACTIN;SRRT;FRG1;SCAF4;PRPF38B;SRP72;TUT7;NOL11;MEX3C;EIF4A2;NAP1L1;MAK16;SRP19;DYNC1H1;RPLP0;SLC25A5;ZCCHC7;NMD3;UTP20;RPL34;BAZ2A;SMG1;DDX23;TFAM;PTCD3;AGFG1;SNRPA1;MAP3K20;EIF4ENIF1;SF3A1;RPL19;LRRC59;LGALS3;OTUD4;HSPA9;RPL11;NSRP1;HNRNPLL;IREB2;RPL30;METTL3;RRP36;NOP58;API5;TNRC6B;RNASEH1;KTN1;RBM38;IFIT1;RPL4;NUFIP2;GPATCH4;PNPT1;LARP4B;UTP18;SECISBP2;RPS2;SYNCRIP;TNRC6A;RPL7;VCP;CANX;AQR;TRMT10C;EIF3E;ZCCHC9;SLTM;MRTO4;DDX10;U2SURP;TENT4B;MAZ;ASS1;FAM133B;RPS15A;DRG2;RRP8;CPSF3;WBP11;SLC16A3;TBL3;NCBP1;PHF5A;TCP1;ENDOV;CELF1;PPHLN1;LRRC47;KPNB1;SIDT2;RBM39;RPS4X;PUM1;TFB1M;PTBP2;TPD52L2;PARP12;PABPC1;TUBA1B;NPM3;SMG6;TNPO1;KPNA2;PUS1;NCOA5;MRPS27;PPIB;EIF1AX;EIF1;ACIN1
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.3845693794419245,0.9131019558157932,0.589171974522293,0.9032845357571663,1.0,11/21,24.29%,POLI;POLL;POLD4;CHRAC1;POLB;POLD1;PRIMPOL;POLK;POLQ;POLE2;POLG
prerank,diacylglycerol kinase activity (GO:0004143),0.4198148233681409,0.9103829199115232,0.5506535947712419,0.906167660391136,1.0,1/11,1.05%,DGKG
prerank,anion:anion antiporter activity (GO:0015301),-0.33416458804581584,-0.9083611734580004,0.5828877005347594,0.8363521495447948,1.0,8/17,30.65%,SLC26A11;SLC25A11;SLC26A2;SLC4A2;SLC26A8;SLC26A6;SLC25A4;SLC4A3
prerank,SH2 domain binding (GO:0042169),0.3513990659550713,0.908067619148717,0.5883190883190883,0.9077987945811808,1.0,8/31,11.22%,LILRB1;JAK2;CRK;CCDC88A;DLC1;AFAP1L2;AFAP1;NLK
prerank,DNA polymerase activity (GO:0034061),0.3771351021936775,0.9060743539172946,0.5971786833855799,0.9091118029002035,1.0,11/22,24.29%,POLI;POLL;POLD4;CHRAC1;POLB;POLD1;PRIMPOL;POLK;POLQ;POLE2;POLG
prerank,peptidase inhibitor activity (GO:0030414),-0.29494143700195874,-0.9039831257975076,0.6348122866894198,0.8416342209425921,1.0,4/33,4.25%,TIMP2;RENBP;PROS1;CST3
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.25288172670226416,-0.9029686498297476,0.6613545816733067,0.8391883040828091,1.0,9/48,13.56%,TRPV2;TRPM3;ATP6V1B2;PKD2;UNC80;TRPC1;MCOLN1;TRPM2;TRPV4
prerank,R-SMAD binding (GO:0070412),-0.32462657843191195,-0.9017545319122867,0.6164021164021164,0.8372520867792923,1.0,4/18,11.84%,LDLRAD4;DDX5;SMAD3;TRIM33
prerank,N-acetyltransferase activity (GO:0008080),0.3855078496076888,0.8991412997812502,0.5961538461538461,0.9210968359521753,1.0,4/19,13.93%,ATAT1;SMARCE1;NAT2;KAT2B
prerank,estrogen receptor binding (GO:0030331),-0.2877097968188656,-0.8988660401727153,0.6178343949044586,0.8389829296762226,1.0,8/32,14.45%,CTNNB1;MMS19;DCAF1;NCOA6;PPARGC1B;RERG;ESR1;PRMT2
prerank,fibroblast growth factor binding (GO:0017134),0.37310020283172696,0.8977439219226542,0.5940298507462687,0.9209329225348981,1.0,9/21,20.79%,KL;API5;RPS2;FGFR3;THBS1;GLG1;FGFR1;GPC1;ITGAV
prerank,methylated histone binding (GO:0035064),0.30998692277862616,0.8959382703085184,0.6230769230769231,0.921890848922689,1.0,24/62,21.63%,KDM7A;MBTD1;PHF19;MSH6;ING3;ING2;TAF7;MSL3;ATRX;MORC3;L3MBTL2;CDYL;KMT2E;RRP8;TAF1;BPTF;LRWD1;PHF13;CBX8;WDR5;TTLL12;RBBP5;KDM5A;GLYR1
prerank,nucleoside diphosphate kinase activity (GO:0004550),-0.3507448536708852,-0.8943944219891204,0.5668449197860963,0.8439175384591393,1.0,7/14,42.16%,DTYMK;AK1;CMPK2;AK4;NME2;AK9;NME4
prerank,ATPase binding (GO:0051117),-0.23428216748596914,-0.8918820843833397,0.6619718309859155,0.8448533859721736,1.0,26/71,22.61%,ABCA1;TCIRG1;ATP1B3;PKD2;ATP1B1;ANK2;PGR;TRPC1;SNTA1;RALA;ATP6V0A1;DERL1;NR1H2;ESR1;SRC;PIH1D1;PTPN3;CLPP;SNU13;AR;TOR1AIP2;RDX;PEX26;BRSK2;S100A1;SLC2A13
prerank,NAD-retinol dehydrogenase activity (GO:0004745),-0.35134924820098323,-0.8894307703517587,0.5890052356020943,0.8457422794313217,1.0,2/14,8.71%,AKR1A1;DHRS3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.42988863130044563,0.8838131775981413,0.6092362344582594,0.9440995824281323,1.0,2/10,11.67%,DPEP1;CAD
prerank,cation transmembrane transporter activity (GO:0008324),-0.2504999261285349,-0.8815051893850187,0.6730769230769231,0.8582122700241711,1.0,9/48,12.61%,SLC38A6;MFSD12;SLC7A1;SLC36A4;SLC36A1;SFXN1;SLC7A2;SLC7A8;SLC3A2
prerank,RNA polymerase II complex binding (GO:0000993),0.3401071469644127,0.879930666569441,0.6309523809523809,0.9488290772107324,1.0,7/32,11.15%,NCOA3;WAC;ELOF1;SCAF8;RPRD2;RPRD1B;RECQL5
prerank,poly(A) binding (GO:0008143),-0.3060743204245982,-0.8794343285888846,0.628099173553719,0.8578857440011887,1.0,8/21,18.27%,RBMS3;ZC3H14;HNRNPDL;TIA1;ELAVL4;KHDRBS2;PPIE;DDX3X
prerank,AMP binding (GO:0016208),0.4081383843032117,0.8776938164906887,0.6183574879227053,0.9501921875519576,1.0,4/11,20.02%,PRKAG2;PRKAG1;PYGL;ACSS2
prerank,deubiquitinase activity (GO:0101005),0.28704316762839943,0.8768658334575021,0.6734449760765551,0.9486566804527595,1.0,26/88,18.12%,MINDY3;USP3;EIF3F;OTUD1;USP49;USP45;JOSD1;USP32;ATXN3;USP31;USP48;USP15;TANK;CYLD;USP42;USP40;USP4;OTUD4;USP37;USP7;VCPIP1;USP9X;USP47;EIF3H;USP14;USP38
prerank,endopeptidase inhibitor activity (GO:0004866),0.29014326074327634,0.8757304170089585,0.6621454993834772,0.9478474484306226,1.0,9/82,10.21%,NGF;ANXA2;BIRC6;SLPI;CAST;PRNP;SERPINB9;CARD16;UBE2Z
prerank,cytokine activity (GO:0005125),0.27637692045272805,0.8735148216170976,0.7016759776536313,0.9493740831769582,1.0,8/131,8.68%,IL1B;CXCL10;GDF1;IL33;CKLF;CXCL16;BMP3;IL6
prerank,methylation-dependent protein binding (GO:0140034),0.3043822460381454,0.8697621935441382,0.6550387596899225,0.953739347019746,1.0,21/57,21.63%,KDM7A;MBTD1;PHF19;MSH6;ING3;ING2;MSL3;ATRX;MORC3;L3MBTL2;CDYL;KMT2E;RRP8;BPTF;LRWD1;PHF13;CBX8;WDR5;RBBP5;KDM5A;GLYR1
prerank,death receptor activity (GO:0005035),0.4066012211729217,0.8685903767585464,0.6206293706293706,0.9531618748463997,1.0,3/11,15.22%,NGFR;TNFRSF1B;TNFRSF4
prerank,RNA polymerase core enzyme binding (GO:0043175),0.3351396556382856,0.8682688636437829,0.6503703703703704,0.9506523094645145,1.0,7/33,11.15%,NCOA3;WAC;ELOF1;SCAF8;RPRD2;RPRD1B;RECQL5
prerank,phospholipase binding (GO:0043274),0.3894070374749088,0.8675581253880827,0.6360601001669449,0.9489799224979748,1.0,4/13,7.28%,FYN;SYK;PDPK1;PAFAH1B1
prerank,chemoattractant activity (GO:0042056),0.34452172973968387,0.8673581504865148,0.6436950146627566,0.9462865310994412,1.0,6/26,12.86%,CXCL10;GDNF;VEGFC;HGF;PGF;LGALS3
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.3683727351574029,0.867296838261038,0.6395705521472392,0.943358005933357,1.0,5/20,17.46%,SLC30A4;SLC30A1;SLC39A11;SLC39A13;SLC39A12
prerank,thiol-dependent deubiquitinase (GO:0004843),0.284201524008501,0.8658019876167395,0.6801909307875895,0.9432661768746533,1.0,22/83,16.11%,MINDY3;USP3;OTUD1;USP49;USP45;JOSD1;USP32;ATXN3;USP31;USP48;USP15;TANK;CYLD;USP42;USP40;USP4;OTUD4;USP37;USP7;VCPIP1;USP9X;USP47
prerank,lipid phosphatase activity (GO:0042577),-0.3424185766302341,-0.8653826035966389,0.6392572944297082,0.8831804131989729,1.0,5/14,19.80%,PLPP3;PLPP1;PLPPR1;PLPP7;PLPPR4
prerank,receptor tyrosine kinase binding (GO:0030971),0.2970213580509392,0.8617241467263926,0.6658031088082902,0.9482935606410509,1.0,12/56,17.15%,STAP1;ITGAX;CBLB;CBL;ELMO2;PITPNM1;PTPN1;MAP3K7;LRP4;FRS2;RNF41;PIK3R2
prerank,"DNA binding, bending (GO:0008301)",-0.34544957426395584,-0.8596986706556107,0.6632390745501285,0.8899183930883071,1.0,7/14,33.89%,HMGB1;HMGB2;TERF1;HMGA2;HHEX;LEF1;HMGB3
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.4080263661850475,0.8596467238039159,0.6369982547993019,0.9495185623779854,1.0,3/10,12.87%,ATXN3;CYLD;OTUD4
prerank,O-acyltransferase activity (GO:0008374),-0.27590082149915185,-0.8587040491884346,0.6594202898550725,0.8872031830692452,1.0,5/30,9.85%,LPCAT2;PLA2G15;LPCAT1;PLA2G4A;GPAM
prerank,protein phosphatase 2A binding (GO:0051721),-0.29363084088990654,-0.858232713858478,0.7041095890410959,0.883602300667138,1.0,8/23,22.49%,CTTNBP2NL;ENSA;MFHAS1;DAB2IP;SMG7;ADCY8;IGBP1;BOD1
prerank,metallocarboxypeptidase activity (GO:0004181),0.3363495348750106,0.8571630850971077,0.6598540145985401,0.9512464310303751,1.0,1/26,0.96%,ACE2
prerank,Hsp70 protein binding (GO:0030544),0.3307787688792195,0.8571262624683715,0.664167916041979,0.9483038248073921,1.0,7/31,10.85%,ERN1;RNF207;SPN;DNAJC8;RPS3;HIKESHI;DNAJB12
prerank,protein kinase activator activity (GO:0030295),0.2947048669624664,0.8563709813229382,0.6968503937007874,0.9467350968684975,1.0,7/60,7.55%,IQGAP1;PRKAG2;GPRC5C;ABI1;STK4;PAK2;AFAP1L2
prerank,metalloendopeptidase activity (GO:0004222),-0.22176823091393807,-0.8543744837861204,0.764102564102564,0.8872617081655775,1.0,19/76,21.75%,ADAM33;MMP16;MMP14;AFG3L2;IDE;ADAMTSL1;ADAMTS16;SPG7;ADAMTSL4;MBTPS2;ZMPSTE24;ADAMTS5;NLN;SPRTN;ADAMTS1;NRDC;ADAMTS2;ECE1;MMP19
prerank,endopeptidase regulator activity (GO:0061135),0.3147787986344756,0.854302282084669,0.6639004149377593,0.9478275259396047,1.0,5/40,10.15%,PSME3;SLPI;PSME2;CAST;NLRC4
prerank,pre-mRNA binding (GO:0036002),0.33466531147833695,0.8538903124115228,0.6530324400564175,0.9456117062777235,1.0,5/28,10.27%,RNPC3;ERI1;RBM22;SLU7;CELF2
prerank,potassium:proton antiporter activity (GO:0015386),0.4091402805173674,0.853112233613118,0.6567944250871081,0.944131294155609,1.0,1/10,2.07%,SLC9A7
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.34326730273998735,0.8513158962672067,0.6651917404129793,0.938693811551279,1.0,3/22,9.70%,HTR1D;HTR4;HRH1
prerank,serotonin receptor activity (GO:0099589),0.34326730273998735,0.8513158962672067,0.6651917404129793,0.938693811551279,1.0,3/22,9.70%,HTR1D;HTR4;HRH1
prerank,G protein-coupled amine receptor activity (GO:0008227),0.34326730273998735,0.8513158962672067,0.6651917404129793,0.938693811551279,1.0,3/22,9.70%,HTR1D;HTR4;HRH1
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.38078355952451604,0.8506862053053665,0.663961038961039,0.9369583417053318,1.0,4/13,15.68%,ERN1;PDGFD;PTPRJ;ITGA5
prerank,mRNA 3'-UTR binding (GO:0003730),0.2804024813190491,0.8505038677147895,0.7024390243902439,0.9344185156820844,1.0,20/79,17.95%,RPL5;MEX3D;RNF20;RC3H1;RBMS1;PUM2;RBMS2;TUT1;ZFP36L2;IGF2BP3;CELF2;NUDT21;LARP4B;SECISBP2;CELF1;PUM1;PABPC1;BOLL;YBX3;AUH
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.2280964934546436,-0.8504120630231329,0.7916666666666666,0.8908183732597117,1.0,3/70,2.75%,HEXB;LARGE1;B3GALNT1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.34664402932007465,-0.8500292087842547,0.6624685138539043,0.8869508211649181,1.0,5/12,26.03%,SLC25A25;LRRC8A;SLC17A9;SLC35B2;SLC25A42
prerank,glutathione transferase activity (GO:0004364),-0.2825112405426683,-0.8487529818690176,0.6656151419558359,0.884739517499909,1.0,2/23,5.80%,HPGDS;LTC4S
prerank,kinase inhibitor activity (GO:0019210),0.32081695137085775,0.8476842736846724,0.6772793053545586,0.9367089418592485,1.0,8/33,13.89%,GMFG;TAOK3;HEXIM1;PRKRIP1;MBIP;GSKIP;SH3BP5;DNAJC3
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.4088207230732973,0.8469937492058104,0.6666666666666666,0.935053462319714,1.0,3/10,10.44%,SETDB2;SETD5;ASH1L
prerank,GABA receptor binding (GO:0050811),-0.3522052428297316,-0.8448648420812435,0.6802884615384616,0.8878841917525098,1.0,5/11,22.24%,JAKMIP1;ARFGEF2;LHFPL4;GABARAP;AKAP5
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.409334804428779,0.8438461088072975,0.6627118644067796,0.9379855072178802,1.0,1/10,0.77%,CD47
prerank,ribosomal small subunit binding (GO:0043024),-0.30343858993777584,-0.8432560689631324,0.672972972972973,0.8866517711818129,1.0,6/17,18.27%,LARP1;CPEB2;DHX29;NPM1;EIF4H;DDX3X
prerank,phosphatase inhibitor activity (GO:0019212),0.35413391823726675,0.8430576894030786,0.6621004566210046,0.936491524417419,1.0,7/20,21.18%,LMTK2;PPP1R9B;PPP1R2;LGALS3;STYX;CABIN1;SAG
prerank,phospholipase A2 activity (GO:0004623),-0.27758948143227336,-0.8391093998019892,0.7380952380952381,0.89039037253725,1.0,4/26,10.31%,PLA2G15;PNPLA8;PLA2G4A;ABHD3
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.35877152302863946,-0.8379108462162229,0.6683291770573566,0.888138008071785,1.0,2/10,2.71%,NAA50;NAA40
prerank,myosin binding (GO:0017022),0.2924725731972656,0.835924488782361,0.7094240837696335,0.9467314657116203,1.0,17/55,22.84%,LMTK2;RAB3D;CORO1A;SPATA6;RAB6A;RHOA;ARFGEF1;USH2A;TRIOBP;SHROOM1;RAB10;RAB3B;TRAK1;LLGL2;TRAK2;RAB8A;RAB11B
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.31869482154933726,0.8302527585924635,0.7005813953488372,0.9543998434157275,1.0,7/33,11.15%,NCOA3;WAC;ELOF1;SCAF8;RPRD2;RPRD1B;RECQL5
prerank,omega peptidase activity (GO:0008242),0.27146978020184953,0.8293399111308882,0.7541567695961995,0.9531346894466326,1.0,22/89,16.11%,MINDY3;USP3;OTUD1;USP49;USP45;JOSD1;USP32;ATXN3;USP31;USP48;USP15;TANK;CYLD;USP42;USP40;USP4;OTUD4;USP37;USP7;VCPIP1;USP9X;USP47
prerank,telomeric DNA binding (GO:0042162),-0.26314992764588707,-0.8289543208399259,0.7540983606557377,0.9007476720827774,1.0,10/32,19.43%,CTC1;BLM;UPF1;TERF2IP;XRCC5;TEN1;SMG7;TERF1;ZBTB48;HNRNPA2B1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.37241136107072503,0.827227462832514,0.6869851729818781,0.9540134018015825,1.0,1/14,1.02%,NGF
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.3250886628310504,-0.8270858853118984,0.6925133689839572,0.8996052996638816,1.0,7/14,27.54%,SLC26A11;SLC25A11;SLC25A14;SLC26A2;SLC26A8;SLC26A6;SLC25A10
prerank,ferrous iron binding (GO:0008198),0.3391314663963377,0.8266604277975875,0.6765140324963073,0.9522387471722791,1.0,3/21,4.95%,TET2;HEPH;HAAO
prerank,sodium:proton antiporter activity (GO:0015385),0.38587013397774894,0.82478848313122,0.6845637583892618,0.9527026182478843,1.0,1/11,2.07%,SLC9A7
prerank,phosphatidic acid binding (GO:0070300),0.34731762986089176,0.8233324368368978,0.6860282574568289,0.9525753337775215,1.0,5/19,14.24%,RAPGEF2;SESTD1;PITPNM1;PACSIN2;MAPKAP1
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.3043964608859735,0.8233027972312342,0.723589001447178,0.9497907681509378,1.0,7/33,11.55%,ANKIB1;ARIH1;DCUN1D1;RNF217;ARIH2;RPS3;DCUN1D3
prerank,gamma-tubulin binding (GO:0043015),0.33359905162056347,0.8212426195223236,0.7093023255813954,0.9504592714261557,1.0,2/21,2.20%,PAK1;RACGAP1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.4028589762136351,0.8209218214195442,0.708041958041958,0.9481495138514241,1.0,4/10,20.00%,FEN1;EXD2;POLD1;APEX1
prerank,sequence-specific mRNA binding (GO:1990825),-0.35462936233748477,-0.8193486758782815,0.7032710280373832,0.9090413449008262,1.0,3/10,13.86%,SHFL;SSB;DHX9
prerank,phosphoric diester hydrolase activity (GO:0008081),0.3049149589295901,0.819332309420006,0.7291666666666666,0.9480872804331227,1.0,5/35,5.58%,PLD4;SMPDL3B;SMPDL3A;APEX2;GPCPD1
prerank,miRNA binding (GO:0035198),0.3170751929105606,0.8184896277554344,0.7134502923976608,0.946580325360272,1.0,7/30,15.93%,RC3H1;PUM2;RBM10;TRIM71;TUT7;PNPT1;PUM1
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.32695005694587154,0.8175990707143143,0.675226586102719,0.9452564628073088,1.0,4/24,9.01%,ZDHHC7;ZDHHC6;ZDHHC23;ZDHHC17
prerank,acetyltransferase activity (GO:0016407),0.31143458826343506,0.816086400781105,0.7257142857142858,0.945172929352656,1.0,7/31,15.31%,NAA16;KAT6A;NAA15;SMARCE1;ACAT1;KAT2B;CREBBP
prerank,NADPH binding (GO:0070402),-0.33143491468245767,-0.8156315700037886,0.7100737100737101,0.9110409574134891,1.0,3/13,13.05%,QDPR;DUS2;CBR4
prerank,neurexin family protein binding (GO:0042043),-0.3554321763378623,-0.8151278955822311,0.7318181818181818,0.9075032371815777,1.0,4/10,23.82%,NLGN1;NLGN2;NLGN3;CPE
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.362511279738687,0.81365721163739,0.6893039049235993,0.9465167982886542,1.0,3/14,11.50%,SLC25A13;SLC25A12;SLC25A18
prerank,mRNA binding (GO:0003729),0.2433410947485584,0.8132621761286077,0.8508403361344538,0.9444453496287633,1.0,66/249,20.43%,ZAR1;ZC3H12D;RPL5;PTBP3;RBPMS;EIF4G3;SLPI;XPO5;RNF20;RC3H1;RBMS1;CLUH;RPS14;NUP98;PURB;PUM2;RBMS2;YTHDF3;TUT1;KHNYN;MRPL13;SF3B6;ETF1;SCAF8;SRSF4;RPS3;IGF2BP3;CELF2;YTHDC1;NUDT21;RBM15;DCP1A;EIF4ENIF1;NSRP1;HNRNPLL;IREB2;METTL3;LARP4B;SECISBP2;RPS2;SYNCRIP;RPL7;AQR;MARF1;NCBP1;CELF1;PUM1;PTBP2;PABPC1;BOLL;DDX6;NYNRIN;YBX3;AUH;CSTF3;SHMT1;PUM3;SF3B1;RPS13;UPF3B;N4BP1;PARK7;HNRNPC;LUC7L3;LUC7L;EDC3
prerank,glucuronosyltransferase activity (GO:0015020),0.33738926125902047,0.8114571467365199,0.7181964573268921,0.9448842424296572,1.0,1/19,0.85%,EXT1
prerank,NADP binding (GO:0050661),-0.2493354943312478,-0.8092803627251983,0.8006644518272426,0.9135161084714696,1.0,7/32,17.02%,ME3;QDPR;DPYD;DUS2;CBR4;PGD;NNT
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.31227862722429756,0.8036179483829898,0.7177650429799427,0.9556663800642867,1.0,5/31,11.25%,KCNK7;SLC12A7;TMEM38B;SLC12A6;SLC12A9
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.2977632360801878,0.8030126064505925,0.7302725968436155,0.9539125562203775,1.0,7/38,12.61%,PLEKHF1;DENND1A;SESTD1;SNX20;HIP1;WIPI2;SNX3
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.32556222519677275,-0.8025655020606535,0.7443037974683544,0.9205212603014538,1.0,3/12,10.64%,BLNK;IRS1;PIK3R1
prerank,antiporter activity (GO:0015297),0.33129015300762343,0.801383255101068,0.7138461538461538,0.9539084916158341,1.0,2/20,5.61%,SLC25A16;SLC25A30
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.3018652569335796,-0.8012511983938099,0.7327823691460055,0.9185222094835844,1.0,5/16,14.55%,SLC25A26;SLC22A5;SLC7A8;SLC5A7;SLC22A4
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.2977979221613006,-0.8000290442100019,0.7419354838709677,0.9160792949654353,1.0,6/15,44.91%,PLA2G4A;PLA2G3;PLA2G4C;PLA2G5;PLA2G4F;PLA2G2D
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.37023297142448525,0.7988729988310181,0.7323232323232324,0.9552365116045144,1.0,2/12,10.87%,SLC9A7;LETM1
prerank,ubiquitin-specific protease binding (GO:1990381),-0.29227105877165577,-0.7986316683428232,0.7444444444444445,0.9141153984351794,1.0,2/19,5.44%,PRKN;DERL2
prerank,outward rectifier potassium channel activity (GO:0015271),-0.3351944950296134,-0.7979567726519419,0.7259953161592506,0.9109073947680382,1.0,6/11,29.11%,KCND2;PKD2;KCNT2;KCNK2;KCND1;KCNT1
prerank,acetylation-dependent protein binding (GO:0140033),0.33274522747919055,0.7971670255154789,0.7235772357723578,0.9525827337453255,1.0,8/20,20.87%,PSME4;BAZ2A;KMT2A;TAF1;BRD7;BRD2;BRD4;PHIP
prerank,lysine-acetylated histone binding (GO:0070577),0.33274522747919055,0.7971670255154789,0.7235772357723578,0.9525827337453255,1.0,8/20,20.87%,PSME4;BAZ2A;KMT2A;TAF1;BRD7;BRD2;BRD4;PHIP
prerank,metallopeptidase activity (GO:0008237),0.25501901330257193,0.7959041978807236,0.8113425925925926,0.9520762003118515,1.0,19/113,18.03%,ACE2;ACE;ADAM21;LNPEP;MMP1;DPEP1;ADAM17;ADAMTS6;ADAM11;ADAM19;RNPEP;THSD4;ADAMTS12;ADAM9;MIPEP;ADAMTS19;EIF3H;ANPEP;MMP8
prerank,syntaxin binding (GO:0019905),0.2692430115380592,0.7958560926152457,0.7821158690176322,0.9494355482780824,1.0,7/61,9.97%,LRRK2;DAPK1;CACNA1A;STX6;TMED10;SYP;STX7
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.30084277577374785,0.793583850555777,0.7399425287356322,0.9503365678066936,1.0,9/34,20.91%,IQGAP1;STK4;CCNT2;CCNT1;CDK5R2;STK3;MAP2K1;RICTOR;CAB39L
prerank,cAMP binding (GO:0030552),0.3726233992563211,0.7934261088478287,0.7133105802047781,0.947843244319317,1.0,2/11,7.50%,RAPGEF2;PDE2A
prerank,nuclear localization sequence binding (GO:0008139),0.33932625891369983,0.7916732310980915,0.7374392220421394,0.9480205856213529,1.0,6/18,16.35%,NFKBIA;KPNA4;NUP153;KPNB1;TNPO1;KPNA2
prerank,myosin II binding (GO:0045159),0.3848144826023578,0.7913507801919397,0.7097902097902098,0.945933394978769,1.0,4/10,20.64%,MYL4;TRIOBP;SHROOM1;LLGL2
prerank,channel activity (GO:0015267),0.29635926865808204,0.7911986297522209,0.7656903765690377,0.943528668108093,1.0,2/41,2.87%,SLC14A1;MCUB
prerank,leak channel activity (GO:0022840),-0.2863068846750852,-0.789280070274308,0.7162921348314607,0.9208735396479583,1.0,7/18,28.24%,KCNK13;KCNK6;PANX1;KCNK2;KCNK1;KCNK9;KCNK12
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.25432942009195486,-0.7880663246178559,0.8018018018018018,0.9182519584093437,1.0,13/29,31.02%,GALC;NEU1;GAA;ABHD10;HEXD;GANAB;GLA;GBA2;ACER2;ENGASE;MOGS;OVGP1;PGGHG
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.2913316379422821,0.7878338012152362,0.7650429799426934,0.9462117276898299,1.0,3/38,6.81%,ANXA2;SLPI;SERPINB9
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.26469200796869613,0.7869188989618742,0.8200483091787439,0.9450846767107578,1.0,14/74,16.98%,DGKG;NADK;PIK3C2A;PANK1;PANK4;PAPSS1;PAPSS2;PIK3CA;PGM2L1;NT5C3A;GNE;IPMK;GK;MVK
prerank,RNA polymerase binding (GO:0070063),0.3343939530852404,0.7842964231817074,0.758957654723127,0.9467768870248403,1.0,7/18,16.53%,PKN2;SCAF8;STOM;CCNT2;PHRF1;CCNT1;PPIB
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.33071253425589797,-0.7830588228134461,0.7545871559633027,0.9216780707093842,1.0,2/11,2.71%,NAA50;NAA40
prerank,snRNA binding (GO:0017069),0.27963739937872967,0.7828024089822113,0.7813333333333333,0.9465765605274685,1.0,8/42,12.50%,RNPC3;HEXIM1;TUT1;COIL;RBM22;CCNT2;CCNT1;SNRPA1
prerank,Notch binding (GO:0005112),0.3212025576999114,0.782370138692125,0.7595712098009189,0.9446500335845587,1.0,3/22,12.05%,CUL3;ADAM17;MEGF10
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.33620918498370156,-0.7823561512850886,0.7405660377358491,0.9184153708693414,1.0,4/10,11.54%,KDM2A;KDM2B;KDM4A;PHF8
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.2609759203574349,0.7813609674536787,0.7980416156670747,0.9435785585718427,1.0,12/75,13.17%,ME2;HIBADH;HSD17B7;MDH2;LDHD;DHRS4;BDH1;NSDHL;ABCC4;DHRS9;HSD17B11;RDH5
prerank,myosin V binding (GO:0031489),0.34381022716511045,0.7804304855684695,0.7236842105263158,0.9423915611956457,1.0,2/15,6.08%,RAB3D;RAB6A
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.29986987610487137,0.7801140683342318,0.7570370370370371,0.940324887613035,1.0,6/27,11.55%,ANKIB1;ARIH1;DCUN1D1;RNF217;ARIH2;DCUN1D3
prerank,potassium ion antiporter activity (GO:0022821),-0.3039935322727101,-0.7791265528860735,0.7588075880758808,0.9195580204342203,1.0,3/15,7.18%,SLC24A3;SLC9A9;SLC9A6
prerank,hormone receptor binding (GO:0051427),0.3491028677760433,0.7785684856764749,0.7367549668874173,0.94016034063207,1.0,1/14,2.35%,JAK2
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.31367892183944857,-0.7784077625238103,0.7430025445292621,0.9165086630585706,1.0,1/12,1.07%,LARP1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.36126764616799556,0.7777699291237308,0.7298657718120806,0.9388104534338314,1.0,2/12,7.20%,KDM7A;KDM3B
prerank,potassium ion leak channel activity (GO:0022841),-0.2949698952234358,-0.7759077143498797,0.7551020408163265,0.916291812022335,1.0,6/15,28.24%,KCNK13;KCNK6;KCNK2;KCNK1;KCNK9;KCNK12
prerank,nuclear import signal receptor activity (GO:0061608),0.34187474693172576,0.7759006487869547,0.7468152866242038,0.9390239613216907,1.0,5/15,16.35%,KPNA4;HIKESHI;KPNB1;TNPO1;KPNA2
prerank,chloride transmembrane transporter activity (GO:0015108),-0.2950633861196305,-0.7750429981808119,0.7795698924731183,0.9133427894383581,1.0,6/16,26.58%,CLCN6;CLCN7;SLC26A2;SLC1A1;SLC26A8;SLC26A6
prerank,manganese ion binding (GO:0030145),0.2773010238832705,0.7723567160950311,0.7767379679144385,0.9417793958895022,1.0,12/48,17.17%,PIM1;FEN1;IMPA1;WRN;GALNT2;ARG2;MTPAP;EXD2;XXYLT1;PAPOLA;DYRK2;ABL2
prerank,peptide hormone receptor binding (GO:0051428),0.36507438327788583,0.7707286658230758,0.7540394973070018,0.9418846150735176,1.0,11/11,63.52%,ADCYAP1;GPHA2;UCN2;UCN3;GPHB5;PSMC5;GHRH;VIP;GNRH1;PTHLH;CCK
prerank,iron ion binding (GO:0005506),0.27782808623274874,0.7690662115134923,0.8242343541944075,0.9417028749290435,1.0,5/48,4.95%,TET2;KDM7A;ETHE1;HEPH;HAAO
prerank,gap junction channel activity (GO:0005243),0.3209231877819706,0.7688637776453499,0.7653374233128835,0.9394671483474397,1.0,1/22,2.89%,GJA5
prerank,metalloaminopeptidase activity (GO:0070006),0.3349076369805646,0.7680431954133122,0.7418831168831169,0.9381862089475737,1.0,3/16,11.30%,LNPEP;RNPEPL1;RNPEP
prerank,peptide N-acetyltransferase activity (GO:0034212),0.37505932591496793,0.7680304028839295,0.7639405204460966,0.9357053449228336,1.0,2/10,9.21%,NAA16;NAA15
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.37678885262365047,0.767270743431445,0.7606837606837606,0.9342657500189259,1.0,10/10,62.34%,SLC6A11;SLC6A1;SLC10A4;SLC10A5;SLC10A2;SLC6A13;SLC6A12;SLC10A3;SLC10A6;SLC10A1
prerank,mannose binding (GO:0005537),0.3480899939955058,0.7625530187448252,0.7543859649122807,0.9387080525296907,1.0,2/12,10.29%,LMAN2L;MBL2
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.33419385815651764,0.76127782881344,0.7680921052631579,0.9379989034822576,1.0,4/14,18.94%,ATP2A3;APAF1;MAL;BAD
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.3630137298852357,0.7602886654884844,0.7414721723518851,0.9369502302619422,1.0,5/10,18.67%,RPE;GNE;GALM;GLCE;DSEL
prerank,copper ion binding (GO:0005507),0.2759386253546815,0.7602185316697981,0.8092643051771117,0.9345797848502384,1.0,7/42,14.35%,HEPH;PRNP;ATP7A;ATOX1;SUMF1;COX17;CUTC
prerank,active ion transmembrane transporter activity (GO:0022853),-0.22780942847551086,-0.7585783652074758,0.8633093525179856,0.933528790050952,1.0,1/37,0.11%,SLCO2B1
prerank,signal sequence binding (GO:0005048),0.2859985547998136,0.7580137035391844,0.8053221288515406,0.9353519531641428,1.0,9/35,16.35%,NFKBIA;KPNA4;AP2B1;KDELR1;NUP153;PEX5L;KPNB1;TNPO1;KPNA2
prerank,wide pore channel activity (GO:0022829),0.3107989496902015,0.7555820861196084,0.7779456193353474,0.9361644907082074,1.0,1/23,2.89%,GJA5
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.3554752848042545,0.7518876396153568,0.7517605633802817,0.9390256335106093,1.0,2/10,10.40%,LAPTM5;DAXX
prerank,alkali metal ion binding (GO:0031420),0.3454165736643881,0.749785208625106,0.7694915254237288,0.9394830862781809,1.0,3/13,11.97%,IMPA1;TDG;ACAT1
prerank,leucine zipper domain binding (GO:0043522),0.36421576860492505,0.7485994286538025,0.7746967071057193,0.9386526194433183,1.0,3/10,16.43%,PAWR;MRTFA;DAPK3
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.32840266868483486,0.7464112870995946,0.7551669316375199,0.93913552980109,1.0,7/15,21.43%,KMT2C;KMT2A;ASH2L;SETMAR;WDR5;PRDM9;RBBP5
prerank,fatty acid synthase activity (GO:0004312),0.35156367924673065,0.7454718473255799,0.7739130434782608,0.9379716686040113,1.0,2/10,8.34%,ELOVL5;ELOVL6
prerank,translation initiation factor activity (GO:0003743),-0.2283105946175943,-0.7443259925349038,0.8555133079847909,0.9493172761776081,1.0,11/36,20.57%,EIF4A1;EIF2S2;EIF3M;EIF5;EIF2B5;EIF2B4;EIF3L;EIF4G1;EIF3K;EIF3B;EIF2D
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.3300726760603373,0.7442645638955087,0.7725752508361204,0.9372341534171617,1.0,5/14,23.57%,RSAD1;IREB2;NFU1;ACO1;ETFDH
prerank,Tat protein binding (GO:0030957),-0.3192107362716907,-0.7442426881971058,0.7967667436489607,0.9451611396022234,1.0,3/10,18.19%,SMARCB1;NPM1;TRIM32
prerank,metal ion:proton antiporter activity (GO:0051139),-0.2959727766516578,-0.7438877816296126,0.7944162436548223,0.9413131249997042,1.0,3/13,7.18%,SLC11A1;SLC9A9;SLC9A6
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.3195682602857125,-0.7391571435993254,0.8074398249452954,0.9431955435967025,1.0,3/10,11.69%,CFLAR;CASP4;CASP3
prerank,neuropeptide hormone activity (GO:0005184),-0.2553064236157401,-0.7373866601239445,0.8746518105849582,0.941201684726255,1.0,16/22,57.32%,PENK;CCK;PNOC;GRP;NPFF;NPY;CRH;GAL;NMB;VIP;SPX;CORT;NPPA;GHRH;CALCB;PPY
prerank,triglyceride lipase activity (GO:0004806),-0.2632297676473087,-0.7372630447197838,0.8148148148148148,0.93716103079775,1.0,3/20,17.19%,PLA2G15;DDHD2;LIPH
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.2640035128505112,-0.7369997075035996,0.8352601156069365,0.9333066904794755,1.0,8/20,23.89%,LPCAT2;PLA2G15;LPCAT1;GPAT4;LPGAT1;AGPAT3;AGPAT2;DGAT1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.34653762982499914,0.7348878899699964,0.7920962199312714,0.946773225000831,1.0,2/11,9.99%,APEX2;RPS3
prerank,protein phosphatase inhibitor activity (GO:0004864),0.29330545613733855,0.7338498856456568,0.8208516886930984,0.9456639689666566,1.0,5/26,13.15%,LMTK2;PPP1R9B;PPP1R2;LGALS3;PABIR1
prerank,store-operated calcium channel activity (GO:0015279),0.3552276067816093,0.7337649605524319,0.7606837606837606,0.9433476832341706,1.0,4/10,17.29%,STIM2;ORAI3;ORAI1;TRPC5
prerank,Hsp90 protein binding (GO:0051879),0.27769546146269175,0.7313044024130416,0.8579626972740315,0.9441454431776831,1.0,5/33,10.32%,ERN1;AHR;CSNK2A1;RPS3;NR3C1
prerank,histone acetyltransferase binding (GO:0035035),-0.2566287595174629,-0.7308094019620642,0.8771929824561403,0.9370379036116578,1.0,5/21,13.30%,KANSL1L;ECD;HIF1A;GLI3;PCNA
prerank,ribosome binding (GO:0043022),0.26079669560205854,0.7307300356273432,0.8497970230040596,0.9424421177721476,1.0,13/46,18.84%,NAA16;MAIP1;YTHDF3;ERI1;ETF1;NAA15;SRP72;SRP19;MRPS27;EFL1;NCLN;MTIF3;RPSA
prerank,mRNA 5'-UTR binding (GO:0048027),0.29280161429948454,0.7274704798113621,0.8238897396630934,0.9440635574464138,1.0,6/24,19.25%,RPL5;RPS14;IGF2BP3;SYNCRIP;SHMT1;RPS13
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.2536353805206105,0.7266382210649742,0.8544061302681992,0.9426244410204155,1.0,9/57,13.94%,CYB561A3;NDUFA2;NDUFS5;NDUFA3;NDUFA10;NDUFS2;NDUFS4;NDUFA12;NDUFA9
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.274639823018046,0.7255329326535117,0.8337950138504155,0.9392218916014542,1.0,9/34,16.23%,NDUFA2;NDUFS5;NDUFA3;NDUFA10;NDUFS2;NDUFS4;NDUFA12;NDUFA9;NDUFC2
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.274639823018046,0.7255329326535117,0.8337950138504155,0.9392218916014542,1.0,9/34,16.23%,NDUFA2;NDUFS5;NDUFA3;NDUFA10;NDUFS2;NDUFS4;NDUFA12;NDUFA9;NDUFC2
prerank,snoRNA binding (GO:0030515),0.2715615550209918,0.7239753043401467,0.8443804034582133,0.938847968029151,1.0,6/30,15.51%,NUFIP1;DHX37;NHP2;UTP6;NOP58;TBL3
prerank,glycine binding (GO:0016594),-0.31050476303209906,-0.7239574193269125,0.8422273781902552,0.9412977456666497,1.0,2/11,8.17%,GLRA3;GLRA2
prerank,histone deacetylase activity (GO:0004407),0.3084083941170833,0.7227937930059037,0.8070739549839229,0.9379018338220243,1.0,7/19,21.33%,HDAC9;HDAC3;MIER1;SIRT1;HDAC1;SIRT3;HDAC5
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.2761889362887724,-0.7177787730319639,0.8368421052631579,0.9445208742828769,1.0,7/15,25.83%,LPCAT2;LPCAT1;ABHD4;GPAT4;AGPAT3;AGPAT2;ABHD8
prerank,LRR domain binding (GO:0030275),-0.2836854563979272,-0.7166097879296391,0.8672086720867209,0.9417311816665825,1.0,5/14,22.77%,ROBO1;ATF4;ERC1;POLR2J;PMF1
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.28036581001242816,0.7078211958835092,0.8507246376811595,0.953647440096962,1.0,7/30,17.46%,SLC30A4;ATP7A;SLC30A1;SLC39A11;SLC31A1;SLC39A13;SLC39A12
prerank,pyridoxal phosphate binding (GO:0030170),-0.2523876032603397,-0.7033463680086741,0.8710601719197708,0.9520306420065144,1.0,12/20,44.74%,PYGB;PSAT1;ACCS;OAT;SHMT2;PNPO;PDXK;PYGM;CBS;THNSL2;CTH;GLDC
prerank,methyltransferase activity (GO:0008168),-0.2029443868008496,-0.702219801779935,0.9560439560439561,0.9491642306258682,1.0,16/46,26.18%,COMT;MGMT;NSUN2;COQ3;NSUN3;AS3MT;PRMT5;FTSJ3;SUV39H1;LCMT1;COQ5;NDUFAF7;N6AMT1;BCDIN3D;ASMT;BUD23
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.24312041108879,-0.7009700479232478,0.8640226628895185,0.9464343548106054,1.0,5/18,21.91%,WDR91;PIK3R1;SOCS2;PIK3R3;WDR81
prerank,bHLH transcription factor binding (GO:0043425),-0.24860694243215703,-0.6962389268071935,0.8688046647230321,0.9470150149491259,1.0,6/19,20.28%,LMO2;USF2;SMAD3;BHLHE41;SP1;TCF3
prerank,galactosyltransferase activity (GO:0008378),0.32813570939914816,0.6933747101839258,0.8239316239316239,0.967483125927278,1.0,3/11,20.34%,B4GALT5;B4GALT3;B4GALT7
prerank,mRNA methyltransferase activity (GO:0008174),0.3198944608803969,0.689666079000541,0.8540268456375839,0.9693685309074318,1.0,6/12,24.02%,CMTR1;METTL3;TRMT10C;TRMT61B;PCIF1;CMTR2
prerank,organic anion transmembrane transporter activity (GO:0008514),0.21542936661272918,0.689617817179404,0.9555808656036446,0.9670109634323072,1.0,28/134,18.99%,SLC23A2;SLC23A1;CD36;SLC25A13;SLCO1B1;ABCC1;SLC4A8;SLC15A4;SLC1A5;SLC25A12;SLC1A4;SLC25A18;ABCC4;SLC38A1;SLCO1C1;SLC26A7;SLC66A1;SLC35A1;SLC6A9;SLC35A3;SLCO4C1;SLC52A1;SLCO3A1;SLC25A2;SLC16A7;CTNS;SLC25A1;SLC38A2
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.31399261871072326,0.6863664002465916,0.8464106844741235,0.9680738973202839,1.0,5/12,19.95%,CDK13;CDK12;MAPK1;BRD4;CDK19
prerank,methyl-CpG binding (GO:0008327),-0.24327479838419408,-0.6856865918205892,0.9215686274509803,0.9535872980108708,1.0,6/22,13.24%,CXXC5;ZCWPW1;TET1;TET3;ZBTB21;PRMT5
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.3116432174089294,0.6854620879966219,0.8404074702886248,0.9666249355860986,1.0,2/12,10.70%,ATP2A3;APAF1
prerank,regulatory RNA binding (GO:0061980),0.2506958171644084,0.6792257940688924,0.8758716875871687,0.9706808564529354,1.0,7/38,15.93%,RC3H1;PUM2;RBM10;TRIM71;TUT7;PNPT1;PUM1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.27202679234536814,-0.6779116989476629,0.902676399026764,0.9569357165453419,1.0,8/13,42.68%,PYCARD;SRC;BMP6;BMP5;BMP2;BMP4;CDH5;BMP7
prerank,death domain binding (GO:0070513),0.3140514924015121,0.6750420331099284,0.8449111470113085,0.9724541074834674,1.0,2/11,10.73%,MCL1;RIPK1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.23840500372091133,0.6728103180853218,0.9185282522996058,0.9723473287808078,1.0,10/54,18.12%,ACER3;UPB1;NAAA;HDAC9;SIRT4;HDAC3;FAAH;MIER1;SIRT1;HDAC1
prerank,ubiquitin-dependent protein binding (GO:0140036),0.3253790695304861,0.6714970973122921,0.8686131386861314,0.9714021975706912,1.0,2/10,9.37%,LAPTM5;USP15
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.29311983914351675,0.6708376839398732,0.8596774193548387,0.9696524507717851,1.0,3/16,10.75%,SMUG1;RPS3;TDG
prerank,GDP binding (GO:0019003),0.2309470179483283,0.6681456226284579,0.9208173690932312,0.9697619826494462,1.0,17/63,22.84%,RAP1A;RAB7A;RALB;DIRAS1;RHEB;GNAI1;ARL8B;RAB29;RAB35;RAB9B;RAB2A;RAB10;RAB3B;RAB21;RAB8A;RAP1B;RAB11B
prerank,BMP receptor binding (GO:0070700),-0.2720535707791879,-0.6668579817512602,0.8599033816425121,0.9622010378265602,1.0,8/12,42.68%,PYCARD;SRC;BMP6;BMP5;BMP2;BMP4;CDH5;BMP7
prerank,U6 snRNA binding (GO:0017070),-0.2621357179747444,-0.6658542733454508,0.8989637305699482,0.9589930484328647,1.0,5/14,25.01%,DDX39B;PRPF4;EIF5A;LSM3;LSM2
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.22953845468882172,0.659252673814418,0.9404915912031048,0.9755515449303372,1.0,4/55,6.89%,SLC23A2;SLC23A1;SLC38A10;ABCC1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.24200409616340945,0.6555915940192865,0.9159779614325069,0.9763902336984371,1.0,4/37,6.02%,FARS2;VARS1;VARS2;DARS2
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.2586839275470513,0.6548903571268327,0.9032738095238095,0.9747022736162639,1.0,9/28,20.43%,FEN1;DBR1;RNASEH2A;RNASEH1;ENDOV;PRORP;RPP38;APEX1;EDC3
prerank,phosphate ion binding (GO:0042301),0.30810751849215556,0.652562388435895,0.8504347826086956,0.9743692919910195,1.0,2/10,14.95%,PDE2A;RELA
prerank,Wnt-activated receptor activity (GO:0042813),-0.2590728910089144,-0.6521662764174636,0.9102902374670184,0.9659685326580567,1.0,8/15,37.62%,RYK;ROR1;LRP5;FZD4;FZD6;FZD2;TSPAN12;FZD5
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.28637975107890873,0.6466542526054837,0.8899835796387521,0.9769856316062467,1.0,2/15,13.62%,SLC4A8;SLC26A7
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.2687125354343788,0.6454103049433159,0.8933933933933934,0.9756926615008765,1.0,6/20,17.18%,OTULINL;EIF3F;USP7;USP9X;USP47;EIF3H
prerank,symporter activity (GO:0015293),0.3090635199598294,0.6413257276277412,0.878682842287695,0.9765931113053212,1.0,10/10,69.11%,SLC28A2;SLC28A3;SLC5A8;SLC4A4;SLC5A12;SLC5A5;SLC28A1;MFSD2A;SLC46A2;SLC5A6
prerank,C2H2 zinc finger domain binding (GO:0070742),0.30670893199079075,0.6403983972339692,0.905,0.9749675967127188,1.0,2/11,12.01%,TAF9;MBD2
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.2594865541747087,-0.6394628636119285,0.9132530120481928,0.9709506245016747,1.0,1/12,2.75%,B3GALNT1
prerank,NAD binding (GO:0051287),0.24894177036113554,0.6344100433811668,0.9130434782608695,0.9773824914888904,1.0,7/26,21.25%,ZC3HAV1;PARP9;GLUD1;SIRT1;HPGD;SORD;SIRT3
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.25312174085595873,-0.6333035579048003,0.9081885856079405,0.970993906811666,1.0,2/13,4.62%,LPCAT2;LPCAT1
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.29121492411169464,0.6320445967780103,0.8879456706281834,0.9767389366170612,1.0,3/12,18.17%,NQO2;DHRS4;AIFM2
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.20391015101122908,-0.6299015424359983,0.9616519174041298,0.9692723210906347,1.0,14/26,42.20%,B3GALNT1;CHPF2;GBGT1;CHSY1;B3GALT1;B3GNT7;B4GALNT3;EXTL2;B4GALNT4;B3GNT8;CHPF;B3GNT6;CSGALNACT2;B3GALT4
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.25926255451827956,0.621370140363441,0.9150943396226415,0.9825553159600858,1.0,2/18,9.38%,HSD17B12;FAR1
prerank,dynactin binding (GO:0034452),-0.25202969977289025,-0.619973913431258,0.9191176470588235,0.9715501648039803,1.0,2/12,9.59%,SNX5;SNX6
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.2742437764037049,0.6182949478625933,0.9095477386934674,0.9823816050848935,1.0,2/13,13.71%,IDI1;SREBF2
prerank,semaphorin receptor binding (GO:0030215),-0.20546911085907907,-0.6164768140737406,0.9731343283582089,0.969492318907384,1.0,13/23,35.91%,SEMA3D;SEMA3E;SEMA6D;RIT2;SEMA7A;SEMA5B;SEMA4C;SEMA4G;PLXNB1;SEMA6C;SEMA6B;SEMA3B;SEMA3F
prerank,neuropeptide receptor binding (GO:0071855),0.2709065796082373,0.6093593356911429,0.9398998330550918,0.9859853897731663,1.0,14/14,72.93%,AGRP;NMU;QRFP;UCN2;UCN3;APELA;PPY;GHRH;NPPA;GAL;APLN;SHANK1;NPY;NTS
prerank,ATPase activator activity (GO:0001671),0.2510419387229034,0.6020623418359005,0.9244094488188976,0.988268204325137,1.0,6/20,21.26%,DNAJC1;DNAJC19;TOR1AIP1;ATP1B2;DNAJC10;DNAJB4
prerank,pseudouridine synthase activity (GO:0009982),0.2721725058471848,0.6006204703479573,0.9461279461279462,0.9867614627892048,1.0,4/13,21.55%,PUS3;PUS1;PUS7L;TRUB2
prerank,receptor antagonist activity (GO:0048019),-0.2248566441097436,-0.5992394584060045,0.9344729344729344,0.9748062933079862,1.0,3/17,22.80%,DKK2;DKK3;IL18BP
prerank,acid-thiol ligase activity (GO:0016878),0.2706951122092506,0.5926389352407406,0.9293739967897271,0.9893451643068922,1.0,3/13,20.23%,AASDH;ACSS2;ACSL1
prerank,platelet-derived growth factor binding (GO:0048407),-0.25098734015830815,-0.590721950420693,0.9607843137254902,0.9749388464263506,1.0,1/11,8.47%,PDGFA
prerank,RNA methyltransferase activity (GO:0008173),0.2484008617878198,0.5900682711253354,0.9398373983739837,0.9885057772368195,1.0,5/19,17.98%,TRDMT1;METTL4;METTL3;TYW3;TRMT13
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.2780997759929626,0.5888552589679759,0.9202772963604853,0.986798138303681,1.0,2/11,14.41%,PRMT8;PRMT3
prerank,frizzled binding (GO:0005109),0.22022191752446843,0.5864792298719519,0.9689265536723164,0.9857428470676847,1.0,6/34,18.69%,CCDC88C;DVL3;DVL2;WNT7A;WNT5B;FZD7
prerank,phospholipid transfer activity (GO:0120014),0.23774355440546305,0.5840367694949732,0.9538002980625931,0.9846990242457003,1.0,6/21,19.79%,ABCA3;PITPNB;PITPNM1;PRELID1;PITPNA;PRELID3A
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.25067318022935076,0.5745580617958431,0.935126582278481,0.9872291765991762,1.0,6/15,25.29%,PIK3R6;PIK3R2;PIK3R5;SOCS5;SOCS4;SOCS7
prerank,carboxylic acid binding (GO:0031406),0.21120645162789994,0.5696063321738952,0.9741007194244604,0.9872750310340649,1.0,7/38,15.49%,PSAP;UBR2;GLUD1;CAD;CASTOR2;GRIN3A;SRR
prerank,DNA polymerase binding (GO:0070182),0.23832582223099014,0.566197676705791,0.9595015576323987,0.9865975495445466,1.0,4/18,16.15%,LONP1;FANCI;POLG2;SMG6
prerank,CoA-ligase activity (GO:0016405),0.2486815670517329,0.5610369558955011,0.9589905362776026,0.9865839849003777,1.0,14/14,75.15%,ACSS2;ACSL1;ACSM1;ACSM2B;ACSM2A;AACS;ACSS3;ACSBG2;SLC27A5;ACSM3;ACSF3;SLC27A2;ACSBG1;ACSS1
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.2597886390739094,0.5546931630829286,0.9544658493870403,0.987000633024745,1.0,1/11,6.00%,UBR5
prerank,5'-nucleotidase activity (GO:0008253),-0.21948290020420583,-0.5519819612153442,0.969309462915601,0.9859007174053583,1.0,3/13,20.21%,NT5M;NT5DC3;NT5DC1
prerank,cytochrome-c oxidase activity (GO:0004129),-0.2055628806429334,-0.5421015630533452,0.970108695652174,0.9848090716631581,1.0,15/15,79.47%,COX10;COX5B;COX6A1;CYB5A;COX15;COX6A2;COX8A;COX4I2;COX7A1;NDUFA4L2;COX6B1;COX4I1;NDUFA4;COX7A2L;COX5A
prerank,amino acid binding (GO:0016597),0.2055213614369744,0.5384968714495602,0.9783236994219653,0.9908529936743112,1.0,7/31,18.41%,CAD;CASTOR2;GRIN3A;ASS1;SRR;DDAH1;SHMT1
prerank,neuropeptide receptor activity (GO:0008188),0.1986972826264698,0.5151192433638103,0.986784140969163,0.995748495257364,1.0,2/29,9.12%,TACR1;OPRM1
prerank,hormone activity (GO:0005179),0.17904306534456207,0.5110124227497307,1.0,0.9946364911085641,1.0,1/54,1.99%,METRNL
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.23060719508698127,0.4933443057830363,0.9742268041237113,0.9966052704671314,1.0,1/11,7.42%,DCP2
prerank,nucleotidase activity (GO:0008252),-0.18551132083406233,-0.48989211771751956,0.982051282051282,0.9920768842415504,1.0,3/15,20.21%,NT5M;NT5DC3;NT5DC1
prerank,peptidoglycan binding (GO:0042834),0.23199586438646513,0.4807865229092415,0.9735099337748344,0.9966995027696056,1.0,2/10,12.55%,NLRP3;TLR2
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.21886853006964116,0.4780186082118588,0.9791304347826087,0.9949042220759365,1.0,1/12,10.97%,GPR88
prerank,steroid hydroxylase activity (GO:0008395),0.20571600289942457,0.47699573166937687,0.9777070063694268,0.9928043477607368,1.0,1/16,7.80%,CYP27A1
prerank,lysine N-methyltransferase activity (GO:0016278),0.191053815130666,0.46510237749789385,0.989247311827957,0.9922994797691542,1.0,6/20,23.11%,SETD7;SETD2;EEF1AKMT1;EHMT1;ATPSCKMT;ANTKMT
